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"I want to know how God created this world. I am not interested in this 
or that phenomenon, in the spectrum of this or that element. I want to 
know His thoughts; the rest are details." 
Albert Einstein
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SUMMARY 
Despite tremendous advances in mass spectrometry instrumentation and mass 
spectrometry-based methodologies, global protein profiling of organellar, cellular, 
tissue and body fluid proteomes in different organisms remains a challenging task due 
to the complexity of the samples and the wide dynamic range of protein concentrations. 
In addition, large amounts of produced data make result exploitation difficult. To 
overcome these issues, further advances in sample preparation, mass spectrometry 
instrumentation as well as data processing and data analysis are required.  
The study presented here focuses as first on the improvement of the proteolytic 
digestion of proteins in gel based proteomic approach (Gel-LCMS). To this end 
commonly used bovine trypsin (BT) was modified with oligosaccharides in order to 
overcome its main disadvantageous, such as weak thermostability and fast autolysis at 
basic pH. Glycosylated trypsin derivates maintained their cleavage specifity and showed 
better thermostability, autolysis resistance and less autolytic background than 
unmodified BT. Trypsins conjugated with maltotriose (MAT-BT), raffinose (RAF-BT) 
and RAF-BT with additionally modified by biacetyl arginine residues (RAFR-BT) were 
considered as perspective candidates for gel-based proteomics applications [1]. In line 
with the “accelerated digestion protocol” (ADP) previously established in our 
laboratory [2] modified enzymes were tested in in-gel digestion of proteins. Kinetics of 
in-gel digestion was studied by MALDI TOF mass spectrometry using 18O-labeled 
peptides as internal standards as well as by label-free quantification approach, which 
utilizes intensities of peptide ions detected by nanoLC-MS/MS. In the performed kinetic 
study I characterized the effect of temperature, enzyme concentration and digestion time 
on the yield of digestion products. The obtained results showed that in-gel digestion of 
proteins by glycosylated trypsin conjugates was less efficient compared to the 
conventional digestion (CD) and achieved maximal 50 to 70% of CD yield, suggesting 
that the attached sugar molecules limit free diffusion of the modified trypsins into the 
polyacrylamide gel pores. Nevertheless, these thermostable and autolysis resistant 
enzymes can be regarded as promising candidates for gel-free shotgun approach.  
To address the reliability issue of proteomic data I further focused on protein 
identifications with borderline statistical confidence produced by database searching. 
These hits are typically produced by matching a few marginal quality MS/MS spectra to 
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database peptide sequences and represent a significant bottleneck in proteomics. A 
method was developed for rapid validation of borderline hits, which takes advantage of 
the independent interpretation of the acquired tandem mass spectra by de novo 
sequencing software PepNovo followed by mass-spectrometry driven BLAST (MS 
BLAST) sequence similarity searching that utilize all partially accurate, degenerate and 
redundant proposed peptide sequences [3]. This validation approach was applied in two 
collaboration projects, which aimed to study centrosomal effectors of C.elegans mitotic 
spindle assembly. In the first study, which aimed to determine interaction partners of the 
protein TPXL-1 [4], about 300 proteins were identified by nanoLC -MS/MS analysis 
and database searching, more than 50% of them were of borderline statistical 
confidence. PepNovo/MS BLAST enabled rapid assignment (confirmation or rejection) 
of more than 70% of these hits. In the second study, PepNovo/MS BLAST was applied 
for validation of ambiguous hits obtained by identification of proteins associated with 
the novel protein RSA-1 (RSA complex) [5]. 
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1 INTRODUCTION 
1.1 From genomics to proteomics 
The study of an organism’s genome is fundamental for understanding its biology 
[6]  Advances in this field, such as improvements in DNA sequencing, bioinformatics 
and application of microarray technology to characterize gene expression profiles 
demonstrated the power of high throughput and enabled understanding how genes are 
organized and regulated [7-9]. Complete genomic sequences for different organisms 
were provided [10-12], including entire human genome [13-15]. Although the number 
of genes is relatively small and ranges from a few hundred for bacteria to tens of 
thousands for mammalian species, prediction of possible expressed proteins is a 
complex task, since the same gene can produce multiple protein products by alternative 
splicing of pre-mRNA transcripts or different post-translational modifications (PTM) of 
expressed proteins. Thus, the number of proteins in a species proteome exceeds by far 
the number of genes in the corresponding genome. Genomic approaches also cannot 
predict where proteins are localized in a cell and in what quantity and molecular form 
they are present [16].  
Proteins are involved in all biological processes and considered as most important 
biological molecules. They are characterized by their amino acid sequence, relative 
expression (measured in copies per cell), specific activity, state of modification and 
association with other proteins or different biological molecules Figure (1.2). The 
systematic analysis of protein complement expressed by a genome has been named 
proteomics [17]. Proteome reflects the cellular state in dependence of the physiological 
conditions and is highly dynamic: expressed proteins differ in their abundance, state of 
modification and subcellular location [18]. Therefore the crucial goal of proteomics 
research is directed toward the systematic study of diverse cellular states and molecular 
mechanisms which control them, so providing to understanding of fundamental 
biological processes[19]. In other words proteomics aims to explain the information 
contained in a genome in terms of the structure and biological function [20].  
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Figure 1.1 Representation of a eukaryotic cell. 
A section through eukaryotic cell highlights diverse properties of proteins: the subcellular 
distribution, quantity, modification and interaction state, catalytic activity and structure (adapted 
from [17]).  
 
1.2 Mass spectrometry based proteomics  
1.2.1 Ionization techniques 
For long time mass spectrometry was mostly applied for the analysis of small and 
thermostable compounds because of lack of effective techniques to and transfer the 
ionized molecules from the condensed phase into the gas phase without excessive 
fragmentation and then softly ionize to yield the intact molecular ion [21].  
The development of two major soft ionization techniques electrospray ionisation 
(ESI) [22] and matrix-assisted laser desorption/ionisation (MALDI) [23] enabled 
application of mass spectrometry for generating ions from large, nonvolative analytes 
such as proteins and peptides. Those techniques are complementary and differ in way 
how molecules are converted into ions:  
1) In ESI, charged droplets are produced by passing a solubilised sample through 
a high voltage needle at atmospheric pressure, followed by their desolvation (till analyte 
is a  solvent-free molecular beam ) prior to entrance into the high vacuum of the mass 
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spectrometer; this ionization technique allows on-line coupling to chromatography or 
electrophoresis.  
2) In MALDI samples are cocrystallized on a sample plate with a small organic 
matrix compound that usually has an aromatic ring structure, which absorbs at the 
wavelength of the laser; the analyte is then ablated and ionized out of dry, crystalline 
matrix via laser pulses.  
MALDI and ESI differ in charge of produced ions; MALDI ionization results 
predominantly in single charged ions, in ESI MS tryptic peptides are typically ionized 
as doubly or triply charged ions. Multiply charged ions can be efficiently fragmented at 
lower collision energy in contrast to single charged ions, which require higher collision 
energy. It is also known that differences in ionization efficiencies exist between these 
two ionization methods. For instance, positive ion ESI preferentially ionizes 
hydrophobic peptides [24] while MALDI has been reported to preferentially ionize 
basic [25] and aromatic residues [26]. In general, MALDI is more tolerant to salts and 
buffer components [18] while the determination of low-mass peptides might be better 
done by ESI than MALDI because of chemical noise associated with MALDI matrix 
peaks [27]. Both ionization techniques provide to some extent complementary 
information, allowing their use in combination to maximize protein sequence coverage 
[26, 28, 29]. 
 
1.2.2 MS instrumentation 
On the basis of ESI and MALDI ionization techniques different mass 
spectrometers were developed to address various proteomics questions. Generally, mass 
spectrometers measure the mass-to-charge ratio of analytes; for protein studies this can 
include intact proteins and protein complexes, fragment ions produced by gas-phase 
activation of protein ions (top-down sequencing), peptide produced by enzymatic or 
chemical digestion of proteins (mass mapping), and fragment ions produced by gas-
phase activation of mass-selected peptide ions (tandem mass spectrometry) [30]. Mass 
spectrometers consist of three basic components: an ion source, a mass analyser and an 
ion detector. The mass analyser is central to the technology. In the context of 
proteomics, its key parameters are resolution, sensitivity, mass accuracy and the ability 
to generate information-rich ion mass spectra from peptide fragments [31]. There are 
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several basic types of mass analysers: quadrupole, time-of-flight, ion trap, Fourier 
transform (FT) and Orbitrap.  
Quadrupole mass analyzer developed by Wolfgang Paul consists of 4 circular 
rods, set parallel to each other. It works as a filter, which selectively isolates sample 
ions based on the stability of their trajectories in the oscillating electric fields that are 
applied to the rods (each opposing rod pair is connected together electrically and fixed 
DC (direct current) and alternating RF (radio frequency) potentials applied between one 
pair of rods, and the other). This allows selection of an ion with particular m/z, or 
scanning a range of m/z-values by continuously varying the voltages. 
The triple quadrupole spectrometer is one of the most popular instruments based on 
quadrupole mass analyzer [32]. In this device, the first Q1 and the third Q3 quadrupole 
are mass filters, in which Q1 serves to select the precursor ion and Q3 scans the masses 
of fragment ions. The fragment ions are produced in the collision cell under collision-
induced dissociation (CID) enclosed in a quadrupole ion guide q2.  
A complete mass spectrum can be obtained from a quadrupole mass filter only by 
scanning. This considerably reduces the sensitivity of the acquisition, since different 
ions in the spectrum are examined one at time, discarding all others. Serious drawback 
of the quadrupole mass analyzer is also its low mass resolution. 
In Time-of-flight (TOF) analyzer the mass-to-charge ratio of an analyte ion is 
computed from its flight time through a vacuum tube of the fixed length; the flight time 
is proportional to the square root of the m/z [33]. It is a non-scanning analyzer and is 
widely used in mass spectrometry because of its speed, high sensitivity and wide 
detectable mass range. Commercial TOF instruments can typically achieve resolution 
up to 40,000 (full width at half maximum, FWHM) [34]. Thus, by proper mass 
calibration mass accuracy in the low-parts per million (ppm) range is achievable. 
MALDI-TOF, Q(q)TOF and TOF-TOF are instruments based on TOF mass analyzer. 
MALDI-TOF instruments operate with MALDI source and are used in analysis of 
intact peptides. This approach is defined as peptide mass fingerprinting (PMF) and has 
been proved to be powerful proteomic tool because of its characteristics of speed, 
robustness, sensitivity and automation [35-37]. MALDI-TOF mass spectrometers 
equipped with reflectrons are able to analyze fragment ions produced from precursor 
ions that spontaneously decompose in flight. Such ions are generally referred to as 
metastable ions, and the process of decomposition in the field free region between the 
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ion source and the reflectron is commonly referred to as post source decay (PSD) [38, 
39]. The analysis of such PSD ions is an established technique that is capable of 
providing complementary MS/MS information. However, acquisition of PSD is rather 
slow and less sensitive than peptide mass fingerprinting. Moreover, the spectra show 
low resolution and mass accuracy. Several developments such as LIFT method [40] or 
new “parallel PSD” technique [41] considerably reduce the analysis time of MALDI 
PSD spectra. 
Vestal et al. [42] developed a tandem TOF mass spectrometer (MALDI-
TOF/TOF) to use the high-speed capabilities of the TOF mass analyzer to create a high-
throughput tandem mass spectrometer. The first TOF mass analyzer is used in the ion 
selection process, and the selected ions are then transferred into a collision cell. 
Analysis of products is performed in a second TOF mass analyzer. MALDI-TOF/TOF 
instruments allow high sensitive peptide analysis and comprehensive fragmentation 
information, using high energy collision-induced dissociation (CID) instead of relying 
on post source decay [43].  
The Q(q)TOF mass spectrometers (referred as hybrid instruments) combine the 
ion selection and tandem MS capabilities of a triple quadrupole with the resolution of  
TOF spectrometers [44]. The quadrupole operate as ion guides in MS mode to transmit 
the ions to the TOF analyzer. In the MS/MS mode, the precursor ions are selected in the 
first quadrupole and undergo fragmentation through collision-induced dissociation in 
the second quadrupole (RF-only) and the product ions are subsequently analyzed in the 
TOF analyzer. Obtained spectra show good mass accuracy and high resolution, which 
allows the determination of the charge state and unambiguous assignment of the mono-
isotopic masses. Q(q)TOF mass analyzers take advantage of implementation of both 
ionization techniques ESI and MALDI (using rapidly switchable ESI/MALDI ion 
source) [45, 46], which produce different data sets and complement each other [29].  
Ion trap (IT) analyzer focus ions into a small volume with an oscillating electric 
field; ions are resonantly activated and ejected by electronic manipulations of this field. 
Ion traps are very sensitive, because they concentrate ions in the trapping field for 
varying lengths of time [47]. IT instruments allow fast data acquisition, because they 
can rapidly shift between MS and MS/MS modes during data collection and enable in 
conjunction with data-dependent experiment high-throughput analyses. However, IT 
analyzers have limited resolution, low ion-trapping capacity, and space-charge effects 
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that negatively impact mass measurements accuracy [48]. The development of linear 
ion trap analyzer with higher ion-trapping capacities has expanded the dynamic range 
and the overall sensitivity of this technique [47, 49, 50]. Typically, LIT instruments 
have multiple-stage sequential MS/MS capabilities, often referred as MSn in which 
fragment ions are iteratively isolated and further fragmented, a strategy that has proven 
to be very useful for the analysis of posttranslational modifications (PTM) such as 
phosphorylation [51]. 
Linear ion traps [52] can be combined with two quadrupoles (Q-Q-LIT) to create 
a configuration similar to a triple quadrupole. When quadrupoles are combined with an 
ion trap, ions can be isolated and fragmented outside the ion trap and then accumulated 
in the trap for analysis of the fragment ions [53]. Additionally, ions can be simply 
passed through the mass filters and accumulated in the linear ion trap for analysis. Q-Q-
LIT instruments offer increased sensitivity and some additional features derived from 
quadrupole technology such as 1) precursor ion scanning, which is typically used to 
detect subsets of peptides in a sample that contain a specific functional group, for 
instance a phosphate ester or a carbohydrate modification, 2) neutral loss scanning, 
which is used to detect those peptides in a sample that contain a specific functional 
group (for instance for detection of peptides phosphorylated at serine or threonine 
residues via a loss of phosphoric acid), and 3) multiple reactions monitoring (MRM), 
which is used for the detection of a specific analyte with known fragmentation 
properties [53, 54].  
A mass spectrometer with excellent resolving power and mass accuracy is the 
Fourier transform–ion cyclotron resonance (FT-ICR) [55, 56]. Mass measurement 
accuracies of 1-2 ppm and resolution in excess of 105 can be achieved by this 
instrument[57]. FT-ICR MS use high magnetic fields to trap the ions and cyclotron 
resonance to detect and excite the ions. An external LIT combined with FT-ICR allows 
isolation and fragmentation of ions outside FTMS device and so combines rapid 
acquisition of low-resolution MS/MS spectra with accurate measurement of precursor 
masses [58]. FTMS is applied in shotgun proteomics and the analysis of fragments of 
intact proteins, termed top-down proteomics [59]. A limitation of the hybrid ion trap FT 
system is the relatively slow acquisition rate (several s per cycle) and the limited 
dynamic range of IT devices. Another limitation of FT and hybrid FT systems is 
significant maintenance cost of high magnetic field detector. 
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A relatively new mass analyzer called orbitrap [60, 61] is an ion trap, which is 
based on a new physical principle - the ions are separated by their oscillating in an 
electrostatic field [62]. This instrument offers also excellent resolution and mass 
accuracy [63] similar to an FT-ICR mass spectrometer but without an expensive 
superconducting magnet. On the basis of this analyzer a new hybrid mass spectrometer 
was developed which combines a linear ion trap mass spectrometer and an orbitrap 
mass analyzer; C-shaped storage trap is used to store and collisionally cool ions before 
injection into the orbitrap [64]. As in hybrid FT-ICR mass spectrometers this instrument 
combines two mass analyzers: the fast and sensitive LIT and the orbitrap with high 
resolving power and mass accuracy [63, 65]. This allows experiments in which both 
mass analyzers work in parallel in acquiring high resolution/mass accuracy spectra of 
precursor ions and their fragmentation in fast linear ion trap [64, 66, 67]. Further, high 
mass accuracy and resolving power of this instrument allows its application in the 
analysis of PTM [68] and in the top-down approach, which analyzes intact proteins 
[69]. 
Despite variety of mass spectrometers no one instrument has all the features 
which allow ideal proteomics analysis [21]. Choice of the mass spectrometric method 
always depends on the analytical problem to be solved and the experimental setup.  
 
1.3 Proteomics strategies: top-down versus bottom-up 
Profiling of proteins represents a complex analytical task, because of high 
complexity and dynamic range of proteome. Protein abundances in a proteome ranges 
from five to six orders of magnitude for yeast cells and more than ten orders of 
magnitude for human blood serum [70]; this dynamic range exceeds the dynamic range 
of any analytical method or instrument [71]. To overcome this problem several 
separation methods were developed, which are based on physical or chemical properties 
of peptides/proteins, such as solubility, localization, charge, size, hydrophobicity and 
affinity to certain matrices [72-81]. There are, for instance, fractionation methods 
(differential extraction, centrifugation), chromatography (affinity, ion exchange, 
hydrophobic, gel filtration) and electrophoresis (1D, 2D, capillary electrophoresis) [82, 
83].  
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There are two mass spectrometry based strategies to profile proteins: top-down 
proteomics, which involves direct protein fragmentation in the gas phase and bottom-up 
proteomics, which relies on peptide analysis of proteolyzed proteins [84]. Application 
of top-down or bottom-up approaches in proteomics analysis depends on the question to 
be answered. Given the complementary nature of the information provided by top-down 
and bottom-up strategies, both will continue to be employed in proteomics. 
 
1.3.1 Top-down proteomics 
In top-down approach intact proteins are ionized by ESI and subsequently 
fragmented in the mass spectrometer. Sufficient number of fragments provides 
comprehensive information of the analyzed protein and its modifications [85]. 
However, gas-phase fragmentation of intact protein ions, especially from large proteins 
has been critical aspect in bottom-up approach. Han et al. [86] demonstrated 
informative fragmentation of intact proteins with molecular masses exceeding 200 kDa. 
Significant improvement was achieved by the development of new fragmentation 
methods such as electron capture dissociation (ECD) [87] and electron transfer 
dissociation (ETD) [88, 89]. 
The main advantage of top-down approach (compared to peptide based strategy) 
is high sequence coverage up to 100% and therefore the ability to characterize all PTMs 
and changes in protein sequences [90]. In addition, the time-consuming protein 
digestion required for bottom-up methods is eliminated. The analysis of intact proteins 
generally requires high resolution mass measurements to resolve highly charged ions 
and their isotopes and has been generally performed on FT-ICR instruments [59, 91-
94]. Recently Macek et al. [69] showed the applicability of LTQ-Orbitrap for top-down 
analysis. Further, Waanders et al. [95] extended this work by application of SILAC 
technology to quantification of intact proteins.  
Top-down proteomics suffers from several limitations. First, separation of 
proteins in complex mixtures prior mass spectrometric analysis is challenging because 
of different physico-chemical properties of proteins [85]. Second, it is still difficult to 
obtain sufficient fragmentation of intact proteins larger than 50 kDa. Third, ECT and 
ETD offer not sufficient fragmentation efficiency, requiring long ion accumulation, 
activation, and detection times. Fours, there is necessary to understand comprehensively 
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the protein dissociation mechanisms [96], including the impact of precursor ion charge 
state and the role of protein primary, secondary and tertiary structure, what will provide 
development of sophisticated bioinformatics tools [97-100]. Because of mentioned 
limitations application of top-down approach is restricted for special cases (analysis of 
PTM’s) and is not used in high-throughput proteomics. 
 
1.3.2 Bottom-up proteomics 
Bottom-up proteomics relies on mass spectrometric analysis of peptides in 
proteolytic digests of analyzed proteins. Generally, there are two approaches for protein 
identification: peptide mass fingerprinting (PMF) and tandem mass spectrometry 
(MS/MS).  
In PMF usually acquired by MALDI-TOF MS, a unique mass fingerprint of a 
protein is created. Because mass mapping requires an essentially purified target protein, 
the technique is commonly used in conjunction with prior protein fractionation using 
two-dimensional gel electrophoresis (2DE), where proteins are separated on the basis of 
their isoelectric point in the first dimension and by their molecular mass in the second 
dimension [35, 36]. 2DE offers several advantages: 1) ability to separate related protein 
forms, such as differently modified forms, 2) low sample complexity and 3) additional 
information obtained from 2D gel (isoelectric point and molecular mass) [101, 102]. 
However it has limitations when dealing with very large or small proteins, proteins at 
the extremes of the pI scale, membranes, and low-abundant proteins [103, 104]. 
Tandem mass spectrometry is more prominent technique in bottom-up 
proteomics, since it elucidates structural features of the analysed peptides. Generally, 
there are two main approaches to analyse protein mixture by tandem mass spectrometry: 
1) gel-free approach, referred as shotgun proteomics [73, 105, 106], in which purified 
proteins are directly digested in solution, the resulting tryptic peptides are separated by 
one-dimensional or multidimensional chromatography and on-line injected into a 
tandem mass spectrometer via nano-ESI (this method is also known as nanoflow liquid-
chromatography-tandem mass spectrometry (nanoLC-MS/MS)) and 2) gel-based 
approach, referred as Gel-LCMS, in which proteins are first separated by one or two-
dimensional electrophoresis, enzymatically digested in-gel with proteolytic enzymes 
and the extracted peptides are either directly analyzed by tandem mass spectrometry or 
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subjected to one or multidimensional chromatographic separation prior to mass 
spectrometric analysis [107]. 
 
1.3.2.1 Gel-free approach 
Given the limitations of two-dimensional gel electrophoresis, alternative 
methodologies employing multidimensional chromatography for the separation of 
complex peptide mixtures prior to analysis by MS have found preferential application in 
many proteomic studies. Multidimensional separation couples two or more different 
separation methods. Greater chromatographic resolution obtained by multidimensional 
separation methods can be achieved by taking into consideration criteria established by 
Giddings et al. [108-110], who demonstrated that the overall peak capacity of 
multidimensional separations is the product of the peak capacities in each independent 
dimension only if the separation dimension are orthogonal and component separated in 
one dimension remain separated in any additional separation dimension [105]. 
The multidimensional peptide separation methods reported following Giddings' 
criteria include chromatographic techniques based on hydrophobicity, charge, molecular 
weight, or functionality of peptides. For instance, the separation of peptide mixtures by 
2 D LC/LC methods can be performed using several orthogonal combinations such as 
strong cation exchange / reversed phase liquid chromatography (SCX/RPLC), anion 
exchange chromatography / reversed phase liquid chromatography (AE/RPLC), and 
affinity chromatography / reversed phase liquid chromatography (AFC/RPLC). 
Typically, the second dimension is performed by RPLC because the mobile phase is 
compatible with the mass spectrometric analysis [71]. 
The most prominent and commonly used strategy, however, applies SCX 
(separation on the basis of charge) coupled to RPLC (separation on the basis of 
hydrophobicity). There are two main approaches, offline and online. In offline 
separation, developed by Link et al. [73], the first dimension (SCX) is not directly 
coupled to the second dimension (RP) or SCX-RP. Fractions from the SCX column are 
collected and later subjected to the RP column. The online approach, refined by 
Washburn et al. [106] employs coupling the two chromatographic methods together so 
that the eluent from the first dimension (SCX) is directly eluted onto the second 
dimension (RP) or SCX/RP, thus avoiding the need for fraction collection. Online 
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approaches are substantially faster than off-line approaches, and sample loss is 
minimized due to the direct coupling of the two dimensions. There are different 
variations of the online approach such as using separated columns for the SCX and RP 
connected by switching valves, or using multidimensional protein identification 
technology (referred as MudPIT), where the SCX and RP stationary phases are packed 
together in the same microcapillary column [105, 106]. To enable desalting of 
biological samples, which typically contain urea and other salts for optimal protein 
digestion, triphasic and split-three-phase [111, 112] column were designed. These 
developments enabled direct loading of samples on the column without offline 
desalting, which leads to sample loss and longer analysis times.  
MudPIT technology has become an important technique in bottom-up proteomics. 
It has been applied in a wide range of application, ranging from extensive proteomic 
analysis of different organisms or their subcellular components [105, 106, 113-115] to 
characterization of multiprotein complexes [116-118] and their quantification [119-
122].  
High sensitivity in shotgun analysis is achieved by microcapillary column (50-100 
µm i.d. columns, operating at 100-350 nl/min) [123], which were first introduced by 
Hunt et al. [124]. Further advances in nanoHPLC technology will also bring great 
improvements in this field. Giddings demonstrated the importance of orthogonality and 
how this increases the number of theoretical plates in a given analysis [108-110]. 
Another way to increase the number of theoretical plates in a chromatography analysis 
is to apply smaller particle size, which then requires higher pressures for 
chromatographic analysis. Ultrahigh-pressure reversed phase liquid chromatography 
(UHPLC) has become an active area of research [125-128]. Smaller reversed phase 
particles have been synthesized and applied in UHPLC [128, 129] and early efforts to 
implement an ultrahigh-pressure MudPIT system have been promising [130]. However, 
to have a fully integrated orthogonal two-dimensional UHPLC shotgun proteomics 
system, research into small particle and high-pressure resistant strong cation exchange 
particles is required [71].  
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1.3.2.2 Gel-based approach 
Gel-LCMS is a powerful method in the analysis of complex protein mixtures 
[131-135]. From practical point of view gel-based approach has several advantages 
compared to the gel-free shotgun strategy. First, gel electrophoresis separates proteins 
into narrow mass range bands, significantly increasing the dynamic range of proteomic 
analysis. Second, in gel-based approach detergents and buffer salts, which are not 
compatible with mass spectrometry (especially based on ESI), are washed out from the 
gel matrix, making this method appropriate to high-throughput MALDI-MS and 
nanoES MS/MS analysis of isolated protein bands. And finally, gels can be stored for 
years without noticeable changes in pattern of tryptic peptides and in their recovery 
[136].  
Although in-gel digestion is well established for bottom-up proteomics and has 
been routinely used for more than a decade [137], it has significant limitations. Its major 
limitation is poor peptide yield that limits the analysis sensitivity. One of the basic 
factors responsible for reduced peptide recovery is the limited efficiency of in gel-
digestion due to slow diffusion of trypsin molecules inside the gel matrix [2]. Therefore, 
to achieve better efficiency much higher concentrations of enzymes (compared to in-
solution proteolysis) have to be applied, resulting in significant autolytic background.  
Next, each step of gel processing, such as performing of electrophoresis, gel 
staining, cutting of protein bands, in-gel digestion and extracting of tryptic peptides 
increase the risk of contaminating samples with keratins or other contaminants, so 
enhancing chemical noise in analyzed samples.  
And, finally, compared to shotgun approach, which is based on in-solution 
digestion of proteins and enables protein identification in relatively short time, in-gel 
digestion is a time-consuming procedure, which requires overnight protein cleavage and 
additionally pre-digestion sample preparation.  
Significant improvement of in-gel digestion was achieved by Havliš et al. [2]. He 
addressed mentioned limitations using porcine trypsin with methylated ε-amino group 
of lysine residues, which represent better thermostability and autolysis resistance (by 
kept cleavage specifity) than its unmodified form and commonly used in proteomics 
bovine trypsin. Havliš et al. developed accelerated in-gel digestion protocol, which 
considerably reduced the proteolysis time (down to 0.5-1h instead of overnight 
incubation) and improved the recovery of digestion products. Thus, it has become 
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apparent that further development of autolysis resistant and thermostable trypsin 
conjugates (provided that they maintain their catalytic activity and cleavage specifity) 
would enable major advance towards fast and flexible protein analysis. 
Trypsin undergoes rapid autolytic inactivation at basic pH (corresponding to pH 
optimum of the enzymatic reaction) presumably due to hydrolysis of C-terminal lysine 
and arginine peptide bonds. Such autolysis may be prevented or minimized by chemical 
modification of the ε-amino group of lysine residues and guanidino group of arginine 
residues. A number of experiments to modify these amino acid residues were carried 
out in order to stabilize trypsin [138-141]. It was shown that reductive methylation 
increases autolysis resistance and thermostability [142] of trypsin, without strong 
impact on its catalytic activity and without altering of its substrate specificity. However, 
in many cases chemical modification of enzymes has been reported to provoke 
significant losses of catalytic activity [138, 140].  
The interest for modifying enzymes with sugar moieties has been raised because 
of the better stability and functional properties showed by the naturally occurring 
glycoenzymes [143]. Their stability against thermal inactivation is assumed to derive 
mainly from the hydrophilization of the non-polar areas of the enzyme, as a result of the 
covalent attachment of the oligosaccharide to exposed lysine residues [140, 144]. 
Hydrophilization hinders thermal denaturation associated with the formation of new 
intra- and inter-molecular hydrophobic interactions in the course of thermal treatment 
[144].  
In order to further improve the thermostability of trypsin in line with fast 
digestion approach developed by Havlis et al., Šebela et al. synthesized trypsin 
conjugates by coupling oligosaccharides to its lysine residues and characterized them 
bioanalytically [1]. Trypsin conjugates significantly increased thermostability and 
autolysis resistance of trypsin, without affecting its cleavage specifity, revealing their 
great potential for accelerated digestion of proteins both in-solution and in-gel.  
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1.4 Analysis and validation of proteomic data produced by nanoLC-
MS/MS  
Nanoflow liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) is 
an automated, high-throughput analytical method and generates thousands of tandem 
ion spectra in a single analysis [105, 112]. The correct assignment of these MS/MS 
spectra to peptide sequences and identification of analyzed proteins is a complex 
process, which involves pre-processing of raw data, peptide/protein identification and 
validation of the obtained results [145-147].  
 
1.4.1 Pre-processing of raw data 
Successful protein identification depends on good pre-processing of mass 
spectrometric data. The main goal of pre-processing of MS/MS spectra is to increase the 
specifity, sensitivity and accuracy of automatic database searches. Pre-processing 
includes peak detection, noise reduction, and monoisotopic peak determination. These 
parameters strongly depend on the quality of the acquired data [148].  
Analysis of complex peptide mixtures by shotgun approach results in huge 
number of fragment ion spectra, while many of them are redundant [149], because of 
repeated fragmentation of highly abundant peptides. This dramatically increases the 
complexity of data-analysis, in terms of computational processing time required and 
time required for validation of the obtained results. To overcome this problem 
significant efforts have been undertaken to develop algorithms, which enable clustering 
and merging of redundant tandem mass spectra [149-153]. Further Zhang et al. 
introduced software capable to recognize spectra generated from cofragmentation of 
two or more peptides [154]. 
Another challenge in analysis of acquired spectra derives from presence of 
background peaks, which complicate database searches. Low-energy CID fragmentation 
generates predominantly a, b, y ions and their derivates, which have lost ammonia (-17 
Da, a*, b* and y*) and water (-18 Da, a°, b° and y°). However, MS/MS spectra contain 
many more peaks. These can result not only from isotope variants and multiply charged 
replicates of the peptide fragmentation products but also from unknown fragmentation 
pathways, sample-specific or systematic chemical contaminations or from noise 
generated by the electronic detection system [155, 156]. The presence of this 
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background not only complicates spectrum interpretation by increasing computational 
time, but also might lead to incorrect protein identification. To address this problem 
considerable efforts have been made to study in depth peptide fragmentation chemistry 
[157-159] and to develop algorithms for detection and  transformation of multiply 
charged peaks into monoisotopic peaks, removal of heavy isotope replicates, and 
random noise [156, 160]. Sophisticated charge determination software [161, 162] were 
introduced to this end. Since acquired data contain high number of poor quality spectra, 
which are often of non-peptidic nature, several strategies have been addressed to 
measure the quality [163] of tandem mass spectra filtering low quality spectra prior 
database searching [164-168].  
Analyzed samples also contain peptides from common contaminants like human 
and sheep keratins, proteolytic enzymes, antibodies, GST etc. Many of these sequences 
are either not present in a database or scattered through a large number of partially 
redundant database entries. When abundant, they also give rise to a large pool of 
polymorphic sequences, orifice fragmentation products, sodium adducts etc. [169]. 
Therefore, it would be advantageous to remove these spectra prior to database searches. 
To this end computational algorithms have been developed, which recognize and 
remove these background spectra [152, 169], so decreasing the amount of data and 
avoiding possible false positives. 
 
1.4.2 Peptide/protein identification based on database searching  
A large number of computational methods have been developed to assign peptide 
sequences to acquired tandem mass spectra. Generally, there are three ways to identify 
analyzed proteins: 1) database searching involves assignment of acquired spectra to 
theoretical spectra in silico predicted for each peptide contained in a protein sequence 
database [170-176]; 2) de novo sequencing derives peptide sequences directly from 
MS/MS spectra based on peptide fragmentation rules [159, 177-182]; 3) hybrid 
approach, pioneered by Mann [183] involves de novo identification of short sequence 
tags followed by ‘error-tolerant’ database searching [184, 185].  
Database searching is most suitable approach for large-scale proteomics and 
several database search programs have been developed to this end, such as MASCOT 
[170], SEQUEST [172], X!TANDEM [171], ProbID [173], Phenyx [174] etc. All these 
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algorithms rely on comparison of the acquired MS/MS spectra with theoretical spectra 
predicted from a sequence database using common peptide fragmentation rules. A 
number of search parameters need to be considered here, for instance, searching 
database, proteolytic enzyme specifity, amino acid modifications (stoichiometric, called 
“fixed” or non- stoichiometric, called “variable”), and mass tolerance of precursor and 
fragment ions. Database searching programs apply scores, which represent the degree of 
similarity between the acquired and the theoretical spectrum, and therefore serve as the 
primary discriminating parameter for separating correct from incorrect identifications 
[186].  
Automated database search enables fast large-scale protein identification. 
However, high number of acquired MS/MS spectra remains unmatched or matches 
peptides with low scores, resulting in proteins that were not actually in the sample – 
false positives and leaving out proteins that were in the sample – false negatives. There 
are several reasons for this problem [187].  
First, database searching approach only enables identification of those peptides 
that are present in the searched sequence database. Since the peptide molecular weight 
is used as a filter to derive candidate sequences from a database, an incorrect molecular 
weight will provide incorrect sequences. Thus, in ex vivo / in vitro modified peptides 
(with oxidized methionines or carbomidomethylated cysteines residues), which were 
not specified by database search or peptides derived from post-translationally modified 
proteins remain unassigned or might match incorrect peptides. The same problem 
concerns protein identification from organisms not well represented in any sequence 
database. Even, for organisms with completely sequenced genomes, sequence 
polymorphisms can still cause difficulties, since these are sometimes indicated only as 
annotations, rather as separate sequence entries. Common background proteins might 
also lead to false positives by database searching in small species-restricted databases. 
Second, typically database search is performed under specification of the applied 
proteolytic enzyme. Peptides derived from cleavage by another proteolytic activity 
present in the sample or from fragmentation of intact peptide ions in the ion source prior 
to mass analysis will not be correctly identified.  
Third, since the peptide mass is a filter parameter by database searching, an 
incorrectly determined peptide mass (for example, incorrectly called monoisotopic 
peak) or charge state of a peptide ion selected for fragmentation will provide incorrect 
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sequence candidates, leading to possible false positive identifications or unassigned 
spectra.  
Fourth, database search is based on a simplified representation of the peptide ion 
fragmentation rules. Unexpected fragmentation pathways complicate peptide 
identification [188].  
Fifth, for better sensitivity QTOF and IT instruments are typically operated with 
an isolation window for precursor ions of 3-4 Da. Therefore, it is uncommon that 
acquired MS/MS spectra contain fragment ions from coeluted precursor ions that are 
close in mass.  
Sixth, dirty solvents used in HPLC might contain alkali metal cations, which can 
build sodiated peptide ions. This lead not only to increased peptide mass, but also 
changes the fragmentation pattern compared to unmodified peptide ions.  
Seventh, high number of acquired spectra derives from non-peptide 
contaminations, resulting in incorrect peptide identifications or unassigned spectra.  
Generally, the accuracy of peptide/protein identification strongly depends on the 
performance of the applied mass spectrometer, data quality, and the appropriate chosen 
database [186]. 
 
1.4.3 Protein identifications with borderline statistical confidence 
A major limitation in identifying peptides from complex mixtures by shotgun 
proteomics is the ability of search program to accurately assign peptide sequences to the 
acquired MS/MS spectra. This problem is addressed by all search engines by applying 
sophisticated scoring techniques, which evaluate the probability of false positive 
identifications. MASCOT algorithm, for instance, applies probability based scoring and 
typically establishes threshold scores which reflect 95% (usually used) confidence level 
when searching data from peptide mass fingerprints and tandem mass spectra. However, 
in large scale proteomics projects, when thousands of peptides are identified, this level 
of confidence may be unsatisfactory, resulting in false positive peptide/protein 
identifications. On the other hand, these threshold scores depend on the database size. 
To confidently identify a protein in a comprehensive database (even at this moderate 
confidence level), the ion scores of analyzed peptides should exceed a relatively high 
threshold score. Given the complexity of analyzed mixtures (up to 10 orders of 
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magnitude [70]) and limited sensitivity of current analytical instruments, many of 
acquired MS/MS spectra are of not sufficient quality. Thus, identification of high 
number of proteins relies on matching one or two marginal quality mass spectra with 
scores far below this threshold score (for comprehensive database). Rejecting of these 
hits would significantly increase number of false negatives. On the contrary, for 
database searches in small species-restricted databases threshold scores are lower. 
Accepting hits corresponding to these threshold scores would inevitable result in 
increased number of false positives.  
The problem of borderline hits is more pronounced when peptide sequencing is 
performed at low femtomole level, where peptide precursors are often contaminated by 
co-selected background ions, and are affected by poor ion statistics [152]. Moreover, 
background proteins originated from exogenous species, such as human and sheep 
keratins, fragments of proteolytic enzymes, antibodies, fragments of expression vectors 
or protein from host organisms contribute to the false positive rate if database searching 
is performed against a small species-restricted sequence database. Independent of the 
applied algorithm [170-174], database searching is a probabilistic process, in which the 
confidence of hits is evaluated by the comparison of some matching quality scores 
against empirical or semiempirical statistical significance thresholds.  
Manual evaluation can not be regarded as appropriate validating tool in such big 
scale analyses. Thus, revealing real hits (false negatives) among ocean of ambiguous 
protein identification is a challenging task in today’s proteomics, requiring 
improvement statistical methods of database searching engines, and deeper 
understanding of peptide fragmentation pathways and their impact on the accuracy of 
spectrum-to-sequence matching [158, 159, 189-191].  It is also important to 
independently validate borderline hits irrespectively of statistical properties of both the 
spectra dataset and sequence database. 
Several strategies have been developed to validate ambiguous hits based on 
additional information, such as agreement between sequence composition of the 
identified  peptide and its chromatographic behaviour [192, 193], probability of missed 
cleavages [194] or exact mass measurements [192]. In addition, some methods have 
applied intensity information in validating of data [191, 195, 196].  
However, in many proteomics studies manual validation of borderline 
identifications is still regarded as the method of choice. The main weakness of this 
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approach is that it is completely based on subjective decision of the analyst. It is 
therefore not surprising that high number of proteomics publications represent 
ambiguous protein hits, whose identifications are often based on matching a single 
peptide, of completely non-tryptic termini [197, 198]. Recently introduced “Manual 
Analysis Emulator” (MAE) was developed to automate key aspects of manual analysis, 
minimize subjective decisions, and enable high-throughput processing [199]. The 
method is based on the de novo sequencing program MassAnalyzer, developed by 
Zhang et al. [159, 200], which simulates MS/MS spectra including relative fragment ion 
intensities. This program applies new kinetic model for peptide fragmentation integrated 
from recently investigated gas phase chemistry mechanisms of peptides [30, 201, 202].  
To address the issue of database independent validation, Savitski et al. [168] 
introduced a new scoring method (S-score), which utilizes the advantage of combined 
use of complimentary fragmentation techniques collisionally activated dissociation 
(CAD) and electron capture dissociation (ECD). S-score is based on the maximum 
length of the peptide sequence tag predicted from CAD and ECD data, enabling 
confirmation of some of the below threshold hits, and revealing false positives and 
modified sequences. The quality of MS/MS spectra assessed by S-score also allows 
poor data to be filtered out before the database search, speeding up the data analysis and 
eliminating a major source of false positive identifications. 
Despite undertaken efforts to develop methods [168, 199], which provide database 
independent validation of hits with borderline statistical confidence, there is a particular 
need in validation algorithms applicable in high-throughput proteomics. 
 
1.4.4 Statistical assessment of peptide assignments in large-scale datasets 
One of the first strategies to separate correct from incorrect peptide assignments in 
data analysis was application of ad hoc filtering criteria based upon database search 
scores and some properties of the assigned peptides often in conjunction with manual 
validation [193, 203-206]. However, the numbers of rejected correct identifications and 
accepted false identifications that result from applying such filters are not known. 
Moreover, the obtained score distributions depend on several factors, such as the 
performance of the mass spectrometer, data quality, and the size of the database. 
Therefore, application of the same thresholds to data from different experiments would 
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result in different (and unknown) error rates, making comparison between datasets 
practically impossible [186]. Thus, consistent and reliable interpretation of data to 
enable the comparison of results from different experimental groups requires robust 
statistical methods to validate peptide assignments to MS/MS spectra [188]. 
Several statistical methods for validating of peptide identifications have been 
developed on top of existing database search tools [207-211]. Generally, the global 
statistic approaches can be broadly grouped into two categories: target-decoy searching 
and empirical Bayes approaches [186]. 
The first strategy relies on searching target-decoy databases, and computes an 
optimized cut-off score for each database. Two different types of searches have been 
described: in the first step the MS/MS spectra are searched against the database of 
interest and a randomized database independently [212]. In the second step the original 
database and a randomized database are joined (concatenated) and searched 
simultaneously [211]. Peptide assignments are then filtered using various cut-offs, and 
the corresponding FDR for each cut-off is estimated as 2ND/N, where N is the number 
of peptide matches with scores above the cut-off and ND is the number of matches to 
decoy sequences among them. Target-decoy approach assumes that matches to decoy 
peptide sequences and false matches follow the same distribution and has been 
proposed to be very robust method.  It is simple and can be applied in large-scale 
proteomics by evaluation of data generated by LC-MS/MS analyses. However, doubled 
database search time should be considered. Still, the serious concern is whether 
reversing or randomizing sequences can provide an accurate assessment of the 
distribution of false peptide matches when many of those are known to be sequences 
homologous to the true peptides rather than completely random sequences [186].  
The second statistic approach exemplified by PeptideProphet algorithm developed 
by Keller et al. [207] is based on linear discrimination analysis and estimate the 
accuracy of peptide assignments to tandem mass (MS/MS) spectra made by database 
searches [188]. In this approach each peptide assignment to a spectrum is evaluated 
with respect to all other assignments in the dataset, including necessarily some incorrect 
assignments. It uses the observed information about each assigned peptide in the 
dataset, learns to distinguish correct from incorrect assignments and, finally, computes 
the probability for each assignment. By evaluation of peptide assignments 
PeptidePhrophet typically includes database search scores, the difference between 
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measured and theoretical peptide mass, the number of termini consistent with the type 
of enzymatic cleavage used, and the number of missed cleavage sites. In addition, 
PeptideProphet can apply auxiliary features, such as peptide retention time [212, 213], 
pI of identified peptides [75, 214], presence of special amino acids (for example, 
cysteine in the case of avidin affinity purification of peptides containing biotinylated 
cysteins), expected number of missed cleavages (for example, missed cleavages can 
occur in the presence of acidic groups near cleavage site, otherwise they can result due 
to cleavage sites being adjacent to one another), providing valuable information for 
validation of ambiguous hits [188].  
The described statistical approaches are widely used in proteomic data analysis. 
However, they both evaluate thresholds of statistical significance and do not imply the 
validity of individual spectrum-to-sequence matches. These methods do not replace the 
need for data base independent validation strategies.  
 
1.4.5 Validation of protein identification: protein interference problem 
A separate problem in data analysis is validation of protein identifications. In 
bottom-up proteomics proteins are digested prior to LC-MS/MS and their identification 
is based on analyzed peptides. The connectivity between peptides and proteins is 
usually quite straightforward when analysed protein mixtures are not complex and 
separated by 2D electrophoresis (additionally information of protein mass and its 
isoelectric point is available). In case of complex protein samples analyzed by MuDPIT 
technology this connectivity is lost, interfering protein identities (when one particular 
peptide can be assigned to multiple proteins) from the set of identified peptides becomes 
a serious problem. This problem arises from protein paralogues, splicing variants, or 
redundant entries within the database. Here again, statistical methods were developed 
[208, 210, 215]. The statistical method of Nesvizhskii et al. used in software tool 
ProteinProphet computes probabilities that a protein is present in the sample by 
combining the probabilities that corresponding peptides are correct [215]. Here 
individual peptide probabilities are aligned for observed protein grouping information. 
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1.4.6 De novo sequencing and homology searching 
 An alternative approach to peptide/protein identification is de novo sequencing, 
where peptide sequences are directly derived from fragmentation spectra without 
recourse to a sequence database. Significant efforts have been invested into 
development of de novo sequencing algorithms [159, 177-182]. However, de novo 
sequencing is difficult and error-prone approach that typically produces ambiguous 
results [187]. There are several reasons for it.  
 First, there are difficulties in differentiating between some amino acids of 
identical (leucine and isoleucine) or nearly identical masses (e.g. glutamine/lysine and 
phenylalanine/oxidized methionine, which, however, can be resolved by instruments 
with high resolution and mass accuracy). Moreover, some pairs of amino acids have 
identical or nearly identical masses to certain amino acid residues. Second, ion series 
are rarely complete, since fragmentation does not occur at every peptide bond. In 
addition, fragment ions are present in varying abundances (often below noise level), in 
many cases with associated losses of water and/or ammonia, what complicates de novo 
sequencing. Third, it is usually not known whether an ion contains the C- or N-terminus 
of the peptide. To address this problem Shevchenko et al. [216] introduced isotopic 
labeling of C-terminus by trypsin proteolysis in 50 % H218O, which labels y ions as 
doublets separated by 2 Da, so helping to connect the observed ion series to the correct 
termini. 
It seems to be reasonable that de novo sequencing can be combined with 
homology-based searches, providing complementary validation approach to database 
searching [217]. However, de novo interpretation of tandem mass spectra results in 
many relatively short (usually 6-12 amino acid residues) sequence proposals, which are 
highly redundant and error-prone. Conventional database search algorithms such as 
BLAST [218] or FASTA [219] are optimized for accurate and long (>35 amino acid 
residues) sequence queries, where amino acid permutations (such as leucine/isoleucine 
and glutamine/lysine), gaps or insertions/deletions are strongly penalized. In addition, 
homology searching is computationally demanding. To address these difficulties 
existing sequence alignment algorithms have been modified in order to match de novo 
sequences to protein sequence databases. For example MS-BLAST [220], MS-Shotgun 
[221], CIDentify [222] and FASTS [223] can be used to align de novo sequences to 
database homologues using highly efficient sequence alignment algorithms.  
1 INTRODUCTION 35
 
 
The idea to use de novo sequencing for validation of ambiguous results is not 
new. Taylor et al. [217] applied automated program Lutefisk in conjunction with a 
homology-based database search program CIDentify, which uses a modified FASTA 
sequence comparison algorithm to screen the sequences produced by automated 
interpretation of low-energy CID spectra, in validation of database searches. The 
authors also showed that this strategy can be used for identification of homologous 
protein families from data obtained from unknown proteins [222] as well as by 
characterization of posttranslational or chemical modifications and peptide originated 
from nonconsensus proteolytic cleavages. However, because of rapid growth of 
sequence databases, the throughput of the approach is limited by the relatively long 
running times required by the modified FASTA algorithms [221-223]. In addition, the 
significance of hits in these algorithms depends not only on the number of matched 
peptides, but decreases with the increasing number of redundant peptide sequence 
candidate in the query.  
Mass spectrometry driven BLAST (MS BLAST), developed by Shevchenko et al. 
[220, 224], utilizes degenerate, redundant and partially inaccurate peptide sequence 
candidates obtained by de novo interpretation of tandem mass spectra. MS BLAST is 
web accessible program, which is operated at servers of very high computational 
capacity and can be applied for high-throughput analysis of data. MS BLAST doesn’t 
employ original statistical evaluation procedure of classical BLAST (no E-values or p-
values) instead it uses a scoring matrix optimized for peptide sequences produced by de 
novo sequencing of MS/MS spectra [225]. 
 
 
 
 
 
 
 
 
 
 
 
1 INTRODUCTION 36
 
 
1.5 Quantitative mass spectrometry in proteomics  
Mass spectrometry is increasingly used for quantitative proteomic profiling of 
complex biological samples. Quantitative proteomics is important to provide 
fundamental understanding of biological processes because the kinetics/dynamics of the 
cellular proteome is described in terms of changes in the concentrations of proteins in 
particular compartments [226]. Generally, the quantification strategies can be divided 
into two categories: 1) quantification using stable isotope labeling, including 
metabolical, enzymatical labeling, labeling by chemical means or provided by spiked 
synthetic peptide standards and 2) label-free quantification using spectral counting or 
spectral feature analysis (Figure 1.2) [227]. 
 
 
 
Figure 1.2. Common quantitative mass spectrometry workflows. 
Boxes in blue and yellow represent two experimental conditions. Horizontal lines indicate 
when samples are combined. Dashed lines indicate points at which experimental variation 
and thus quantification errors can occur (adapted from [227]). 
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1.5.1 Stable isotope labeling 
One commonly used approach in bottom-up proteomics employs stable isotope 
labeling (12C vs. 13C, 14N vs. 15N, 2H vs.1H), allowing comparison of peptides between 
samples. Stable isotopes labeled peptides are chemically identical to their native 
counterparts and therefore have similar behaviour during chromatographic and mass 
spectrometric analysis. Isotope labels can be introduced into amino acids 1) 
metabolically, 2) chemically, 3) enzymatically or, alternatively, by spiking of synthetic 
peptides.  
Metabolic labeling involves in vivo incorporation of stable isotopes into the 
proteins in special media containing these isotopes. In this method cells are grown in 
two different media containing 14N or 15N isotopes, then combined and analyzed by MS 
[228-230]. The main disadvantage of this strategy is not predictable mass shift, since the 
method labels all nitrogen atoms of the backbone and side-chains. In an alternative 
approach, termed “stable isotope labeling with amino acids in cell culture (SILAC)” 
[231], proteins are labeled in vivo by growing cells in media containing isotopically 
labeled amino acids, such as 2H-leucine, 13C-lysine, 13C-tyrosine, 13C-arginine[232-
234]. This method has become popular because of the predictability of the mass shift. 
Generally, isotope labeling in vivo has the advantage that it happens in the early stage of 
preparation, so reducing variance between samples. A disadvantage, however, is that 
this approach can not be applied for analysing biological samples that cannot be grown 
in culture, such as tissues and body fluids [235]. 
In vitro labeling approach involves incorporation of stable isotopes by chemical 
reaction at the amino- or carboxyl- terminal of targeted peptides, or on specific amino-
acid residues, such as cysteine, lysine, tyrosine etc. ‘Isotope-coded affinity tags’ (ICAT) 
approach introduced by Gygi et al. [236] applies a reagent consisted of biotin affinity 
tag for selective purification, a linker that incorporated stable isotopes (1H or 2H) and an 
reactive iodoacetamide group, which reacts with cysteinyl thiols. This method has been 
significantly improved by introducing an acid-cleavable linker that allows removal of 
the large affinity tag prior to MS and incorporation of carbon-13 instead of deuterium 
that prevents possible chromatography shifts [237-240]. ICAT quantification strategy 
was applied to variety of species [204, 241]. However, ICAT is not suitable for 
quantifying of proteins, which do not contain any cysteine residues. Thus, many 
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biologically ‘interesting’ protein changes might remain uncharacterized by this 
approach [242].  
Other groups of reagents targetN-terminus of peptides and amino group of lysine 
via the very specific N-hydroxysuccinimide (NHS) chemistry or other active esters and 
acid anhydrides [243-247], as well as via methylation of lysine residues by 
formaldehyde via Schiff base formation and subsequent reduction by cyanoborohydrate 
[248-250], iTRAQ reagent (isotope tags for relative and absolute quantification) has to 
be pointed out [251]. In contrast to ICAT and similar mass-difference labeling 
strategies, quantitation is performed at the MS/MS stage rather than in MS. iTRAQ 
reagent consists of a reporter group, a balancer group and a peptide reactive group, 
which reacts with primary amino groups of peptides. The specifity of this approach is 
that the mass of balancer and reporter group remains constant, whereas the reporter 
group ranges from 114 to 117 Da, and balancer group ranges from 28 to 31 Da, making 
differently labeled peptides isobaric (they have similar chromatographic behaviour) 
(Figure 1.3). During CID, the reporter group ions fragment from the backbone peptides, 
representing different masses from 114 to 117 Da, allowing multiplexed quantification. 
 
         
         Figure 1.3. Strategy for protein quantification by iTRAQ. 
(A), structure of iTRAQ reagents. (B), differentially labeled reporter and balancer groups. 
(C), four isobaric combinations with four different reporter group masses. Following 
CID, the four reporter group ions appear as distinct masses (114–117 Da); adapted from 
[251].  
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Carboxylic acids in side chains of glutamic and aspartic acid residues as well as 
the C-termini of peptide chains can be isotopically labeled by esterification used 
deuterated alcohols [252]. This reaction has become attractive especially for 
quantification of phosphopeptides, because esterification improves the specifity of their 
enrichment procedure [253]. Several stable isotope labeling methods have been 
developed for quantification of phosphorylated [254-257] and glycosylated peptides 
[258]. 
Stable isotopes can be introduced enzymatically to the C-termini by proteolytic 
digestion of proteins in H218O, or after proteolysis by incubation of the obtained 
peptides with a protease in H218O, resulting in mass shift of 2 Da per 18O atom [259-
261]. Acid- or base-catalyzed back-exchange can occur at extreme pH values, but under 
mild acidic conditions 18O-containing carboxyl groups of peptides are stable [262]. The 
main disadvantage of this method is that the full labeling is seldom achieved and that 
incorporation of one or two oxygen atoms depends on the nature of peptide, 
complicating the analysis [263, 264]. 
A method known as AQUA applies isotope-labeled synthetic standards [265]. 
Known quantities of labeled peptides added to protein digests provide information for 
absolute quantification. Application areas of this approach are analysis and validation of 
potential biomarkers in a large number of clinical samples [266] and determination of 
protein stoichiometry in protein complexes [267, 268]. However, this approach can not 
be used in large-scale quantifications, because of the high manufacturing cost of 
standard peptides, which have to be chemically synthesized in stable isotope−labeled 
form and independently quantified. This approach has been refined by constructing 
synthetic genes that express artificial proteins what are concatemers of tryptic peptides 
for several proteins or group of proteins [269].  
One practical limitation of the AQUA approach is that by given complexity (first 
and foremost high dynamic range) of analyzed tryptic digests it is difficult to decide 
how much of the labeled standard should be added to a sample; this amount might 
significantly vary for all proteins of interest. Another limitation is the specifity of the 
spiked standard as there are likely multiple isobaric peptides present in the mixture. 
Both of these issues can be improved by multiple reaction monitoring (MRM) in which 
the mass spectrometer monitors both the intact peptide mass and one or more specific 
fragment ions of that peptide [270]. Application of auxiliary information, such as 
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retention time, peptide mass eliminates ambiguities in peptide assignments and extends 
the quantification range to 4-5 orders of magnitude [271].  
Although protein quantification using stable isotopic labeling has been proved as 
accurate, sensitive and reproducible method it has several limitations. As first, labeling 
with stable isotopes is often very expensive, and some labeling procedures involve 
complex sample preparations. Second, labeling methods make acquired LC-MS spectra 
more complex due to the presence of additional isotopic peaks, which often overlap 
with co-eluting components of similar masses, complicating peak detection and 
quantification. And finally, chemical labeling approaches are prone to side reactions 
(e.g. thiol reactions of serine and threonine residues with iTRAQ reagent), leading to 
unexpected products [227]. 
 
1.5.2 Label-free quantification 
Label-free quantitation strategies are promising alternatives to stable isotope 
labeling approaches. Their advantages are simple and less expensive sample 
preparation, lower sample complexity, applicability to any samples, including tissues 
and ability to quantify and compare multiple samples. There are two fundamentally 
different strategies for label-free quantification: the first one measure and compares 
mass spectrometric signal intensities of peptide precursor ions of a given protein [272-
276] and the second one counts and compares the total number of MS/MS spectra of 
any peptide for a given protein [106, 226, 277, 278]. 
Spectral feature analysis is a quantification approach, which is based on 
measuring and comparing the mass spectrometric signal intensities of peptide precursor 
ions of a particular protein. This is typically done by creating extracted ion 
chromatograms (XICs) for the mass to charge ratios determined for each peptide. The 
intensities for each peptide in a given sample can be compared with intensities of the 
corresponding peptides in other samples, enabling relative quantification of multiple 
samples. Integrated peak areas, however, can be influenced by different factors 
including ion suppression, limited ion trapping capacity of mass spectrometers, or 
simply by the parameters applied to create extracted ion chromatograms, e.g. m/z 
tolerance, background subtraction etc [279]. Spectral feature analysis is not applicable 
to low abundant proteins, due to difficulties to accurately define peaks and signal to 
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noise ratio [280]. This quantification approach requires stringent statistical methods and 
replicate analyses and strongly depends on the accuracy of the mass measurement and 
the chromatographic reproducibility [281]. It is therefore advantageous to apply high 
mass accuracy instruments, which minimize the interference of peptides with close 
masses. The chromatography should be also optimized for better resolving of peptides, 
especially in complex protein mixtures. Special software have been developed to 
accurately align and profile features between many LC-runs [275, 282-285]. In addition, 
the right balance between acquisition of survey and fragment spectra has to be found, 
since better quantification accuracy, which requires multiple sampling of the 
chromatographic peaks by survey MS, means poorer proteome coverage (high proteome 
coverage can be achieved by extensive peptide sequencing by tandem mass 
spectrometry). To address this issue the analysis can be performed in two steps: in first 
experiment the instrument is adjusted to identify as many peptides as possible and in the 
second experiment mass spectrometer operates only in MS-mode to optimize sampling 
of peptide signals. An another approach refers to differential feature detection: here as 
first a survey scan is performed to profile ions showing differences and subsequently the 
sample is reanalyzed by tandem MS to identify those ions [276, 286].  
The ability to determine the absolute concentration of a protein (or proteins) in 
protein complexes is important to understand their stoichiometry. The absolute amount 
of a protein can be obtained using synthetic labeled internal standards chemically 
identical to the proteotypic peptides generated by protein proteolysis [266, 269]. Due to 
the limitations of this strategy, mentioned before, there is a particular need in 
development of label-free quantification methods to estimate absolute quantities of 
proteins. Recently Silva et al. [287] showed that the average MS signal response for the 
three most intense tryptic peptides per mole of protein is constant. Given an internal 
standard, this relationship is used to calculate a universal signal response factor, so 
providing method for absolute quantification. 
Spectral counting approach is based on the observation that the number of 
acquired MS/MS spectra for sequenced peptides depends on the quantity of a given 
protein. This method sums the total number of tandem mass spectra of any peptide of a 
given protein observed at different charge states, or in different chromatographic 
fractions. The protein abundance is then estimated from the number of obtained MS/MS 
spectra for a corresponding protein normalized to its length or expected number of 
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tryptic peptides [226, 279]. Spectral counting enables relative quantification by 
comparing the protein abundance between different experiment sets. In contrast to 
quantification by peptide ion intensities, spectral counting benefits from extensive 
MS/MS data acquisition across LC-MS/MS experiment. Dynamic exclusion is a 
commonly used tool in tandem mass spectrometry, which employs exclusion of ions 
that have already been selected for fragmentation, enabling fast collection of 
information without repetitions. However, it is disadvantageous for accurate protein 
quantification by spectral counting. Spectral counting approach is still controversial, 
mainly because it assumes linear response for different proteins [227]. In fact, the 
response is varying for different peptides due to their distinct physical properties. 
Reasonable results can be obtained when sufficient number of MS/MS spectra was 
obtained for a given protein. Old et al. showed that protein ratios 2-fold or greater could 
be estimated, however, to achieve high confidence at this level ≥4 spectra/protein were 
required [281]. On the other side, saturation effects can be obtained at higher spectral 
counts, complicating quantification of complex protein mixtures with high dynamic 
range. Nevertheless, the practical utility of spectral counting approach has been 
demonstrated in several applications [279, 288]. 
It should be noted, when comparing both label-free quantification methods, that 
spectral counts strategy more accurately quantify large changes in abundance, whereas 
spectral feature approach provides better estimates of smaller changes [121, 281]. 
Although, both label-free quantification methods are not as precise as stable isotope 
labeling, they can be used to address many biological questions, including those cases 
where labeling is not possible. In addition, label-free methods provide higher dynamic 
range of quantification than stable isotope labeling strategies, since the complexity of a 
sample significantly increases by adding of labeled internal standards [227]. 
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1.6 Questions and aims of the thesis 
LC-MS/MS analysis often in combination with 1 or 2 D gel electrophoresis has 
been the standard method for identification and quantification of proteins in bottom-up 
proteomics. Despite continuous improvements of MS instrumentation and software, 
several bottlenecks have been recognized, such as:  
 
1) low efficiency of in-gel digestion, which requires long processing times and 
results in poor peptide yield, strongly contaminated with autolysis products of the used 
protease,  
 
2) large number of protein identifications with borderline statistical confidence at 
the edge of sensitivity and finite dynamic range of MS instruments.  
 
To address these issues I set the following goals for my thesis work:  
 
 1. Evaluate the performance of trypsin derivates modified with oligosaccharides, 
which offer better thermostability [1] than unmodified commercially available 
bovine trypsin.  
 
 2. Study the kinetics of in-gel digestion of proteins by glycosylated trypsins, in 
order to evaluate how the reaction temperature, enzyme concentration and 
digestion time affect the yield of digestion products [2]. 
 
 3. Establish a reliable, automated and database independent method for rapid 
validation of protein identifications with borderline statistical confidence and 
test its performance in large-scale protein identifications. 
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2 RESULTS AND DISCUSSION 
2.1 Thermostable trypsin derivates for enhanced in-gel digestion in high 
throughput proteomics 
In collaboration with Prof. Dr. Marek Šebela from Department of Biochemistry, 
Palacky University, (Olomouc, Czech Republic) I tested trypsins conjugated with di-, 
tri-, tetrasaccharides and cyclodextrins in accelerated in-gel digestion of proteins as in 
protocol previously established in our laboratory [2]. These conjugates offer higher 
thermostability and autolysis-resistance compared to the commonly used in proteomics 
bovine trypsin. Their relatively small size represents a compromise between the 
stabilizing role of sugar moieties and molecular size of the enzyme.  
 
2.1.1 Introduction in synthesis and bioanalytical characterization of 
bioconjugated enzymes 
2.1.1.1 Chemical modification of bovine trypsin: glycosylation 
Marek Šebela synthesized bovine trypsin conjugates by coupling oligosaccharides 
to its lysine residues (Figure 2.1).  
Since the diffusion of enzymes into the gel pores during in-gel digestion is 
controlled by their size [2, 289],  we selected oligosaccharides so, that if lysine residues 
were almost completely modified, the molecular mass of the conjugate should not 
exceed approximately 35 kDa [1]. 
To obtain lactose, maltose and melibiose trypsin conjugates (LAC-BT, MAL-BT 
and MEL-BT, respectively) trypsin was reacted directly by the aldehyde (acyclic) forms 
of the disaccharides in the presence of sodium cyanoborohydride, which reduced 
intermediate Schiff bases (Figure 2.2 A). Maltotriose, raffinose, stachyose, α- and β-
cyclodextrin trypsin conjugates (MAT-BT, RAF-BT, STA-BT, ACD-BT and BCD-BT, 
respectively) were synthesized by coupling BT with oligosaccharides activated by 
potassium periodate oxidation (Figure 2.2 B). This was followed by the reduction with 
cyanoborohydride. Free arginyl residues in raffinose modified trypsin (RAF-BT) were 
optionally reacted with biacetyl, yielding an RAFR-BT with modified arginine residues. 
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In both glycosylation methods, BT was protected from autolysis during the reaction by 
its competitive inhibitor benzamidine.  
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Figure 2.1. Oligosaccharides applied for chemical modification of bovine trypsin. 
Disaccharides: maltose, lactose and melibiose; trisaccharides: maltotriose and raffinose; 
tetrasaccharide: stachyose and cyclodextrins (α-cyclodextrin). 
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Figure 2.2. Preparation of saccharide modified trypsins. 
A) Trypsin modification by disaccharides: a disaccharide (in this case, maltose) dissolved in 
water undergo mutarotation, resulting in partially acyclic molecules containing free aldehyde 
groups, which react with lysine residues of trypsin. The formed Schiff bases are subsequently 
reduced by cyanoborohydride.  
B) Trypsin modification by higher oligosaccharides: an oligosaccharide (in this case, 
maltotriose) is first oxidized with sodium periodate, resulting in a polyaldehyde, which reacts 
with lysine residues of trypsin via formation of a Schiff base. The final stabilization is achieved 
by cyanoborohydride reduction. 
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Marek Šebela determined the extent of trypsin modification by oligosaccharides. 
The degree of saccharide modification was independently measured in three ways: by 
spectrophotometric quantification of free amino groups, by spectrophotometric 
quantification of neutral sugar content and, in some cases, amino acid analysis via the 
content of unmodified lysine residues determined by amino acid analysis.  
Considering the total number of lysine residues in its sequence plus the N 
terminus, BT comprises 15 primary amino groups [141]. Despite large molar excess of 
modifying regents, a maximum of 9 modified lysine residues was achieved. The 
carbohydrate content of modified conjugates was in the range of 8 to 25%, which 
agreed well with the corresponding number of modified lysine residues. The amino acid 
analyses of RAF-BT, RAFR-BT and BCD-BT confirmed that the content of free lysine 
residues was substantially decreased (5, 4 and 5 residues per molecule, respectively) [1]. 
 
2.1.1.2 Glycosylated trypsins: molecular masses and pI values 
To further characterize the obtained trypsin conjugates Marek Šebela determined 
their molecular masses and pI values.  
The molecular masses of the conjugates were determined by discontinuous 
tricine-SDS-PAGE and by MALDI TOF MS. As anticipated, the molecular mass of the 
disaccharide conjugates of BT (~ 25 kDa) was only slightly higher than that of 
unmodified BT (~ 23 kDa), whereas masses of other conjugates were significantly 
higher (~ 27-33 kDa). The molecular mass of RAF-BT conjugate was directly 
determined by MALDI-TOF mass spectrometry as 26.29 kDa (Figure 2.3 A). Similarly, 
masses of MAL-BT and STA-BT were determined as 25.23 kDa and 28.52 kDa, 
respectively. Intact BT was detected as a narrow symmetric peak corresponding to a 
more accurate mass value of 23.29 kDa. After the coupling with relatively large 
molecules of the activated cyclodextrins, a strong mass heterogeneity of the produced 
BT conjugate was apparent. For example, MALDI-TOF spectrum of BCD-BT revealed 
a series of partially resolved peaks between m/z 29 032 and 33 260 with the most 
abundant component at m/z 31 126 (Figure 2.3 B). The mass differences between 
adjacent peaks in the series matched the mass of BCD [1].  
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Figure 2.3. MALDI-TOF mass spectra of intact RAF-BT and BCD-BT. 
(A) Spectrum of intact RAF-BT; (B) Spectrum of intact BCD-BT; 
Spectra were acquired in the linear mode by Dr. Jan Havliš, from Laboratory of functional 
Genomics and proteomics, Masaryk University, Brno, Czech Republic. 
 
  The single-chain form of BT (β-trypsin) is a strongly basic protein with pI 10.5 
[290]. Since lysine residues significantly contribute to the net charge, Šebela et al. 
performed IEF in order to estimate how their modification affected the pI of the 
enzyme. The RAF-BT band in IEF gel was more acidic (pI 6.7), compared to the native 
BT. Similar pI values were found for MAT-BT (6.6), RAFR-BT (5.9), STA-BT (6.3) 
and BCD-BT (6.1) [1]. 
 
2.1.1.3 Activity and thermostability of glycosylated trypsins 
To characterize kinetic properties of the synthesized conjugates, Marek Šebela 
determined their specific activity and Km values using a low molecular weight substrate 
BAPNA. The modification decreased the specific activity by 10-30 % compared to that 
of unmodified BT (28 nkat/mg), most substantially for the disaccharide conjugates 
(Table 2.1). Their Km values were all in the millimolar range, with no considerable 
difference compared to unmodified BT (Km = 2.8 mM). Thermostability of the 
conjugates was evaluated by their T50 constant, defined as a temperature at which 50% 
of the activity is retained upon 30 min incubation. T50 of unmodified BT was only 41°C. 
For LAC-BT, MAT-BT and MEL-BT, it was higher by ~ 10°C, and for MAT-BT, 
2 RESULTS AND DISCUSSION 49
 
 
RAF-BT, RAFR-BT and STA-BT by ~ 20°C. Among all conjugates, ACD-BT and 
BCD-BT were the most stable with T50 close to 70°C [1] (Table 2.1). 
 
Table 2.1: Catalytic activity and thermostability of saccharide modified trypsin 
conjugates determined by BAPNA substrate. 
native BT LAC-BT MAL-BT MEL-BT MAT-BT RAF-BT RAFR-BT STA-BT ACD-BT BCD-BT
activitya [nkat/mg] 28.4 10.7 11.4 11.6 25.6 21.4 18.1 20.6 22 20.5
Km
b [mM] 2.8 3 2.8 2.8 3.6 3.1 3.1 5.1 3.3 4.2
T50
c [oC] 41 50 48 49 60 57 68 58 67 68
 
a the calculated specific activity for BAPNA substrate;  
b the calculated Michaelis constant for BAPNA substrate; 
c the temperature at which 50% of enzyme activity is retained upon 30 min incubation; 
The data were obtained by Prof. Dr. Marek Šebela, Department of Biochemistry, Palacky 
University, Olomouc, Czech Republic. 
 
Figure 2.4 shows a plot of the residual enzyme activity versus the temperature of 
incubation for intact BT and for MAT-BT and BCD-BT conjugates.  
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Figure 2.4. Thermostability of modified trypsin conjugates. 
Enzyme aliquots were incubated at different temperatures ranging from 20 to 75°C for 30 min: 
BT (-■-), MAT-BT (-●-) and BCD-BT (-▲-). After rapid cooling, residual activity was 
determined by hydrolysis of BAPNA substrate at 30°C. The corresponding T50 values are 
indicated by vertical lines. The data were obtained by Prof. Dr. Marek Šebela, Department of 
Biochemistry, Palacky University, Olomouc, Czech Republic. 
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Importantly, the increased T50 resulted in more efficient cleavage of BAPNA at 
elevated temperatures. The rate of BAPNA cleavage by RAF-BT increased up to 55°C 
and then remained constant up to 70°C, whereas for BT it rapidly declined above 50°C 
[1].  
 
2.1.1.4 Glycosylation of bovine trypsin: what was achieved? 
Šebela et al. introduced oligosaccharide conjugating of bovine trypsin as facile 
and inexpensive method, which significantly increased its thermostability and 
suppressed autolysis. Since oligosaccharides moieties are relatively small the conjugates 
can be used for in-gel digestion of proteins. Better thermostability and autolysis 
resistance of glycosylated trypsins compared to its unmodified form enable their 
implementation in accelerated digestion protocol [2]. 
 
2.1.2 Performance of glycosylated trypsins in accelerated in-gel digestion of 
proteins 
 Conventional in gel-digestion by BT is performed at 37°C overnight. Accelerated 
in-gel digestion protocol (ADP) developed by Havliš et al. applies thermostable 
methylated porcine trypsin at higher enzyme concentrations (compared to conventional 
digestion) and at higher temperature (55°C), enabling to reduce digestion time to 0.5-1 h 
[2]. Based on the kinetic study Havliš demonstrated that ADP dramatically simplifies 
and accelerates the sample preparation routine without compromising the yield of 
digestion products, sensitivity of peptide detection and confidence of protein 
identification. In line with protocol established by Havliš et al. [2] I set out to evaluate 
the performance of trypsin conjugates in in-gel digestion at accelerated temperature. To 
this end I digested in-gel several standard proteins using BT (under conventional 
conditions) and its glycosylated conjugates (under accelerated conditions). The obtained 
digests were analyzed by MALDI TOF MS. Here I aimed to compare the quality of 
their peptide mass fingerprints and confidence of protein identification. Further I aimed 
to analyze whether the cleavage specifity of the modified enzymes was altered 
compared to their unmodified form. And finally I compared the number of autolytic 
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products and their abundance of trypsin conjugates with those of unmodified bovine 
trypsin. 
 
2.1.2.1 In-gel digestion of protein standards by glycosylated trypsins 
 5 pmol of standard proteins (Cytochrom C, Myoglobin, Aldolase, and BSA) were 
separated by gel electrophoresis, stained with Coomasie and digested by BT (under 
conventional conditions: overnight digestion at 37°C and enzyme concentration about 
0.5 μM) and glycosylated trypsins (under accelerated conditions: 1-3 h digestion at 
55°C and higher enzyme concentration ranging from 0.9 to 3 μM). The obtained 
peptides were subsequently analyzed by MALDI-TOF MS.  
 The reaction temperature of 55°C was selected to balance the reaction rate against 
the rate of thermal inactivation, both of which accelerate along with the temperature 
increase. The relatively high load of protein standards allowed me to acquire spectra 
that were rich in tryptic peptides, and hence I could better evaluate and find possible 
changes in the cleavage specificity of the trypsin conjugates. In acquired MALDI TOF 
spectra, m/z of all peaks with S/N ratio > 2 were fetched and used for searches against 
MSDB protein sequence database with mass tolerance 150 - 200 ppm. Figure 2.5 a 
represents peptide mass fingerprint of a BSA in-gel digest (5 pmol) obtained by 
accelerated digestion using RAF-BT at 55°C and at the enzyme concentration of 0.86 
μM; the digestion time was 1.5h. All abundant peaks matched m/z of BSA tryptic 
peptides when searched against protein sequence database, whereas autolytic 
background (see chapter 2.1.2.2) of the applied enzyme (peaks m/z 2162.885, 2272.984 
and 2288.987, corresponding to the autolysis products LGEDNINVVEGNEQFISASK, 
SIVHPSYNSNTLNNDIMLIK and SIVHPSYNSNTLNNDIM(ox)LIK) didn’t overload 
the spectrum and didn’t hamper the peak picking. Altogether, nineteen BSA peptides 
could be identified upon database search (Figure 2.5 b), covering 28% of protein 
sequence (Figure 2.5 c).  
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Figure 2.5: MALDI TOF MS analysis and protein identification upon database 
searching of BSA in-gel digest obtained by accelerated digestion using RAF-BT. 
(a) Peptide mass map of a BSA in-gel digest. A gel band containing 5 pmol BSA was digested 
by RAF-BT at 55°C; the digestion time was set at 1.5h and the applied enzyme concentration 
was 0.86 µM (enzyme stock solution was subjected to amino acid analysis in the laboratory of 
Dr. Hunziker (University of Zürich, Switzerland)); (b) peptides identified upon database 
searching. Peaks with S/N ratio > 2 were fetched and submitted for searches against MSDB 
protein sequence database with mass tolerance 150 - 200 ppm, up to one miss cleavage site was 
allowed and oxidation of methionine was considered as possible modification. BSA tryptic 
peptides are highlighted by red lines in the spectrum; peaks 2162.885, 2272.984 and 2288.987 
correspond to the tryptic peptides of RAF-BT: LGEDNINVVEGNEQFISASK, 
SIVHPSYNSNTLNNDIMLIK and SIVHPSYNSNTLNNDIM(ox)LIK; (c) sequence coverage 
of identified peptides. 
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 Further I compared the sequence coverage (determined as % of the full-length 
protein sequence covered with the matched peptides) of peptide mass maps of the 
digests produced by the BT conjugates with the maps obtained by conventional 
digestion using BT (37°C, overnight) or accelerated digestion using MET-PT (1 h at 
55°C) [2] (Table 2.2).  
MAT-BT, RAF-BT, RAFR-BT and STA-BT performed well under conditions of 
the accelerated in-gel digestion protocol [2]. The sequence coverage and MOWSE 
scores [170] (a merit of statistical significance provided by MASCOT database 
searching software) of the peptide mass maps acquired from the digests with 
glycosylated trypsins or MET-PT (1h at 55°C) and with BT (overnight, 37°C) were 
similar [1] (Table 2.2). Moreover, MALDI TOF peptide mass fingerprints obtained 
from digests by trypsin conjugates were comparable to those acquired from digests by 
unmodified BT or by methylated porcine trypsin, suggesting that their cleavage 
specifity remained unchanged. 
 
Table 2.2: MALDI TOF peptide mass fingerprints of protein standards in-gel 
digested by BT and its conjugates. 
Protein
standard Pep- Cover- Pep- Cover- Pep- Cover- Pep- Cover- Pep- Cover- Pep- Cover-
tides age (%) tides age (%) tides age (%) tides age (%) tides age (%) tides age (%)
Cytochrome C 7 53 10 63 7 30 5 45 6 45 7 43
Myoglobin 12 76 10 71 11 74 11 74 11 74 12 80
Aldolase 15 34 19 49 15 46 15 39 17 45 17 47
BSA 20 32 21 35 16 27 19 28 14 20 10 17
RAFR-BT STA-BTBT (Roche) MET-PT (Promega) MAT-BT RAF-BT
 
Applied digestion conditions: conventional digestion was performed overnight at 37°C by 
commercially available BT (Roche) at an enzyme concentration of 0.5 μM; accelerated 
digestion by MET-PT (Promega) was performed for 1.5 h at 55°C and an enzyme concentration 
of 0.75 μM; accelerated digestion by glycosylated trypsins was performed for 1.5 h at 55°C; the 
applied enzyme concentrations were for MAT-BT 0.98 μM, for RAF-BT 0.86 μM, for RAFR-
BT 1.2 μM and for STA-BT 1.04 μM. 
 
In MALDI-TOF spectra of in-gel digest obtained by LAC-BT, MAL-BT and 
MEL-BT conjugates none detectable peptides of the analyzed proteins were found. 
ACD-BT and BCD-BT, which efficiently digested proteins in solution, demonstrated 
only marginal activity in in-gel digestion. Figure 2.6 demonstrates the peptide yield 
observed by in-gel digestion of BSA using methylated porcine trypsin and glycosylated 
2 RESULTS AND DISCUSSION 54
 
 
trypsins under accelerated conditions as described in experiment before. Digestion 
yields were obtained in kinetic study (see chapter 2.1.3) using 18O-labeled peptides as 
internal standards. The determined yield of conventional digestion was 2.8 pmol, 
accelerated digestion by MET-PT achieved 76 % of CDP yield, whereas MAT-BT, 
RAF-BT, RAFR-BT, STA-BT and BCD-BT reached 33, 39, 63, 20 and 5 % of CDP 
yield, respectively. Although the efficiency of glycosylated trypsins is lower than those 
of methylated porcine trypsin, their higher thermostability and autolysis resistance 
enable adjustment of optimal digestion conditions at higher temperature and enzyme 
concentration. 
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Figure 2.6: Bar diagram representing averaged peptide yield observed by in-gel 
digestion of BSA using methylated porcine trypsin and glycosylated trypsin 
derivates under accelerated conditions. 
Gel bands containing 5 pmol BSA were digested by MET-PT, MAT-BT, RAF-BT, RAFR-BT, 
STA-BT and BCD-BT at 55°C; the digestion time was set at 1.5h and the applied enzyme 
concentrations were 0.75; 0.98; 0.86; 1.2; 1.04 and 0.88 µM, respectively. The digestion yields 
were obtained by kinetic study using 18O-labeled peptides as internal standards (as described in 
chapter 2.1.3). The coloured bars represent the averaged digestion yields generated by MET-PT, 
MAT-BT, RAF-BT, RAFR-BT, STA-BT and BCD-BT (green, purple, pale pink, blue, pink and 
yellow, respectively). The digestion of CDP was 2.8 pmol. 
 
Since the digestion efficiency of BCD and ACD-BT conjugates was very low only 
MAT-BT, RAF-BT, RAFR-BT and STA-BT were subjected to further kinetic study. 
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2.1.2.2 Autolytic background of glycosylated trypsins 
To determine the number and relative abundance of autolysis products, I 
performed control digests of blank gel slabs. The digestion was performed overnight at 
37°C and at an enzyme concentration of ~ 1.0 µM. MALDI-TOF mass spectra of 
autodigests of MAT-BT, RAF-BT, RAFR-BT and STA-BT were acquired and 
compared with the autolytic peptide pattern of BT. Among detected peaks 1020.54 
(peptide APILSDSSCK), 1111.49 (peptide VCNYVSWIK), 2163.06 (peptide 
LGEDNINVVEGNEQFISASK), 2273.18 (peptide SIVHPSYNSNTLNNDIMLIK) and 
2289.18 (peptide SIVHPSYNSNTLNNDIM(ox)LIK) were major autolytic peaks of 
unmodified bovine trypsin (Fig. 2.7 a). But also peptides originating from human 
keratins and minor autolysis products of trypsin were detected. Altogether, six tryptic 
peptides of BT were identified by search in the MSDB protein sequence database (Fig. 
2.7 b). On the contrary, only three tryptic peptides from BT (Figure 2.8), corresponding 
to the peptides LGEDNINVVEGNEQFISASK with m/z 2163.1, SIVHPSYNSN-
TLNNDIMLIK with m/z 2273.2 and SIVHPSYNSNTLNNDIM(ox)LIK with m/z 
2289.2 were found in the autodigests of MAT-BT, RAF-BT, RAFR-BT and STA-BT 
(Fig. 2.7 b). The intensity ratio of the major peaks (m/z 2163.1 and 2273.2) strongly 
varied among the spectra. Importantly, the autodigests of the conjugates contained 
fewer minor autolytic peptides, which complicate database searching and might lead to 
incorrect interpretations. Thus, lower number of autolytic and background peptides of 
trypsin conjugates enhanced the specifity of protein identification (Fig. 2.7 b).  
Interestingly, that the peaks at m/z 2163 and 2273 detected in autodigests of BT 
(as the most abundant peaks) and its conjugates contain C-terminal Lys but not Arg 
residues. The sequence of bovine trypsinogen (Swiss-Prot access. code P00760) 
comprises 243 amino acids, from which the region 21-243 represents the mature chain 
of β-trypsin. The above peptides are located in successive positions 70-89 and 90-109. 
The crystal structure of BT complex with 2-aminobenzimidazole) was downloaded 
from the RCSB Protein Data Bank (www.rcsb.org/pdb). Using the program 
DeepView/Swiss-PdbViewer v3.7 (www.expasy.org/spdbv), we observed that Lys89 
and Lys109 are located close to each other at the molecule surface being in a distance of 
7 Å (Figure 2.9). Because of sterical reasons, they probably cannot be both reacted by 
bulky substituents (for example α-cyclodextrin molecule is about 20 Å long [291], but 
there is only one of them modified randomly [1]. 
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Figure 2.7: Peptide mass fingerprints of autolysis products of BT and MAT-BT. 
(a) Peptide mass fingerprint of BT autolyzate; (b) trypsin peptides identified from the spectrum 
(a) by MASCOT search against MSDB protein sequence database with mass tolerance of 150 
ppm (c) peptide mass fingerprint of MAT-BT autolyzate. Blank gel slabs were incubated in BT 
and MAT-BT (both 1.0 µM) in 50 mM ammonium bicarbonate at 37°C for 12 h. Then aliquots 
(1 µL) were withdrawn and analyzed by MALDI-TOF MS using a CHCA matrix. 
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GYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVR LGEDNINVVEGNEQFISASK  SIVHPSYNSNTLNNDIMLIK LKSAASLNSRVASISLPTSCASAGTQCLISGWGN
----------BT--------- --------BT----------
--------RAF-BT------- -------RAF-BT-------
--------RAFR-BT------ -------RAFR-BT------
--------STA-BT------- -------STA-BT-------
--------BCD-BT------- -------BCD-BT-------
TK SSGTSYPDVLK CLK APILSDSSCK SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK LQGIVSWGSGCAQK NKPGVYTK VCNYVSWIK QTIASN
----BT----- ----BT---- -----BT------- ---BT----
Figure 2.8: Autolytic peptides of BT and its conjugates within sequence of BT. 
Tryptic peptides of BT and its conjugates detected by MALDI TOF MS are highlighted in red 
colour. Dotted lines underline peptides obtained by autolysis of BT or of its glycosylated 
derivates. 
 
   
        
Figure 2.9: Crystal structure of BT complex with 2-aminobenzimidazole. 
The picture was downloaded from the RCSB Protein Data Bank (www.rcsb.org/pdb). Program 
DeepView/Swiss-PdbViewer v3.7 (www.expasy.org/spdbv) was used to observe location of 
trypsin cleavage sites. Red lines represent peptides LGEDNINVVEGNEQFISASK (m/z 
2163.1) and SIVHPSYNSNTLNNDIMLIK (m/z 2273.2); dotted line shows difference of 7 Å 
between Lys89 and Lys109. 
 
2.1.2.3 Dried-droplet probe preparation method for MALDI analysis 
For preparation of MALDI probes I applied dried-droplet method developed by 
Thomas et al. [292]. In this method peptides retain and co-crystallize with the CHCA 
matrix at the hydrophobic polymer surface of the target, while salts and the hydrophilic 
impurities are pooled at the hydrophilic metal anchor. Concentration of the matrix, as 
well as of water and organic solvent are perfectly adjusted in the dried-droplet method 
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for MALDI TOF MS analysis of the tryptic digests produced by CDP, resulting in high 
sensitivity, low matrix-related background and high quality of the acquired spectra. 
However, this method has been observed to be less compatible with saccharide 
modified trypsins. Matrix crystals obtained from in-gel digests of proteins by 
glycosylated trypsins were visually normal (comparable with these derived from 
conventional digestion), but they were relatively rapidly depleted by laser pulses and 
often produced low quality noisy spectra. From several crystals no peptide signals were 
detected in the acquired TOF mass spectra. These effects were stronger pronounced at 
higher enzyme concentration (above 1.5 µM), suggesting that sugar oligomers might 
inhibit desorption of peptides from the matrix crystals (since no trypsin autolysis 
products were also observed). In addition, presence of hydrophilic sugar residues might 
change crystallization efficiency of the tryptic peptides on the target.  
In order to achieve acquisition of good quality spectra accumulation of high 
number of shots was in all experiment required. 
 
2.1.2.4 Performance of glycosylated trypsins in accelerated in-gel digestion of 
proteins: what did we learn? 
In this part of my work I demonstrated that glycosylated trypsins efficiently digest 
proteins under accelerated conditions. They have the same cleavage specificity as BT 
and produce less autolytic background, hence increasing the specifity of protein 
identification. Their better thermostability and autolysis resistance compared to MET-
PT make them promising candidates to further improve protocol of accelerated in-gel 
digestion of proteins developed by Havliš et al. [2].  
Dried-droplet probe preparation routinely applied for MALDI analysis of tryptic 
digests obtained from CDP was less compatible with digests produced by saccharide 
modified trypsins. Generally, increased acquisition time should be taken in account in 
order to acquire spectra of sufficient quality. The above described difficulties in 
acquisition of spectra at increased concentration of glycosylated trypsins set a limit for 
the applied enzyme concentration in further experiments. 
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2.1.3 Kinetic study of accelerated in-gel digestion of proteins by glycosylated 
trypsins 
 Next I set out to evaluate the catalytic efficiency of trypsin conjugates in 
accelerated in-gel digestion of proteins. To this end I studied kinetics of in-gel digestion 
by MALDI TOF MS and applied 18O-labeled peptides as internal standards for 
quantifying the yield of digestion products. In order to optimize the digestion 
conditions, I aimed to study the effect of the temperature, enzyme concentration and 
digestion time on the digestion yield. Optimized accelerated digestion protocol was 
subsequently applied by the identification of members of a protein complex isolated 
from the budding yeast. 
 
2.1.3.1 Quantification method: 18O labeling and deconvolution 
The study of digestion kinetics relies on quantifying the yield of in-gel digestion 
products for optimization of digestion efficiency. A relatively simple and convenient 
isotope labeling approach is based on endoprotease-catalyzed incorporation of 18O 
atoms in the C-terminal carboxylic acids during digestion of proteins [259, 293, 294].  
18O-labeled internal standards applied in my quantification experiments were 
generated by in-solution digestion of the model protein BSA in isotopically enriched 
water containing 95% 18O. Previously Havliš et al. evaluated the yield of in-solution 
digestion using synthetic peptides and showed that it is close to 100% [2]. Therefore, 
the protein concentration should be directly proportional to the average concentration of 
individual tryptic peptides in the digest. Thus 18O-labeled peptides can be used for 
absolute quantification of digestion products.  
The general scheme of quantification experiment by 18O-labeled internal 
standards is depicted in Figure 2.10. BSA was used as a model protein for the kinetic 
study. The amount of protein contained in a gel band was relatively high (5 pmol), 
enabling better signal-to-noise ratio, which improves the accuracy of quantification. In 
addition, it allowed compensating various yields of digestion products generated by 
differently modified conjugates.  
In-gel digestion was performed as described in chapter 4.1.2.4 according to the 
tested digestion conditions. Obtained peptides were extracted from the gel matrix and 
extracts were subsequently dried down in a vacuum centrifuge. To prepare a mixture of 
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18O-labeled peptides for the quantification experiment, a solution of 0.3 pmol/μL BSA 
in 25 mM ammonium bicarbonate buffer in H218O was digested overnight at 37°C and 
an enzyme:substrate ratio 1:50 (w/w). Tryptic peptides from in-gel digests were 
redissolved in 10 μL of internal standard and analyzed by MALDI TOF MS.  
MALDI TOF MS
ISTD:
BSA in solution digest in 95% H2
18O
In-gel digestion of BSA (5pmol)
by trypsin conjugates
Extraction of peptides from
the gel matrix
Evaporation of the solvent
using vaccum centrifuge
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Lys/Arg
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Figure 2.10: A workflow for absolute quantification of in-gel digestion products 
using 18O-labeled peptides as internal standards. 
Part highlighted in red colour represents the workflow of in-gel digestion; BSA (5pmol) was in-
gel digested according to the tested conditions; the tryptic peptides were extracted and the 
extract was dried down. Subsequently the peptides were redissolved in 10 μL of 0.3 μM ISTD 
obtained by tryptic digestion of BSA in the buffer containing 95% H218O. An aliquot from the 
obtained mixture was withdrawn, cocrystallized on a sample plate with a matrix solution and 
analyzed by MALDI TOF MS.  
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The incorporation of second 18O into the carboxyl termini of peptides is usually 
incomplete in enzyme-catalyzed reaction. Figure 2.11 a shows merged isotopic clusters 
containing unlabeled BSA peptide DAFLGSFLYEYSR (m/z 1567.74) and its mono-
18O-and double-18O-labeled internal standard.  
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Figure 2.11: Spectral pattern of merged isotopic clusters of a BSA peptide 
DAFLGSFLYEYSR  (m/z 1567.74) and its 18O-labeled standard. 
a) Merged isotopic clusters containing unlabeled peptide and its mono-18O-and double-18O-
labeled internal standard. Symbol A represents peak areas. 1A (highlighted in red) labeled peaks 
refer to underivatized peptide isotopic peaks (1A1 – 1A5), 2A (highlighted in blue) refer to single-
18O-labeled peptide (2A1 – 2A5) and 3A (highlighted in green) refer to double-18O-labeled peptide 
(peaks (3A1 – 3A5). The star character refers to the convoluted peak area value (e.g. *3A = 3A1 + 
1A5 + 2A3). (b) Isotopic distribution for peptide DAFLGSFLYEYSR (m/z 1567.74) computed 
by program PeptideProspector 4.0.4 (University of California, http://prospector.ucsf.edu); 
coefficients f1-f5 were: 1; 0.91; 0.46; 0.16; 0.05, respectively. 
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Monoisotopic peaks from single-18O-labeled and double-18O-labeled internal 
standard differ from the monoisotopic peak of unlabeled peptide by 2 and 4 Da, 
respectively. In Figure 2.11 a the monoisotopic peak at m/z 1569.94 of the single-18O-
labeled internal standard overlaps with third isotopic peak of the unlabeled peptide (45.5 
% of the intensity of the monoisotopic peak). The intensity of the monoisotopic peak 
m/z 1571.94 of the double-18O-labeled internal standard is affected by third isotopic 
peak of the single-18O-labeled peptide and by fifth isotopic peak of the unlabeled 
peptide. 
To calculate the peptide amount from MALDI TOF spectra a signal 
deconvolution method was employed. 
The relation between the amount of non-labeled peptide of a sample, n16, and both 
forms of 18O-labeled peptide amount of the internal standard, n18 is defined in equation 
1. The A16/A18 represents the ratio of peak areas of sample and internal standard. 
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(Equation 1) 
 
The equation 2 defines the peak areas for both, sample and internal standard, 
presuming that maximum of 5 isotopic peaks per compound has peak areas resolvable 
from noise. 
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The equations 3 calculate the peak areas for unlabeled and 18O labeled peptides, 
considering each single isotopic peak as a fraction of the first isotopic peak. The 
theoretic isotopic distributions for all peptides used in quantification experiments were 
calculated using program PeptideProspector 4.0.4 (University of California, 
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http://prospector.ucsf.edu), presuming that the differences in isotopic distribution ratios 
for 18O-labeled and unlabeled peptide are negligible. 
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(Equation 3) 
 
The obtained extended equation 1 can be further rearranged and simplified as it 
can be seen in equation 4: 
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(Equation 4) 
 
The equations 5 and 6 express the peak areas for the first isotopic peaks of the 
single and double labeled forms of the peptide (*2A1 and *3A1, peak areas of the peaks 
m/z 1569.939 and m/z 1571.938 in Figure 2.11 a): 
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Finally, establishing these expressions into the equation 4, we obtain after 
rearrangement equation 7, which can be used for quantification calculations: 
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(Equation 7) 
 
In this equation *3A1 and *2A1 are the areas of the isotopic peaks spaced from the 
monoisotopic peak of the unlabeled peptide by 2 and 4 Da, respectively (peaks 1569.94 
and 1571.94 in Figure 2.11 a). Coefficients f3 and f5 are the calculated ratios of the 
intensity of, respectively, third (+ 2 Da) and fifth (+ 4 Da) isotopic peaks to the intensity 
of the monoisotopic peak of the unlabeled peptide (f3 = 0.46 and f5 = 0.05 for the 
peptide DAFLGSFLYEYSR (m/z 1567.74) in Figure 2.11).  
The above described calculations take into account both the incomplete 
incorporation of 18O and differences in natural isotope distributions of individual 
peptides.  
 
2.1.3.2 What factors affect labeling stability and efficiency? 
Schnolzer et al. [262] systematically studied enzyme-catalyzed 18O-labeling of 
peptides during proteolytic digestion and reported that trypsin, Lys-C, and Glu-C 
incorporate two 18O atoms into the carboxyl termini of all peptides, except the original 
protein carboxyl termini. On the contrary, some reports indicate that lysine-terminated 
peptides do not incorporate two oxygen labels efficiently [295, 296].  
Application of 18O-labeled internal standards requires their stability and therefore 
their general exchange characteristics should be well understood in order to ensure 
analytical accuracy of protein quantification. Therefore I investigated some parameters, 
which affect the labeling efficiency, including effect of pH and nature of the peptide. 
Labeling efficiency (0-100%) in this context refers to the degree to which a peptide is 
labeled with one or two 18O atoms. Labeling can be considered 100% if there remains 
no unlabeled peptides, i.e. at least one 18O atom is incorporated. Further, the efficiency 
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can be then differentiated between singly and doubly labeled peptides, whereas 100% 
double labeling is the maximum labeled state. 
The effect of pH on the stability of 18O-labeled peptide was studied by digestion 
of BSA in 95% atom abundance H218O and subsequent dilution with 16O water 
containing formic acid (FA), so that its amount in the mixture ranged from 0 to 5% 
(v/v). Formic acid is used to reduce the pH and stop the digestion by inhibiting trypsin 
activity. Consistent with previously reports my results [262, 294] confirmed that under 
pH higher than 5 (low content of FA, < 1 % (v/v)) the enzyme is still active and 
continues to catalyze the back-exchange in medium containing 16O. To avoid back-
exchange by mixing of 18O-labeled internal standard with the sample, containing 16O 
acidic conditions (pH 3-4) should be maintained. 
Then I studied the relative labeling efficiency (labeled to non-labeled) and relative 
degree of labeling (18O1/18O2) for different peptides generated by digestion of BSA in 
95% H218O. To this end, I monitored the changes in 18O labeling in dependence on 
digestion time (30 min, 1.5h, 3h and overnight digestion) and temperature (digestion 
temperatures were 22, 37 and 55°C). The labeling efficiency (16O/18O) was in all cases 
close to 95% as is consistent with enzyme-catalyzed hydrolysis of protein. However, the 
degree of labeling (18O1/18O2) was less consistent. My experiments showed that 
incorporation of second 18O was less pronounced by peptides containing lysine-termini 
(Figure 2.12). Although, the degree of labeling with two 18O of arginine terminated 
peptides was in general close to 92% (at all tested temperatures and hydrolysis times; 
Figure 2.13, a), peptides terminated by lysine showed in major cases slow incorporation 
of the second 18O into their carboxyl termini and strong dependence on the digestion 
temperature (Figure 2.13, b). While lysine containing peptide FKDLGEEHFK 
(MR=1248.61) incorporated about 30% of 18O in double-labeled form upon 1.5h 
digestion at temperature 22 and 37°C and about 80% upon overnight digestion at the 
same temperatures, at higher temperature (55°C) the labeling degree with 18O2 increased 
from 5 to 10% during 1.5h of digestion and remained constant, as expected, due to the 
thermal deactivation of trypsin. 
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Figure 2.12: MALDI TOF spectra of peptides DAFLGSFLYEYSR (m/z 1567.74) 
and FKDLGEEHFK (m/z 1249.61) obtained by BSA tryptic digestion in the buffer 
containing 95% H218O. 
(a) and (b) MALDI TOF spectra of peptides DAFLGSFLYEYSR (m/z 1567.74) and 
FKDLGEEHFK (m/z 1249.61), respectively; digestion was performed at 37°C and terminated 
with 5% formic acid after 0.5; 1.5; 4 and 12 h of incubation. Arrows demonstrate monoisotopic 
peaks of unlabeled (red), single-18O-labeled (blue) and double-18O-labeled (green) peptides. 
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Figure 2.13: Degree of labeling (18O2 / 18O1) for peptides DAFLGSFLYEYSR (m/z 
1567.74) and FKDLGEEHFK (m/z 1249.61) obtained by BSA tryptic digestion in 
the buffer containing 95% H218O at different temperatures. 
(c) and (d) degree of labeling (18O2 / 18O1) for peptides DAFLGSFLYEYSR (m/z 1567.74) 
and FKDLGEEHFK (m/z 1249.61), respectively;  coloured curves represent 18O2 / 18O1 
obtained for both peptides at different digestion temperatures (red 55°C, green 37°C and blue 
22°C). 
 
 
My results were consistent with several researches, which showed that the degree 
of 18O labeling is not universal consistent from peptide to peptide and is dependent on 
the nature of the peptide [294-296]. Schnolzer et al. [262] suggested the mechanism of 
enzyme-catalyzed 18O labeling. This process can be divided into two parts: 1) cleavage 
of the peptide amid bond by formation of acyl-enzyme intermediate at the C-terminus of 
the newly formed peptide, which is then hydrolyzed to form the free peptide and 2) 
incorporation of the second 18O atom by reformation of a peptide-trypsin ester complex 
and its subsequent hydrolysis [262] (Figure 2.14). The incorporation of a second 18O 
atom is dependent, whether a formed peptide fragment is accepted as a pseudo-substrate 
ester intermediate and is dependent on the nature of peptide. My results suggest that 
lysine-terminated peptides have poorer enzyme-substrate selectivity compared to 
peptides terminated by arginine, what results in less efficient incorporation of a second 
18O. 
 
0
20
40
60
80
100
0 2 4 6 8 10 12 14 16 18
55°C
37°C
22°C
Time [h]
b)
0
20
40
60
80
100
0 2 4 6 8 10 12 14 16 18
55°C
37°C
22°C
Double labeled peptide a)
2 RESULTS AND DISCUSSION 68
 
 
 
Figure 2.14: Mechnism of enzyme-catalyzed 18O incorporation during proteolysis. 
(adapted from Yao, X et al.) Upper part includes formation of acyl-enzyme intermediate at the 
C-terminus of the newly formed peptide, which is then hydrolyzed to form the free peptide. 
Lower part includes the incorporation of the second 18O atom: a peptide-trypsin ester complex is 
reformed and subsequently hydrolyzed. 
 
 
Since arginine terminated peptides show more than 90 % double labeling they can 
be used for absolute quantification without complex deconvolution method. So the 
equation 7 can be simplified to equation 8: 
 
*n    =16
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18
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(Equation 8) 
 
In addition, MALDI peptide mass fingerprints of tryptic digests are dominated by 
peptides containing arginine residues at the C-terminus, due to differential ionization 
effects and the basicities of arginine- and lysine-containing peptides [25, 297]. 
Therefore for my kinetics studies following three Arg-containing peptides were applied: 
YLYEIAR, m/z 927.49; LGEYGFQNALIVR, m/z 1479.79; and DAFLGSFLYEYSR 
m/z 1567.74 (Figure 2.15). The yield of digestion was calculated by averaging the 
amount of these peptides. 
 
2 RESULTS AND DISCUSSION 69
 
 
900 1700160015001400 18001300120011001000 210020001900 240023002200 2500 2600
100
re
la
tiv
e 
in
te
ns
ity
m/z
KVPQVSTPTLVEVSR
1639.94
DAFLGSFLYEYSR
LGEYGFQNALIVR
1479.80
1567.74
RHPEYAVSVLLR
1439.81
FKDLGEEHFK
1249.62
YLYEIAR
927.49
HLVDEPQNLIK
1305.72
LVNELTEFAK
1163.62
DTHKSEIAHR
1193.59
1568 1570 1572 1574
933931929 m/z
m/z
m/z1480 1482 1484 1486
1571.938
1569.939
1567.94
1479.958
1481.957
1483.958
927
931.665
929.667
927.647
 
Figure 2.15: MALDI TOF spectrum of the mixture containing BSA peptides 
obtained by in-gel digestion and their 18O-labeled internal standards. 
BSA (5pmol) was in-gel digested; the tryptic peptides were extracted and the extract was dried 
down. The obtained peptides were redissolved in 10 μL of 0.3 μM ISTD prepared by BSA 
tryptic digestion in the buffer containing 95% H218O. Tryptic peptides of BSA are depicted in 
the spectrum by arrows with corresponding peptide sequences and m/z calculated for the 
unlabeled monoisotopic ions. Blowouts demonstrate merged isotopic clusters of the peptides 
YLYEIAR, m/z 927.49; LGEYGFQNALIVR, m/z 1479.79; DAFLGSFLYEYSR m/z 1567.74 
and their 18O-labeled internal standards. 
 
2.1.3.3 18O labeling approach: what is important? 
18O labeling approach investigated above provides a relatively simple and 
sensitive method for absolute quantification of proteins in a variety of proteomic 
applications. It has been demonstrated that under mild acidic conditions typically used 
for ESI- and MALDI-MS, 18O-containing carboxyl groups of peptides are sufficiently 
stable. Theoretically, all labeled tryptic peptides can be applied for quantification. 
However, in practice, the number of peptides which can be used for quantification by 
MALDI TOF MS is lower, due to lower (more than 5 times) signal intensities of lysine- 
(compared to Arg)  containing peptides and their poorer enzyme-substrate selectivity, 
which slows incorporation of second 18O into the C-terminal carboxylic acid (so 
requiring deconvolution of isotopic clusters). For this reasons, arginine-containing 
peptides should be favoured in proteomic quantification studies. 
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2.1.3.4 Kinetic study: effect of digestion time and enzyme concentration on the 
recovery of tryptic peptides 
  In the following kinetic study I first monitored the time course of in-gel digestion 
at elevated temperature. To this end BSA gel bands (5pmol) were digested for 0.5h, 1.5 
h, 3 h, and overnight at 55°C by glycosylated trypsins (Figure 2.16); concentration of 
the modified enzymes was on average 0.5 μM and the yield of conventional digestion 
(37 °C, overnight, by native BT at the concentration ~ 0.5 μM) was used as a reference. 
Between 5 and 20% of conventional digestion yield was reached in 30 min of digestion 
by RAF-BT, MAT-BT and STA-BT; about 30 % was achieved by RAFR-BT. 
Overnight cleavage resulted about 40 % of conventional digestion yield for STA-BT 
and between 50 and 70 % for MAT-BT, RAF-BT and RAFR-BT (Figure 2.16).  
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Figure 2.16: Time course of averaged peptide yield observed by in-gel digestion of 
BSA at elevated temperature using glycosylated trypsins at an enzyme concentration 
in average 0.5 µM. 
BSA bands (5 pmol) were in-gel digested by glycosylated trypsins at 55°C; digestion times 
were: 30, 1.5h, 3h, and 12h. The applied enzyme concentrations ranged from 0.43µM for RAF-
BT to 0.6µM for RAFR-BT (enzyme stock solutions were subjected to amino acid analysis in 
the laboratory of Dr. Hunziker (University of Zürich, Switzerland)). The coloured bars represent 
the digestion yields generated by trypsin conjugates (purple, pale pink, blue and pink); yellow 
bar represents the recovery of the conventional digestion (37°C, overnight, BT at concentration 
~ 0.5 μM). 
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According to the enhanced in-gel digestion protocol developed by Havliš et al. [2] 
I set out to investigate whether the low yield of 30 min digestion can be improved by 
increasing the enzyme concentration. T50 constants of the glycosylated trypsins (defined 
as a temperature at which 50% of the enzyme activity is retained upon 30 min 
incubation) are by ~20°C higher than T50 constant of unmodified BT. I assumed that the 
partial deactivation and autolysis of the enzymes for a short time might not negatively 
impact the yield of digestion and might not overpopulate spectrum with autolytic 
products. BSA gel bands were digested for 30 minutes at different enzyme 
concentrations ranging from 0.5 to 3 μM. Consistently with previously reported results 
[2] about 65 % of the yield of conventional digestion was reached by protein digestion 
with methylated porcine trypsin (Promega) at enzyme concentration of 0.75 μM and 
more than 100 % at concentration between 1 and 1.5μM. Protein digestion by MAT-BT, 
RAF-BT and STA-BT at concentrations between 0.5 and 1 μM resulted in less than 
20% of conventional digestion yield and achieved for RAFR-BT about 40% (Table 2.3). 
As anticipated, the digestion yield increased with increased concentrations of modified 
enzymes. The recovery of 40 to 50% of conventional digestion was reached by all 
glycosylated trypsins at enzyme concentrations between 2 and 3 μM. However, the 
digests were strongly contaminated with trypsin autolysis products, which complicated 
protein identification by MALDI MS.  
Figure 2.17 presents a peptide mass fingerprint of a BSA in-gel digest (5 pmol) 
obtained by accelerated digestion using RAF-BT at the highest tested enzyme 
concentration (2.2 µM). Although BSA amount was relatively high peptide mass 
fingerprint of analyzed digest contained abundant autolytic trypsin peptides LGEDNIN-
VVEGNEQFISASK (m/z 2163.1), SIVHPSYNSNTLNNDIMLIK (m/z 2273.2) and 
SIVHPSYNSNTLNNDIM(ox)LIK (m/z 2289.2), which overloaded the spectrum and 
complicated peak picking. Thus, many of detected tryptic peptides of BSA were at the 
noise level. Most intense BSA peaks were obtained from peptides YLYEIAR (m/z 
927.49), RHPEYAVSVLLR (m/z 1439.8), LGEYGFQNALIVR (m/z 1479.79), 
DAFLGSFLYEYSR (m/z 1567.74) and KVPQVSTPTLVEVSR (m/z 1639.93). 
However, their intensity was significantly lower than the intensity of the autolytic 
background of trypsin. Altogether 10 BSA peptides were identified by MASCOT 
database searching, covering 20% of the protein sequence.  
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I found it was impossible to apply trypsin conjugates at concentrations higher than 
1.5 μM. The enzyme concentration of about 1 µM was considered as optimal 
concentration for accelerated in-gel digestion by glycosylated trypsin conjugates. 
 
 
Table 2.3: Averaged peptide yield of BSA obtained upon 30 min of accelerated in-gel 
digestion by glycosylated trypsins at different enzyme concentrations. 
Modified enzyme Concentration [μM] a Yield b [pmol] SD c RSD d Recovery [%] e
native BT f 0.5 2.80 0.89 32
MET-PT 0.75 1.79 0.78 43 64
1.5 3.33 0.83 25 119
MAT-BT 0.5 0.45 0.11 24 16
1.0 0.37 0.08 21 13
2.5 1.22 0.37 30 44
RAF-BT 0.4 0.29 0.12 42 10
0.9 0.54 0.08 15 19
2.2 1.09 0.16 15 39
RAFR-BT 0.6 0.77 0.19 24 28
1.2 1.00 0.19 19 36
3.0 1.47 0.42 28 53
STA-BT 0.5 0.17 0.06 36 6
1.0 0.36 0.14 39 13
2.5 1.20 0.20 17 43  
 
a) Concentration determined by amino acid analysis;  
b) Average peptide yield of the digestion;  
c) Standard deviation of the calculated peptide yield; d) Relative standard deviation of the 
calculated peptide yield;  
e) Percentage of the tryptic peptide recovery of conventional digestion;  
f) Conventional digestion (overnight, at 37 °C and at concentration of BT ~ 0.5 μM). 
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Figure 2.17. Peptide mass fingerprint of BSA in-gel digest obtained by accelerated 
digestion using RAF-BT at high concentration. 
A gel band containing 5 pmol BSA was digested by RAF-BT; the digestion time was set at 0.5h 
and the applied enzyme concentration was 2.2 µM. Bold underlined peaks represent most 
intense BSA peptides: YLYEIAR, m/z 927.49; RHPEYAVSVLLR, m/z 1439.8; 
LGEYGFQNALIVR, m/z 1479.79; DAFLGSFLYEYSR, m/z 1567.74; KVPQVSTPTL-
VEVSR, m/z 1639.93, which were identified by MASCOT search. High abundant peaks 
represent autolytic peptides of trypsin: LGEDNINVVEGNEQFISASK (m/z 2163.1), 
SIVHPSYNSNTLNNDIMLIK (m/z 2273.2) and SIVHPSYNSNTLNNDIM(ox)LIK (m/z 
2289.2). 
 
 
As next, I monitored the time course of in-gel digestion using trypsin conjugates 
at an enzyme concentration of in average 1 µM (Figure 2.18). My intension was to 
investigate whether longer digestion times may improve the digestion yield without 
compromising the quality of the spectrum due to increased autolysis background.  
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The peptide recovery after 1.5 h of digestion achieved 20% for STA-BT and 60% 
for RAFR-BT of conventional digestion yield, digestion for 3h only gained about 10% 
of increase. Considering that the autolysis products of the trypsin conjugates under these 
conditions didn’t overload the spectrum and were not disturbing for MALDI TOF 
analysis the optimal digestion time can be set at 3 hour.  
Table 2.4 represents the peptide yield of in-gel digestion (5 pmol BSA) performed 
by glycosylated trypsins after 3 hours of incubation at 55°C. From 30% (for STA-BT) 
to 65% (for RAFR-BT) of conventional digestion yield could be reached by accelerated 
digestion for 3 hours at an enzyme concentration about 1 µM. In contrast to enhanced 
in-gel digestion method, which applies methylated porcine trypsin in-gel digestion by 
glycosylated trypsin conjugates didn’t reach the yield of the conventional digestion.  
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Figure 2.18: Time course of averaged peptide yield observed by in-gel digestion of 
BSA using glycosylated trypsins at elevated temperature and an enzyme 
concentration in average 1µM. 
BSA bands (5 pmol) were in-gel digested by glycosylated trypsins; digestion times were: 30 
min, 1.5 h., 3 h., and 12 h. The applied enzyme concentrations ranged from 0.86µM for RAF-
BT to 1.2µM for RAFR-BT. The coloured bars represent the digestion yields generated by 
trypsin conjugates (purple, pale pink, blue and pink); yellow bar represents the recovery of the 
conventional digestion (37°C, overnight, BT at concentration ~ 0.5 μM). 
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Table 2.4: : Averaged peptide yield of BSA obtained upon 3 hours of accelerated in-
gel digestion by glycosylyted trypsins at enzyme concentration ~1µM. 
Modified enzyme Concentration [μM] a Yield b [pmol] SD c RSD d Recovery [%] e
native BT f 0.5 2.80 0.89 31.67
MAT-BT 1 1.53 0.37 24.50 55
RAF-BT 0.9 1.38 0.17 12.58 49
RAFR-BT 1.2 1.81 0.53 29.38 65
STA-BT 1 0.86 0.14 16.32 31  
a) Concentration determined by amino acid analysis; b) Average peptide yield of the digestion; c) 
Standard deviation of the calculated peptide yield; d) Relative standard deviation of the 
calculated peptide yield; e) Percentage of the tryptic peptide recovery of conventional digestion; 
f) Conventional digestion (overnight, at 37 °C and concentration of BT ~ 0.5 μM). 
 
 
2.1.3.5 Effect of gel pore size on the yield of in-gel digestion 
Since modification of bovine trypsin with saccharides increased its molecular 
weight and consequently changed its diffusion mobility I set out as next to investigate, 
how the gel pore size influences the yield of in-gel digestion by glycosylated trypsin 
conjugates. To this end I studied kinetics of digestion in 8 and 12 % polyacrylamide gel 
matrix. Figure 2.19 shows digestion yield of BSA peptides generated in 8 and 12 % 
polyacrylamide gels after 30 min (Figure 2.19A) and 3 h (Figure 2.19B) incubation with 
RAFR-BT. As shown in the Figure 2.19 no changes have been obtained in the digestion 
yields generated in 8 and 12% polyacrylamide matrixes.  
Average pore size ranges for 8% polyacrylamide gels from 16 to 22 Å and for 
12% polyacrylamide gels from 10 to 15 Å [298-300]. The molecule size of the most 
bulky trypsin modification with ACD (MR of ACD-BT determined by tricine-SDS-
PAGE was ~32 kDa) was close to 20 Å [291]. Trypsin conjugates modified with ACD 
and BCD were, as expected, not efficient in digestion in 8% as well as in 12% 
polyacrylamide gels. Tested RAFR modified trypsin (MR of RAFR-BT determined by 
SDS-PAGE was ~28 kDa) has smaller molecule size compared to bulky ACD and 
BCD-BT. However, considering quite broad range of pore size in 8 and 12 % 
polyacrylamide gels, it is difficult to predict whether 8% gels allow unrestricted 
diffusion of conjugated enzyme molecules into the gel matrix.  
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Figure 2.19: Effect of polyacrylamide gel pore size on the digestion yield. 
BSA bands (5 pmol) were in-gel digested by RAFR-BT at enzyme concentration of 1.2µM; 
digestion time was set at (A) 30 min and (B) 3 hours. Coloured bars represent the digestion 
yield: pink in 8% polyacrylamide gel; pale pink in 12% polyacrylamide gel.  
 
 
The obtained results rather suggest that the molecule size of the glycosylated 
trypsin conjugates is of borderline value and that their bulky structure limits their 
diffusion mobility in in-gel digestion of proteins. 
 
2.1.3.6 Proof of the method 
I then applied RAF modified trypsin in an ongoing collaborating project under 
accelerated digestion conditions. The efficiency of accelerated digestion was directly 
compared with the efficiency of conventional digestion method by identification of 
members of a NuA4 histone acetyltransferase complex isolated from the budding yeast. 
A protein YNG2 was epitope-tagged and immunoaffinity purified using the tandem 
affinity purification (TAP) method (performed by Luke Buchanan from Prof. Francis 
Stewart laboratory, BIOTEC, Dresden). The purified protein complex was separated by 
one-dimensional gel electrophoresis and the protein bands were visualized by 
Coomassie staining. 11 protein bands in the range of 20-140 kDa, with protein content 
of 0.5 – 2 pmol (according to the staining intensity of BSA standards), were excised 
from the gel and each band was cut into two parts. One part of the protein band was 
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digested by RAF-BT at 55 °C for 3 h at an enzyme concentration of ~1µM and another 
part was digested using conventional method by unmodified trypsin (overnight digestion 
at 37 °C and an enzyme concentration of BT ~ 0.5 μM). The samples were subsequently 
analyzed by MALDI TOF mass spectrometry. To evaluate the quality of the spectra and 
the significance of protein identification I used MOWSE scores (statistical significance 
measure for protein identification provided by MASCOT database search program), 
sequence coverage of identified proteins, number of peaks manually picked from the 
spectrum, and number of peaks matched to the sequence of identified proteins (Table 
2.5).  
Although all proteins were successfully identified by both methods, conventional 
digestion by unmodified trypsin showed better performance than accelerated digestion 
by raffinose-modified trypsin. Sequence coverage of proteins identified by fast 
digestion method was lower than by conventional digestion. On the other hand, RAF-
BT showed less autolytic background in the mass fingerprints and so simplified the 
identification of low abundant proteins that contained few peptides. 
 
Table 2.5: Comparison of conventional digestion by unmodified bovine trypsin and 
accelerated digestion by RAF-BT.  
  
Band Protein MW peaks peaks MASCOT Sequence peaks peaks MASCOT Sequence
kDa totala matchedb scorec coverage,% totala matchedb scorec coverage,%
1 TRA1 432 113 73 241 20 85 47 87 13
2 VID21 112 112 58 363 51 102 57 335 52
3 EPL1 97 121 38 192 47 97 32 144 39
4 SSA2 69 93 22 106 36 76 18 75 33
5 SSB1 66 85 22 117 35 70 17 86 41
6 SWC4 55 105 26 146 42 86 18 95 30
7 ESA1 53 93 20 114 36 83 20 111 39
8 EAF3 45 83 20 119 41 66 20 119 41
9 ACT1 41 76 14 75 42 51 15 75 36
10 EAF5 32 100 19 121 66 87 15 88 50
11 YAF9 26 83 14 108 65 85 16 102 59
Conventional digestion by unmodified BT Accelerated digestion by RAF-BT
 
Applied digestion conditions: conventional digestion was performed overnight at 37°C by 
commercially available BT (Roche) at an enzyme concentration of ~ 0.5 μM; accelerated 
digestion by RAF-BT was performed for 3 h at 55°C and at an enzyme concentration of ~ 1 μM. 
 
a) Total number of peaks picked; b) number of peaks matched the sequence of identified 
proteins; c) MOWSE score. 
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2.1.3.7 Catalytic efficiency of trypsin conjugates in accelerated in-gel digestion: 
what did we learn? 
The described kinetic study provided evaluation of the effect of digestion 
conditions on the yield of in-gel digestion performed using glycosylated trypsin 
conjugates. This study enabled adjustment of the optimal reaction conditions as in ACD 
previously established by Havliš et al. [2].  
Although glycosylated trypsins showed better thermostability compared to 
conventional unmodified bovine trypsin and methylated porcine trypsin, their catalytic 
efficiency in in-gel digestion was lower. As expected, the efficiency of modified trypsin 
derivates in in-gel digestion strongly depends on their modification. Enzymes caring 
larger oligosaccharides, such as a tetrasaccharide stachyose and cyclodextrins are more 
rigid and bulky, and consequently have lower diffusion mobility than enzymes modified 
with disaccharides maltotriose and raffinose, resulting in lower digestion yield. On the 
other hand, poor yield of in-gel digestion by saccharide modified trypsins can be 
explained by their lower specific activity (by 10-30%) compared to those of unmodified 
trypsin.  
 
2.1.4 Label-free quantification by nanoLC-MS/MS 
The quantitative study of digestion kinetics described above is based on stable 
isotope labeling of peptides with 18O (used as internal standards) and MALDI TOF MS 
analysis. This approach, however, has some limitations. First, it is expensive. Second, 
the number of peptides, which can be used for quantification, is rather low because the 
absolute intensities of the detected ions depend on their chemical nature and 
suppression effects occur. Spectral quality is also greatly affected by the method of 
sample preparation, MALDI matrix composition, and possible sample impurities.   
Label-free protein quantification methods offer less expensive and simple sample 
handling. Several studies have demonstrated that mass spectral peak intensities of 
peptide ions obtained from LC-MS/MS data correlate well with protein abundances in 
complex samples [272-276]. Therefore I set out to investigate the performance of this 
quantification method in nanoLC-MS/MS analysis. Further I aimed to test this approach 
in the study of digestion kinetics as it was previously carried out by MALDI TOF MS 
using 18O-labeled peptides as internal standards. 
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2.1.4.1 Quantifying proteins by mass spectrometric signal intensities of their 
peptide ions  
 
a) Study of a single protein 
To check the performance of this quantification method in nanoLC-MS/MS 
analysis I first started with study of a single protein. BSA was enzymatically digested 
and 8 aliquots of its serial dilutions containing protein amounts from 6 to 750 fmol were 
separated on a 75 μm i.d. reversed-phase column and directly electrosprayed (via a 
dynamic nanospray probe) into a LTQ ion trap mass spectrometer (Thermo Electron 
Corp.), which was operated in data-dependent acquisition mode (see chapter 4.1.3.4). 
The experiment was repeated on five consecutive days in order to evaluate the 
analytical reproducibility of MS signal and retention time.  
To calculate peptide ion intensities extracted ion chromatograms (XICs) were 
generated from the full scan mass spectra within a narrow m/z range, corresponding to 
different charge states of a peptide (triple, double, and single). The ion intensity of a 
peptide was subsequently calculated by summing peak areas of its triple, double, and 
single charged ions.  
Narrow m/z range has to be chosen in order to minimize number of peaks in XICs 
generated by peptides, which have similar m/z values. On the other hand, the mass 
tolerance for precursor ions (given for the applied MS instrument) should be considered 
and selected m/z range should enable inclusion of at least 3 isotopic peptide peaks. To 
this end I used m/z range with  
a lower limit of m/z = ((peptide monoisotopic mass – 1) + charge)/charge and  
upper limit of m/z = ((peptide monoisotopic mass + 2) + charge)/charge.  
The correct retention time of a peptide was determined from the scan number of 
its MS/MS spectra confidently identified by MASCOT search.  
Figure 2.20 a shows base peak ion chromatogram of a BSA tryptic digest and 
XICs of its peptide LVDEPQNLIK eluted at 32.23 min, which was represented by 
triple, double, and single charged states (Figure 2.20 b, c and d). Peptides characterized 
in this analysis are depicted in the table 2.6 among with their retention times, observed 
charge states and calculated peak areas. 
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a)
c)
b)
d)
 
Figure 2.20: Base peak ion chromatogram of a BSA tryptic digest and extracted ion 
chromatograms of differently charhed ions of BSA peptide LVDEPQNLIK. 
a) Base peak ion chromatogram of a BSA tryptic digest; the amount of protein analyzed by 
nanoLC-MS/MS was 188 fmol. (b), (c), (d) XICs of the triple, double and single charged ions of 
BSA peptide HLVDEPQNLIK, respectively. Scan numbers corresponding to the MS/MS 
spectra of this peptide helped to identify its correct retention time, at 32.23 min. 
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Table 2.6: Peptides characterized in nanoLC-MS/MS analysis of the BSA tryptic 
digest, including m/z values and corresponding charge states, calculated peak areas 
and retention times. 
Molecular Peak  Retention no. Peptide 
 weight 
Charge m/z area time 
     2+ 345.19 2.18E+07   
1 AWSVAR 688.37 1+ 689.37 3.92E+06 24.65 
          2.57E+07   
      2+ 379.71 1.18E+07   
2 GACLLPK 757.42 1+ 758.42 2.07E+06 26.49 
          1.39E+07   
     2+ 395.23 2.22E+07   
3 LVTDLTK 788.46 1+ 789.46 5.08E+06 24.78 
        2.73E+07   
      2+ 424.25 3.22E+07   
4 LSQKFPK 846.5 1+ 847.50 8.46E+05 16.28 
          3.31E+07   
      2+ 461.74 2.57E+07   
5  AEFVEVTK  921.48 1+ 922.48 2.45E+06 27.42 
          2.81E+07   
      2+ 464.25 2.98E+07   
6  YLYEIAR  926.49 1+ 927.49 3.18E+06 34.41 
          3.30E+07   
      3+ 330.85 2.85E+06   
7 EKVLTSSAR 989.55 2+ 495.78 1.56E+07 11 
      1+ 990.55 1.06E+05   
          1.86E+07   
      3+ 334.53 3.49E+06   
8 ALKAWSVAR 1000.58 2+ 501.29 1.28E+07 28.55 
          1.63E+07   
     2+ 507.81 4.27E+07   
9 QTALVELLK  1013.61 1+ 1014.61 1.13E+06 42.19 
          4.38E+07   
      3+ 361.86 3.38E+06   
10 YLYEIARR 1082.59 2+ 542.30 9.67E+06 29.9 
          1.30E+07   
11 CCTESLVNR 1137.49 2+ 569.75 1.03E+07 21.6 
          1.03E+07   
      3+ 381.57 5.19E+06   
12 KQTALVELLK 1141.71 2+ 571.86 3.48E+07 37.06 
      1+ 1142.71 2.67E+05   
          4.02E+07   
      2+ 582.31 3.53E+07   
13 LVNELTEFAK  1162.62 1+ 1163.62 7.92E+05 40.16 
         3.61E+07   
      3+ 417.20 4.42E+07   
14 FKDLGEEHFK 1248.61 2+ 625.31 2.74E+07 26.35 
      1+ 1249.61 1.22E+05   
          7.17E+07   
      3+ 435.90 4.85E+06   
15 HLVDEPQNLIK 1304.71 2+ 653.36 6.80E+07 32.23 
      1+ 1305.71 5.15E+05   
         7.34E+07   
      3+ 473.90 2.65E+07   
16 SLHTLFGDELCK 1418.69 2+ 710.35 5.18E+07 39.75 
      1+ 1419.69 3.50E+05   
          7.86E+07   
      3+ 480.60 5.55E+07   
17 RHPEYAVSVLLR  1438.8 2+ 720.40 3.34E+07 35.2 
          8.89E+07   
     2+ 722.32 6.79E+07   
18 YICDNQDTISSK 1442.63 1+ 1443.63 5.09E+05 23.06 
          6.84E+07   
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Molecular Peak  Retention no. Peptide 
 weight 
Charge m/z area time 
      3+ 488.53 1.30E+07   
19 TCVADESHAGCEK 1462.58 2+ 732.29 2.81E+07 10.34 
      1+ 1463.58 2.41E+05   
          4.13E+07   
      3+ 493.93 4.54E+05   
20 LGEYGFQNALIVR  1478.79 2+ 740.40 1.13E+07 43.76 
         1.18E+07   
      3+ 511.59 7.06E+07   
21 LKECCDKPLLEK 1531.77 2+ 766.89 2.46E+07 21.27 
         9.52E+07   
      3+ 513.94 3.56E+07   
22 LCVLHEKTPVSEK 1538.81 2+ 770.41 1.51E+07 24.91 
          5.07E+07   
23 DAFLGSFLYEYSR  1566.74 2+ 784.37 1.37E+06 51.82 
          1.37E+06   
      3+ 547.31 1.06E+08   
24 KVPQVSTPTLVEVSR  1638.93 2+ 820.47 6.60E+07 34.54 
         1.72E+08   
      3+ 627.64 1.48E+07   
25 RPCFSALTPDETYVPK 1879.91 2+ 940.96 7.50E+06 38.09 
          2.23E+07   
      3+ 673.99 2.42E+07   
26 LKPDPNTLCDEFKADEK 2018.96 2+ 1010.48 4.22E+06 34.8 
         2.84E+07   
      3+ 749.98 1.56E+07   
27 ECCHGDLLECADDRADLAK 2246.94 2+ 1124.47 7.11E+05 32.43 
          1.63E+07   
 
 
 
In nanoLC-MS/MS analysis of the BSA dilution series (ranged from 6 to 750 
fmol) I plotted peak areas (averaged for five measurements on different days) of all 
identified peptides against the analyzed amount of the protein (Figure 2.21).  
The obtained results indicated that peptide peak areas correlate linear in the given 
concentration range, and are repeatable (Figure 2.22). The analytical variability of MS 
signal (RSD) associated with measurements on five consecutive days was typically 
above 50 % for BSA at 6 fmol, indicating that the acquisition was at the noise level. 
RSD of MS signal for 12 fmol was about 40% and at higher concentrations in dilution 
series came below 20% for each peptide. The RSD of retention time for each peptide 
was less than 3 %.  
Table 2.7 represents R2 values corresponding to linear regression lines obtained 
for the characterized peptides in the dilution series of the BSA tryptic digest (Table 2.6). 
The linearity of the peptide peak areas over applied concentration range (of about 2 
orders of magnitude) can be expressed in averaged R2 value of 0.9878. 
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It should be noted that in some experiments several peptides, especially 
hydrophobic and those with long peptide sequences showed nonlinear behaviour. They 
smeared on the applied columns and almost completely disappeared at lower protein 
concentrations. I tested several columns and concluded that old columns are responsible 
for this problem. 
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Figure 2.21: Peptides characterized by nanoLC-MS/MS analysis of the dilution 
series from the BSA tryptic digest. 
A bar plot represent the characterized BSA peptides and their corresponding peak areas. The 
amount of protein loaded on the analytical column ranged from 6 to 750 fmol and is indicated 
by different colours, as shown in the legend.  
 
 
It is, therefore, recommendable first to check linear correlation between MS signal 
of the identified peptides and amount of the analyzed protein for each applied analytical 
column. 
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Figure 2.22: Correlation between chromatographic peak area and amount of the 
analyzed proten obtained for BSA peptide HLVDEPQNLIK in the dilution series of 
the BSA tryptic digest. 
The analyzed amount of BSA ranged from 6 to 750 fmol. (a) Averaged peak area (of five 
measurements) for BSA peptide HLVDEPQNLIK plotted against the corresponding protein 
amount loaded on the analytical column. A linear curve fit was calculated for the entire dataset 
(y = 441420x - 3E+06, R2 = 0.9994) (b) calculated peak areas for each analyzed protein amount 
obtained in 5 consecutive measurements. Standard and relative standard deviations were 
calculated for each data point. 
Table 2.7: R2 values corresponding to linear regression lines obtained for the 
characterized peptides in the BSA dilution series. 
     
1 AWSVAR 0.9959 15 HLVDEPQNLIK 0.9979
2 GACLLPK 0.9985 16 SLHTLFGDELCK 0.9992
3 LVTDLTK 0.9915 17 RHPEYAVSVLLR 0.9991
4 LSQKFPK 0.9941 18 YICDNQDTISSK 0.984
5  AEFVEVTK 0.9974 19 TCVADESHAGCEK 0.9798
6  YLYEIAR 0.9959 20 LGEYGFQNALIVR 0.9874
7 EKVLTSSAR 0.987 21 LKECCDKPLLEK 0.9676
8 ALKAWSVAR 0.9675 22 LCVLHEKTPVSEK 0.9733
9 QTALVELLK 1 23 DAFLGSFLYEYSR 0.9577
10 YLYEIARR 0.9581 24 KVPQVSTPTLVEVSR 0.9977
11 CCTESLVNR 0.998 25 RPCFSALTPDETYVPK 0.9987
12 KQTALVELLK 0.9994 26 LKPDPNTLCDEFKADEK 0.9985
13 LVNELTEFAK 0.9992 27 ECCHGDLLECADDRADLAK 0.9966
14 FKDLGEEHFK 0.95 Average 0.9878
no. Peptide R2 no. Peptide R2
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b) Study of a five protein mixture 
To further evaluate the quantification method for protein profiling of protein 
digest mixtures I analysed tryptic digest of a five protein-mixture containing myosin 
(223724 kDa), β-galactosidase (116409 kDa), BSA (69193 kDa), alcohol 
dehydrogenase (37282 kDa), and myoglobin (16940 kDa). Tryptic digest of the biggest 
protein myosin resulted in high number of peptides and significantly increased the 
complexity of the analyzed samples. The amounts of proteins contained in serial 
dilutions and analyzed by nanoLC-MS/MS are represented in the Table 2.8.  
 
Table 2.8: Proteins contained in the five-protein digest mixture and their amounts 
analyzed by nanoLC-MS/MS. 
Molecular 
weight [kDa] mixture 1 mixture 2 mixture 3 mixture 4 mixture 5 mixture 6
Myosin 223 18 36 73 145 290 580
b-Galactosidase 116 27 53 106 213 425 850
BSA 69 23 47 94 188 375 750
Alc. Dehydrogenase 37 24 48 96 193 385 770
Myoglobin 17 29 58 116 233 465 930
Amount of protein loaded onto the analytical column, [fmol]Protein
 
 
Figur 2.23 represents a base peak ion chromatogram of the analyzed five-protein 
digest mixture as well as base peak ion chromatograms of each separately analyzed 
protein. Altogether more than 200 peptides could be identified by nanoLC-MS/MS 
analysis here.  
From the full scan mass spectra of the analyzed dilution series of the five-protein 
digest mixture I generated XICs for all BSA peptides characterized before (Table 2.6 
and 2.7). Here I aimed to prove whether MS peptide signal in the protein mixture 
linearly correlates with the analyzed amount of protein. Figure 2.24 shows XICs of 
differently charged ions of BSA peptide KVPQVSTPTLVEVSR.  
The obtained data showed that the peak areas of the peptides obtained from the 
dilution series of the five-protein digest mixture linearly correlated to the amounts of the 
analyzed proteins. Linear regression R2 values for the BSA peptides characterized from 
the five-protein digest mixture (as previously characterized in the BSA digest, Table 
2.7) are shown in the Table 2.9. The linearity within dilution range was here in average 
0.9908. The variability of the MS signal for a single peptide (measured in three runs) 
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slightly increased in the protein mixture compared to the analysis of the single protein 
but not exceeded 30% in the tested concentration range (from about 20 to 1000 fmol).  
 
a)
f)e)
d)c)
b)
 
Figure 2.23: Base peak ion chromatogram of the analyzed five-protein digest 
mixture as well as base peak ion chromatograms of each separately analyzed 
protein. 
a) Base peak ion chromatogram of the five-protein digest mixture; (b), (c), d), (e), (f) base peak 
ion chromatograms of the tryptic digests of myosin (290 fmol), β-galactosidase (425 fmol), 
BSA (345 fmol), alcohol dehydrogenase (385 fmol) and myoglobin (465 fmol), respectively.  
 
Table 2.9: R2 values corresponding to linear regression lines obtained for the 
characterized BSA peptides from the five-protein digest mixture. 
              
1 AWSVAR 0.9989 15 HLVDEPQNLIK 0.9888
2 GACLLPK 0.9988 16 SLHTLFGDELCK 0.9966
3 LVTDLTK 0.993 17 RHPEYAVSVLLR 0.9887
4 LSQKFPK 0.999 18 YICDNQDTISSK 0.9866
5  AEFVEVTK 0.9974 19 TCVADESHAGCEK 0.9872
6  YLYEIAR 0.9992 20 LGEYGFQNALIVR 0.991
7 EKVLTSSAR 0.9756 21 LKECCDKPLLEK 0.9808
8 ALKAWSVAR 0.9725 22 LCVLHEKTPVSEK 0.9979
9 QTALVELLK 0.9922 23 DAFLGSFLYEYSR 0.9935
10 YLYEIARR 0.9798 24 KVPQVSTPTLVEVSR 0.9962
11 CCTESLVNR 0.993 25 RPCFSALTPDETYVPK 0.9975
12 KQTALVELLK 0.9995 26 LKPDPNTLCDEFKADEK 0.99
13 LVNELTEFAK 0.9968 27 ECCHGDLLECADDRADLAK 0.9732
14 FKDLGEEHFK 0.9878 Average 0.9908
Peptide R2no. Peptide R2 no.
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a)
b)
c)
 
Figure 2.24: Base peak ion chromatogram of the five-protein digest mixture and 
extracted ion chromatograms (XICs) of the differently charhed ions of BSA peptide 
KVPQVSTPTLVEVSR. 
a) Base peak ion chromatogram of the five-protein digest mixture, containing myosin (290 
fmol), β-galactosidase (425 fmol), BSA (345 fmol), alcohol dehydrogenase (385 fmol) and 
myoglobin (465 fmol). (b), (c), (d) XICs of triple, double and single charged ions of the BSA 
peptide KVPQVSTPTLVEVSR, respectively. Scan numbers corresponding to the MS/MS 
spectra of this peptide helped to identify its correct retention time, at 35.58 min. 
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Proteins present in the five-protein digest mixture were analyzed separately; their 
amounts contained in serial dilutions were the same as depicted in the Table 2.8. I 
plotted linear curves for some peptides analyzed from the single protein digest (β-
galactosidase, BSA, alcohol dehydrogenase and myoglobin) and from the five-protein 
digest mixtures (Figure 2.25). The results showed consistency between peptide peak 
intensities as well as linearity in the analysis of the single proteins and of the protein 
mixture. 
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Figure 2.25: Linear curves plotted for β-galactosidase, BSA, alcohol dehydrogenase, 
and myoglobin peptides analyzed from the single protein digest and from the five-
protein digest mixtures. 
The amounts of proteins contained in serial dilutions (of the single protein digest and of the 
five-protein digest mixtures) and analyzed by nanoLC-MS/MS are represented in the Table 2.8. 
Linear regression lines were obtained for β-Galactosidase peptide TPHPALTEAK (a), BSA 
peptide KVPQVSTPTLVEVSR (b), alcohol dehydrogenase peptide EALDFFAR (c) and 
myoglobin peptide YKELGFQG (d). 
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2.1.4.2 Application of this approach for absolute quantification of proteins  
The study presented above demonstrated that peptide peak areas from nanoLC-
MS/MS analysis can be used for quantitative protein analysis in relatively simple 
mixtures such as gel bands (spots) from one- or two-dimensional electrophoresis. This 
method appeared to be accurate and reproducible.  
The applicability of this quantitation approach to measure changes in relative 
protein concentration even in complex samples such as digest of total human plasma 
protein has been proved by several research groups [272-276].  
I presumed that this method might also be useful for absolute quantification of 
simple protein digest mixtures, when applying calibrating curves of the reference 
peptides obtained by in-solution digestion of known amounts of the corresponding 
protein standards (assuming that the recovery of in-solution digestion is close to 100%).  
I set out to employ this method in quantification of in-gel digestion products in the 
kinetic study previously described in chapter 2.1.3.4. This would provide independent 
information to the quantitative study based on 18O-labeled peptides and MALDI MS.  
 
2.1.4.3 Kinetic study of accelerated in-gel digestion of proteins by glycosylated 
trypsins 
 As in previously described kinetic experiments I monitored the time course of the 
peptide yield observed by in-gel digestion of a standard protein (BSA) by glycosylated 
trypsins at accelerated conditions.  
Gel bands containing 1 pmol BSA were digested for 0.5, 1.5 and 3 h at 55°C by 
MAT-BT and RAF-BT applied at the concentration of 1.4 and 2.8 μM. The obtained 
peptides were extracted from the gel matrix and dried down. The peptide mixture was 
redissolved in 10 μL of 0.05% TFA and 2 μL of the sample were analyzed by nanoLC-
MS/MS. For each peptide subjected for quantification a calibration curve of the 
corresponding peptide was generated, which was obtained from serial dilutions of in-
solution digest of BSA (chapter 4.1.3.7).  
It should be noted that analysis even of the same sample results in differences in 
the peak areas of the peptides from one run to other. This may be caused by experiment 
dependent parameters such as differences in sample preparation (pipetting errors, 
incomplete digestion) or instrument dependent parameters such as errors in sample 
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injection, HPLC or MS instrument performance. To get better statistics of the 
experiments each sample as well as each analysis was prepared in triplicate.  
 The calculated digestion yields were compared with those of conventional 
digestion (37 °C, overnight, by native BT at concentration ~ 0.5 μM) and accelerated 
digestion developed by Havliš et al. [2] (55°C, digestion time ranging from 0.5 to 1 h, 
by methylated porcine trypsin at the concentration ~ 1.5 μM) (Figure 2.26). In contrast 
to the quantification method based on stable isotope labeling of peptides with 18O and 
MALDI TOF MS label-free approach based on nano-LC-MS/MS analysis allowed me 
to use more reference peptides for quantification experiments. In addition higher 
dynamic range of detection and ability to analyse complex protein mixtures employed 
in this technology enabled application of enzymes at high concentration. To evaluate the 
digestion yield amounts of the following six peptides were averaged: AEFVEVTK (M = 
921.48), YLYEIAR (M = 926.49), KQTALVELLK (M = 1141.71), LVNELTEFAK (M 
= 1162.62), HLVDEPQNLIK (M = 1304.71), KVPQVSTP-TLVEVSR (M = 1638.93).  
 The peptide recovery of BSA obtained upon 30 min of in-gel digestion by MAT-
BT and RAF-BT at the concentration of 1.4 μM gained 38 and 39 % of conventional 
digestion yield, respectively (Table 2.10). This recovery was higher than those 
determined in former kinetic study based on 18O-labeled peptides and MALDI TOF 
analysis (13 and 19 % of CD yield for MAT-BT and RAF-BT applied at the enzyme 
concentration of 0.98 and 0.86 μM, respectively) (Table 2.3). These results can be 
explained by quantification errors present in both experiments. I also reasoned that the 
yield of in-gel digestion was underestimated by 18O-labeling quantification method, 
since less reference peptides were applied here compared to the label-free approach.  
On the other hand, 30 min of in-gel digestion of BSA using both conjugates at the 
enzyme concentration of 2.8 μM resulted in a peptide recovery of 43 and 44 % 
(determined by label-free approach), well in agreement with results obtained in previous 
quantification experiments (44 % recovery for MAT-BT applied at the concentration of 
2.45 μM, and 39 % recovery for RAF-BT applied at the concentration of 2.2 μM).  
Between 68 and 71% of conventional digestion yield was reached upon 3 hours of in-
gel digestion of BSA by trypsin conjugates at the tested concentrations (Table 2.11). 
These results were consistent with results obtained in previous quantification 
experiments (54 and 62% recovery for MAT-BT applied at the concentration of 0.98 
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and 2.45 μM, respectively, and 49 and 58% recovery for RAF-BT applied at the 
concentration of 0.86 and 2.2 μM, respectively).  
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Figure 2.26: Time course of the averaged peptide yield observed by in-gel digestion 
of BSA using MAT-BT and RAF-BT at accelerated conditions. 
Applied enzyme concentrations: a) 1.4 µM and b) 2.8 µM.  
BSA bands (1 pmol) were in-gel digested by MAT-BT and RAF-BT at 55°C and an enzyme 
concentration 1.4 (a) and 2.8 µM (b); digestion times were: 30, 1.5h and 3h. The blue and pink 
coloured bars represent the recovery of accelerated digestion by MAT-BT and RAF-BT, 
respectively. The red and yellow coloured bars represent the recovery of accelerated digestion 
by MET-PT (55°C, 0.5 to 1 h, MET-PT at concentration ~ 1.5 μM) and conventional digestion 
(37°C, overnight, BT at concentration ~ 0.5 μM), respectively. 
 
Interestingly, the digestion yield could not be improved by increasing 
concentration of trypsin conjugates (in contrast to the former kinetic study). Taking into 
account that a typical band of 12% polyacrylamide gel (with approximate size 0.8 mm x 
0.8 mm x 6.4 mm) absorbs 4 μL of digestion buffer [2], a gel band contacting 1 pmol of 
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BSA would result in the initial protein concentration of 0.26 μM, if reaction occurs in-
solution. According to the reported Km of 1.6 ± 0.2 μM μM for trypsin-catalyzed 
protein cleavage in-solution [301], at this protein concentration trypsin is not saturated 
with substrate. These results rather confirm the assumption of poor accessibility of the 
in gel matrix imbedded substrate for the bulky molecules of glycosylated trypsins.  
 
Table 2.10: : Averaged peptide yield of BSA obtained upon 30 min of accelerated in-
gel digestion by MAT-BT and RAF-BT at  enzyme concentration 1.4 and 2.8 µM. 
Modified enzyme Concentration [μM] a Yield b [fmol] SD c RSD d Recovery [%] e
native BT f 0.5 618 189 31
MET-PT g 1.5 678 209 31 110
MAT-BT 1.4 234 93 40 38
2.8 263 94 36 43
RAF-BT 1.4 244 94 39 39
2.8 276 100 36 45
 
a) Concentration determined by amino acid analysis; b) Average peptide yield of the digestion; c) 
Standard deviation of the calculated peptide yield; d) Relative standard deviation of the 
calculated peptide yield; e) Percentage of the tryptic peptide recovery of conventional digestion; 
f) Conventional digestion (overnight, at 37 °C); g) accelerated digestion protocol [2].  
 
Table 2.11: Averaged peptide yield of BSA obtained upon 3 hours of accelerated in-
gel digestion by MAT-BT and RAF-BT at enzyme concentration 1.4 and 2.8 µM. 
Modified enzyme Concentration [μM] a Yield b [fmol] SD c RSD d Recovery [%] e
native BT f 0.5 618 189 31
MAT-BT 1.4 441 140 32 71
2.8 426 120 28 69
RAF-BT 1.4 400 141 35 65
2.8 422 136 32 68
 
a) Concentration determined by amino acid analysis; b) Average peptide yield of the digestion; c) 
Standard deviation of the calculated peptide yield; d) Relative standard deviation of the 
calculated peptide yield; e) Percentage of the tryptic peptide recovery of conventional digestion; 
f) Conventional digestion (overnight, at 37 °C). 
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 Further I set out to investigate whether digestion of proteins at higher temperature 
would accelerate the protein cleavage. The tested digestion temperature was set at 65°C 
and in-gel digestion was performed for 30 min at the enzyme concentration of trypsin 
conjugates of 2.8 μM. Figure 2.27 represents the peptide recovery obtained by in-gel 
digestion of BSA by MAT-BT (Figure 2.27 a) and RAF-BT (Figure 2.27 b) at 55 and 
65°C. No significant changes were observed at the tested digestion conditions. 
Digestion recovery could not be improved by increasing incubation temperature. 
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Figure 2.27: Averaged peptide recovery obtained by in-gel digestion of BSA by 
MAT-BT and RAF-BT at different temperatures. 
BSA bands (1 pmol) were in-gel digested by MAT-BT (a) and RAF-BT (b) at 55 and 65°C and 
at an enzyme concentration of 2.8 µM; the digestion was performed for 30 min. The blue and 
pink coloured bars represent the recovery of digestion obtained by MAT-BT and RAF-BT at 
55°C, respectively. The green and pale blue coloured bars represent the recovery of digestion 
obtained by MAT-BT and RAF-BT at 65°C, respectively. 
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MS/MS information available by the applied technique (in contrast to peptides 
mass fingerprinting by MALDI TOF MS) enabled me to compare the cleavage specifity 
of trypsin conjugates and native trypsin. To this end I performed database searches 
without restricting the enzyme cleavage specifity in order to see whether some non-
tryptic peptides were produced during the digestion. Figure 2.28 represents peptides 
identified upon MASCOT searches from nano-LC-MS/MS data of BSA in-gel digests 
obtained by accelerated digestion using MAT-BT (55°C, 3h of digestion) and by 
conventional digestion using native bovine trypsin (37°C, overnight digestion).  
With exception of two half-tryptic peptides GLVIAFSQYLQQ (obtained by 
MASCOT searches of LC-MS/MS data from an accelerated in-gel digest of BSA by 
MAT-BT) and GLVIAFS (obtained by MASCOT searches of LC-MS/MS data from a 
conventional in-gel digest of BSA by native BT) all fragmented peptides were fully 
tryptic, confirming unchanged cleavage specifity of trypsin conjugates. Both half-tryptic 
peptides are probably derived from orifice fragmentation of the long tryptic peptide 
GLVIAFSQYLQQCPFDEHVK. The number of identified peptides in accelerated in-
gel digestion was 22, (covering 36 % of BSA sequence) in conventional digestion 28 
(covering 37% of BSA sequence). 
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Figure 2.28: Peptides identified upon MASCOT database searches from nano-LC-
MS/MS data of BSA in-gel digests obtained by accelerated digestion using MAT-BT 
and by conventional digestion using native bovine trypsin. 
(a) and (c) peptides identified upon MASCOT database searches from nano-LC-MS/MS data of 
BSA in-gel digests obtained by accelerated and conventional digestion, respectively; (b) and (d) 
sequence coverage of identified peptides within BSA protein sequence for data obtained by 
accelerated and conventional digestion, respectively. 
Gel bands containing 1 pmol BSA were in-gel digested using accelerated conditions by MAT-
BT (55°C; 3 h, at an enzyme concentration of 1.4 µM) and conventional digestion (37°C; 
overnight, at an enzyme concentration of 0.5 µM); Database searching was performed using 
mass tolerance for precursor and fragment ions of 2.0 and 0.5 Da, respectively; oxidation of 
methionine was considered as a variable modification. 
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2.1.4.4 Conclusion on the performed kinetic study 
Application of two different quantification approaches in the described kinetic 
study allowed me to evaluate the catalytic efficiency of the tested trypsin conjugates in 
accelerated in-gel digestion of proteins. Both quantification studies were in general 
consistent and showed that the recovery of conventional in-gel digestion could not be 
improved using glycosylated trypsins. At the best between 60 to 70% of conventional 
digestion yield could be achieved upon accelerated in-gel digestion of BSA by MAT 
and RAF-BT. The outcome of the performed experiments prompted me to conclude that 
sterically hindered enzyme/substrate binding (due to the bulky structure of glycosylated 
trypsins) is the main factor responsible for the reduced efficiency of trypsin conjugates 
in in-gel digestion of proteins. 
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2.2 Validations of protein identifications with borderline statistical 
confidence  
In first part of my work I focused on the improvement of the conventional in-gel 
digestion protocol in order to simplify sample preparation and increase the efficiency of 
digestion. This goal, however, could not be achieved by application of glycosylated 
trypsin conjugates.  
Another important issue in bottom-up proteomics is reliability of the protein 
identifications. This problem derives from the high complexity of the analyzed protein 
mixtures and limited sensitivity and dynamic range of the common analytical 
instruments. Thus, the identification of large number of proteins relies on matching one 
or two spectra of marginal quality, yielding protein identifications with borderline 
statistical confidence. These borderline protein identifications include false positive and 
false negative hits. How can we distinguish false hits from true? Probabilistic scoring, 
which is applied in a variety of search engines such as MASCOT [170], Sequest [172] 
etc. only suggest the threshold of statistically reliable assignments. To answer this 
question I set out to develop fast and reliable method for validation of borderline hits, 
which complements conventional database searching and can be applied in large scale 
proteomic analysis. 
 
2.2.1 Combination of de novo sequencing (PepNovo) and MS BLAST searches for 
independent validation of database searching hits 
 In contrast to conventional database searching de novo sequencing algorithms 
read out peptide sequences directly from fragment ion spectra independently of 
available sequence resources [159, 177-182]. Since de novo interpretation of tandem 
mass spectra results in many sequence proposals, which are highly redundant and error-
prone, we proposed to combine it with sequence-similarity searching tool MS BLAST 
[220, 224], which tolerates redundancy and partial inaccuracy of candidate peptides and 
employs an independent scoring scheme. The combination of de novo sequencing and 
MS BLAST would provide a cross-validation tool for obtained database searching hits.  
 De novo sequencing program PepNovo developed by Frank et al. [179] has been 
reported to have good quality predictions and transparent internal quality score. 
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Moreover it is fast and can be interfaced to MS BLAST. To assess if a combination of 
de novo program PepNovo and MS BLAST could validate MASCOT hits with marginal 
ions scores, I composed a dataset comprising 100 high-quality tandem mass spectra that 
unequivocally matched sequences of full tryptic peptides in a database. In each 
spectrum the actual signal-to-noise level was in silico altered by gradually decreasing 
the intensities of matching peaks, while the abundance of peaks of chemical noise was 
fixed (Figure 2.29). So we simulated the situation, where the protein identification only 
relies on matching a single spectrum of marginal quality. Each series of spectra with 
perturbed signal-to-noise ratios was subjected, in parallel, to MASCOT searches and de 
novo interpretation by PepNovo software. Up to seven sequence candidates per each 
interpreted spectrum were merged into a query string, which was then submitted to MS 
BLAST search. The whole procedure was done using a script written by Henrik Thomas 
(Shevchenko Group, MPI-CBG). 
Within each series, I aimed to determine the MASCOT ions score and PepNovo 
quality score for the two spectra having the lowest signal-to-noise ratios, whose 
PepNovo sequencing and MS BLAST searching either confidently identified (according 
to MS BLAST scoring scheme) the correct peptide in a comprehensive database or 
listed the correct peptide among the top 50 nonconfident hits in the MS BLAST output 
(Figure 2.30). However, in several cases, such spectra were not identified (altogether six 
peptide sequences). On several occasions, PepNovo/MS BLAST failed to match the 
expected sequence by interpreting even the initial high-quality spectrum, or the 
expected peptide was missing among nonconfident hits in the MS BLAST output. 
Therefore, the actual number of data points in Figures built using this dataset (Figures 
2.31 and 2.32) was less than the expected 100. 
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Figure 2.29: Workflow representing in silico simulation of signal-to-noise ratio of 
peptide spectra for evaluation of the PepNovo/MS BLAST potential to positively 
validate the assignment of spectra. 
The dataset contained 100 high-quality peptide spectra, which confidently matched upon 
MASCOT search a peptide sequence of in average 12 amino acid residues with ions scores > 
70. A dedicated script (written by Henrik Thomas, Shevchenko Group, MPI-CBG) reduced the 
absolute intensities of all peaks with relative intensities above 1% of the base peak intensity 
with the steps of 1% and produced the series of 100 spectra with gradually altered signal-to-
noise ratios. Their dta files were merged into a single mgf file and submitted to MASCOT 
search, and ions scores of spectra matched to the correct database peptide sequences were 
registered. The same mgf file was sequenced de novo by the PepNovo program in a batch mode, 
recording up to seven sequence candidates for each interpreted spectrum. PepNovo scores of 
predicted sequences were registered, and sequences were merged into a query and submitted to 
MS BLAST searches. The outcome was sorted in three groups: 1) where MS BLAST produced 
a hit that was confident according to MS BLAST scoring scheme (first group); 2) where the 
target peptide was listed in the output of the MS BLAST search as a borderline or nonconfident 
hit (second group); 3) or where the target protein was not hit by MS BLAST at all (third group). 
In the first and the second groups two spectra were identified (if possible) with the lowest 
signal-to-noise ratio and their ion scores (MASCOT), sequence quality scores, and MS BLAST 
scores were registered.  
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Figure 2.30: Altering MS/MS spectra for in in silico simulation experiments. 
(a) The presented tandem mass spectrum assigned upon MASCOT search the peptide 
(K)ELVYSAEDLEMSK from C. elegans protein Snf5 with ions score of 84; (c) a spectrum 
with altered signal-to-noise ratio, produced from the spectrum in panel (a) by reducing the 
intensity of fragment ions by 95%, while maintaining the same intensity of noise peaks. 
MASCOT search identified the same peptide, albeit the ions score was 37. (b) De novo 
interpretation of the spectrum in panel (a) by PepNovo software produced seven partially 
redundant candidate sequences, with the top candidate having a quality score of 11.3. According 
to MS BLAST conventions, (M.) stands for mono-oxidized methionine residues, and B stands 
for a generic trypsin cleavage site (arginine or lysine residues) preceding the peptide sequence. 
Since isobaric oxidized methionine and phenylalanine residues were not distinguished in ion 
trap spectra, both candidate sequences were included into the query string for MS BLAST 
search, which also produced a confident hit (MS BLAST confidence threshold score for a single 
reported high scoring pair (HSP) was 64). (d) The same procedure was applied to the modified 
spectrum from panel (c). Both ions score and PepNovo score decreased, yet MS BLAST search 
was still able to produce a confident hit. 
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2.2.2 There is a correlation between MASCOT ions scores and PepNovo quality 
scores?  
I first checked if MASCOT ions scores and PepNovo quality scores correlated 
when both interpretations of the same marginal quality spectrum pointed to the same 
correct peptide sequence (Figure 2.31).  
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Figure 2.31: Plotted diagram of MASCOT ions scores versus PepNovo sequence 
quality scores. 
Diagrams are built using the series of simulated spectra (Figure 2.29) that enabled their 
confident (panel a, data for 94 spectra) and nonconfident (panel b, data for 48 spectra) 
assignment to the correct database sequences by MS BLAST. 
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Although weak correlation was observed, I noticed that PepNovo scores 
corresponding to spectra with a given MASCOT score (or vice versa) varied within a 
broad range of values. This indicated that the two interpretations were, indeed, 
complementary and in many instances could independently cross-validate each other 
[3]. 
 
2.2.3 Validation of MS/MS spectra assignment 
Figure 2.32 presents cumulative distributions of PepNovo scores (panel a) and 
MASCOT ion scores (panel b) obtained for the same dataset of in silico modified 
peptide spectra (Figure 2.29). They provide a complementary view on the ability of MS 
BLAST (Figure 2.32a) and PepNovo/MS BLAST combination (Figure 2.32b) to 
positively validate the assignment of spectra, depending on their PepNovo scores and 
MASCOT ions scores, respectively. 
More than 60% of spectra, in which candidate peptide sequences were produced 
with PepNovo scores above 8, were confidently (according to MS BLAST scoring) 
matched to the correct protein entries by MS BLAST (Figure 2.32a), and for almost 
80% of these spectra, correct peptide sequences were listed in search outputs. Once 
PepNovo scores exceeded 10, more than 90% of these spectra were confidently 
matched. This provided us with a qualitative estimate of the de novo interpretation 
reliability, irrespective of the actual MASCOT ions scores of examined spectra. 
Using the same spectra dataset, we plotted the cumulated proportion of positive 
PepNovo/MS BLAST assignments of spectra against their MASCOT ions scores 
(Figure 2.32b). It should be noted that ions scores do not depend on the database size in 
contrast to thresholds scores of statistical confidence for performed MASCOT searches 
(Figure 2.32b). 
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Figure 2.32: Cumulative distributions of confident and low confident MS BLAST 
hits obtained by searches with de novo sequences produced from tandem mass 
spectra with altered signal-to-noise ratio are plotted against their PepNovo scores 
(panel a) and MASCOT ions scores (panel b). 
The dataset was the same as in Figure 2.31. Vertical bars in panel b stand for MASCOT 
thresholds of statistically confident protein identifications supported by matching a single 
peptide (p < 0.05) in the organism-specific databases: C. elegans (30 304 proteins entries), 
threshold score of 36; all mammals (287 223 protein entries), threshold score of 43; a 
comprehensive (all species) database (2 011 425 protein entries), threshold score of 53. 
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To positively identify a protein in a comprehensive (all species) database, the ions 
score of a one peptide hit should exceed a relatively high threshold (>53), even at the 
moderate p < 0.05. Therefore, positive protein identifications with one or two matched 
peptides would require exceptional quality of corresponding MS/MS spectra, and 
therefore, false negatives are common. For searches in smaller, species-restricted 
databases, threshold scores are lower (Figure 2.32b). These searches, however, often 
produce false positives by matching the spectra of peptides from exogenous protein 
contaminants to sequences of the assumed organism. 
Figure 2.32b suggests that approximately 80% of borderline (potentially, false 
negative) one-peptide hits produced by searches against a comprehensive database 
should be directly verifiable via de novo sequencing and MS BLAST. Although the 
expected success rate also remains substantial for smaller species-restricted databases, 
de novo verification would be most helpful in discriminating against false positive, 
rather than validating false negative hits. Ions scores of false-positive hits are often 
marginal, since they are falsely matched to wrong database entries, although rich 
patterns of fragment ions together with low chemical noise enable confident readout of 
long stretches of their sequences [3]. 
 
2.2.4 The protein identification and validation workflow 
A protein identification and validation routine employed in my work is depicted in 
Figure 2.33 and started with the stringent database search against a species-restricted 
database, in order to minimize the analysis time and to identify low abundant proteins 
whose spectra represent limited information (less than 3 peptides, poor quality, noisy 
spectra) [3].  
It should be noted that different proteomics laboratories apply varying confidence 
criteria, even if the same software was used for database mining [188, 302]. The 
database independent validation by PepNovo/MS BLAST allowed me to use conserved 
criteria of positive protein identifications together with relatively loose selection of 
nonconfident hits, although this strategy yielded a large number of borderline hits. 
Many of them were produced by matching one or two spectra, and therefore, we could 
use their ions scores as direct selection criteria (Figue 2.33).  
Since background proteins increase number of false positives by search in species 
restricted database first step in validation of borderline hits was their conformation in a 
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comprehensive database. To this end corresponding dta files were fetched by Windows 
Shell Scripts developed in-house (Henrik Thomas, Shevchenko Group, MPI-CBG) and 
re-submitted to another round of MASCOT searches, now against a full database with 
unrestricted species specificity. The second search typically identified and removed 
good quality spectra of full tryptic peptides, originating from trypsin, keratin, GST, and 
other background proteins, which produced statistically confident hits in searches 
against a full database.  
The remaining spectra were interpreted de novo, and the obtained sequence 
candidates were merged into a single query [224, 225] and searched against a 
comprehensive database by MS BLAST. The results of MS BLAST searches were 
interpreted as follows: if the same peptide as in the MASCOT search was either 
confidently matched by MS BLAST, or was present in the output of the MS BLAST 
search, and the reported high-scoring segment pair [303] (HSP), which corresponds to 
the alignment of the database peptide sequence and the sequence deduced from MS/MS 
spectrum by its de novo interpretation [225], covered at least 50% of the verified 
peptide sequence, then these hits were considered confirmed. It should be noted, that by 
PepNovo produced sequence proposals were not fully accurate, especially in case of 
poor quality and noisy target spectra. The predicted de novo sequences might contain 
correct sequence stretches that, however, did not produce statistically significant 
alignments and therefore were not reported within an HSP. In most cases, the length of 
the aligned non-interrupted peptide sequences exceeded six amino acid residues. 
The MASCOT hits were considered as false positives and rejected if MS BLAST 
searches either confidently hit another protein, or hit a common background protein and 
more than 50% of the peptide sequence (and, at least, 6 amino acid residues) were 
covered by the aligned HSP.  
The third criterion came from the consideration of the expected de novo 
interpretation accuracy, which is related to the PepNovo quality score. If de novo 
interpretation of validated MS/MS spectra produces peptide sequence candidates with 
PepNovo scores above 10, then, according to Figure 2.32, it was expected that 
subsequent MS BLAST searches would confirm more than 90% of the corresponding 
MASCOT hits. Otherwise, these hits were considered false positives, even if MS 
BLAST searches produced no significant alignments to other proteins.  
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Figure 2.33: Protein identification workflow that involves PepNov/MS BLAST 
vaidation of borderline hits. 
Diamonds stand for the workflow junctions, where the following selection criteria were applied. 
Hit selection I: (1) confident hits: more than three peptides matched by MASCOT with ions 
scores above the confidence threshold for a species-specific database (36 for C. elegans protein 
database), or at least one score was above the threshold for a comprehensive database (53 for 
MSDB). (2) Borderline hits: MASCOT matched less than four peptides and the ions score of at 
least one peptide was within the range of ±30% of the threshold score (from 26 to 46 for C. 
elegans). (3) Nonconfident hits: the rest. Hit selection II: (1) rejected hits: the searched peptide 
confidently hit other than expected protein in a comprehensive database (ions score should 
exceed 53). (2) Borderline hits: the rest. Hit selection III: (1) confirmed hits: hits either 
confidently matching the expected protein by MS BLAST or in which the aligned HSP covered 
more than 50% of the expected peptide sequence spanning over more than six amino acid 
residues. (2) Rejected hits: common background proteins (trypsin, keratins, GST) matching the 
same criteria; or other proteins confidently matched by MS BLAST; or hits that did not match 
the expected peptide albeit their PepNovo scores were above 10. (3) Not assigned hits: the rest. 
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Low PepNovo scores (practically, less than 5) indicated that, for any reason, 
PepNovo failed to produce a reliable sequence of sufficient length. In these cases, 
negative outcomes of MS BLAST searches were inconclusive and the hits remained 
unassigned. 
 
2.2.5 False positives and false negative hits revealed by PepNovo/MS Blast: case 
studies  
To demonstrate the practical applicability of the proposed workflow, here is 
presented the validation of two borderline hits produced by nanoLC-MS/MS analysis of 
gel-separated C. elegans proteins [4]. 
The protein Y6B3B.8 was identified by MASCOT search in a C. elegans protein 
database under the fixed trypsin cleavage specificity settings. The protein was hit by a 
single MS/MS spectrum with the ions score of 31 (Figure 2.34), while the proposed 
confidence threshold for C. elegans database was 36. Manual inspection of the spectrum 
suggested that almost all abundant peaks matched m/z of expected fragment ions.  
To validate this hit, the corresponding spectrum was first searched against a 
comprehensive database. The search pointed to the same protein; however, the 
confidence of the identification was low, because of the increased database size. 
Therefore, the hit was further validated by PepNovo/MS BLAST (Figure 2.34b), which 
confidently hit a half-tryptic peptide VVEGNEQFISASK that originated from bovine 
trypsin, presumably via orifice fragmentation of the abundant autodigestion product 
LDEDNINVVEGNEQFISASK. It should be noted that approximately the same number 
of peaks matched the expected fragment ions in panels (a) and (c) of Figure 2.34, 
illustrating that manual inspection might be biased.  
To further check the MS BLAST identification, another MASCOT search was 
performed without restricting the enzyme cleavage specificity. The search against a full 
species database resulted in the same trypsin peptide identified by PepNovo/MS 
BLAST. Despite higher ions score (67 for trypsin peptide versus 31 for C. elegans 
peptide), the hit was still nonconfident since the threshold score under the assumed 
settings was 74. The Expect value (the expected number of false-positive hits produced 
by searching a database with the given spectrum) was not improved and stayed well 
within the nonconfident range. 
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Query:    17 VVEGNEQFLSASK 29
             VVEGNEQF+SASK
Sbjct:    77 VVEGNEQFISASK 89
PepNovo score 11.4
a)
c)
b)
 
Figure 2.34: PepNovo/MS BLAST validation of the protein identification with 
borderline statistical confidence: example of a false-positive hit. 
(a) MASCOT search performed against the C. elegans database hit the protein Y6B3B.8. Search 
against a full database also confirmed this hit. Trypsin was specified as proteolytic enzyme in 
both searches. (b) The same spectrum was interpreted de novo, and candidate sequences were 
submitted to MS BLAST search, which matched the half-tryptic peptide VVEGNEQFISASK 
from bovine trypsin as a single confident hit. (c) The same spectrum as in panel (a) with 
fragment ions matching the sequence of VVEGNEQFISASK. MASCOT search was here 
performed without restricting the enzyme cleavage specificity in a comprehensive database; the 
threshold score under the assumed settings was 74. 
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In another case, C. elegans protein C56G2.1 was identified by matching one 
peptide with ion score of 31, which is below the threshold ion score for the chosen 
database (Figure 2.35). MASCOT search against a comprehensive database with and 
without trypsin cleavage specificity restrictions also pointed to the same protein, 
although both ions scores were statistically insignificant. At the same time, de novo 
interpretation of the spectrum followed by MS BLAST search confidently hit the 
expected peptide sequence from C56G2.1 protein, thus, rescuing this, otherwise false 
negative, hit (Figure 2.35b). 
 
de novo sequences
       (PepNovo)
    MS BLAST search C56G2.1 - Caenorhabditis elegansBLTVPAALDTESR
BTLVPAALDTESR
BXXVPAALDTESR
VPAALDTESR
VPAALDTE
BLTVPAAL
BTLVPAAL
 Score = 86 (44.7 bits)
 Identities = 11/13 (84%), Positives = 13/13 (100%)
Query:     1 BLTVPAALDTESR 13
             ++TVPAALDTESR
Sbjct:   838 RITVPAALDTESR 850
PepNovo score 5.8
a)
b)
 
 
Figure 2.35: PepNovo/MS BLAST validation of the protein identification with 
borderline statistical confidence: example of a false-negative hit. 
(a) MASCOT search against C. elegans database hit C56G2.1 protein with insignificant ions 
score. Search against a comprehensive database pointed to the same protein. (b) The same 
spectrum was interpreted de novo, and candidate sequences were searched by MS BLAST that 
confidently hit the same C. elegans protein. 
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2.2.6 Validating of borderline hits at the large scale: biological applications 
2.2.6.1 Determination of interaction partners of the protein TPXL-1 required for 
mitotic spindle assembly in C. elegans.  
Functional analysis of an uncharacterized novel gene tplx-1, performed by Nurhan 
Özlü (Tony Hyman, MPI-CBG) revealed that TPLX-1 is the invertebrate orthologue of 
TPX2, which is known from studies in Xenopus and mammalian cells to be involved in 
mitotic spindle assembly, and to interact with Aurora A kinases [304].  
A genome-wide Yeast Two-Hybrid screen of C.elegans proteins identified an 
interaction between TPXL-1 and AIR-1 [305]. To test if TPXL-1 and AIR-1 form a 
complex in vivo and determine other possible interaction partners, Nurhan Özlü 
performed a GST pull-down using GST::TPXL-1 as a bait. The eluted proteins were 
separated by SDS-PAGE and subjected to nano-LC-MS/MS analysis. 
In the analysis of 10 Coomassie-stained bands, 127 proteins (44%) were 
confidently identified, among them AIR-1, confirming the assumption that both protein 
interact, and another 164 hits (56%) were regarded borderline (Figure 2.36), according 
to the criteria discussed above (Figure 2.33).  
borderline hits 
56%
confident hits
44%
 
Figure 2.36: Fraction of borderline hits obtained by LC-MS/MS analysis of the GST 
pull-down experiment performed to study protein-protein interactions of the 
C.elegens protein TPLX-1. 
GST pull-down was performed using GST::TPLX-1 expressed in E.coli. GST::TPLX-1 was 
bound to glutathione beads; the prepared worm extract was incubated with the resin, washed 
and the bound proteins were eluted by adding reduced glutathione. The eluted proteins were 
separated by SDS-PAGE and stained with Coomasie (Nurhan Özlu, MPI-CBG). 10 bands were 
cut and in-gel digested; subsequently the obtained peptides were extracted from the gel matrix 
and analysed by nano-LC-MS/MS. The acquired tandem mass spectra were searched by 
MASCOT against the C. elegans database. 127 proteins were confidently identified and another 
164 hits were regarded borderline.   
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Many of these hits were of substantial biological interest. However, searching 
MS/MS spectra against a comprehensive database revealed that the preparation was 
heavily contaminated with exogenous proteins, such as fragments of the GST construct, 
proteins from Escherichia coli (host organism in which the GST-fused bait protein was 
expressed), and human keratins  (Figure 2.37). 
de novo sequences
       (PepNovo)
    MS BLAST search glutathione S-transferase [Expression vector
            pGST-parallel1]
PepNovo score 7.6
a)
Score = 66 (35.9 bits)
Identities = 7/10 (70%), Positives = 10/10 (100%)
Query:     1 BLTQSMALLR 10
             +LTQSMA++R
Sbjct:    64 KLTQSMAIIR 73
BLTQSMALLR-
BLTQSFALLR-
BLTGASMALLR-
BLTGASFALLR-
BLTQSMAL-
BLTQSFAL-
BLTGASMA
b)
c)
de novo sequences
       (PepNovo)
    MS BLAST search Type II keratin Kb39
PepNovo score 9.6
Score = 74 (38.9 bits)
Identities = 10/10 (100%), Positives = 10/10 (100%)
Query:     4 EQQNQVLQTK 13
             EQQNQVLQTK
Sbjct:   189 EQQNQVLQTK 198
BYPEQQNQVLQTK-
BYPEQKNQVLQTK-
BYPEQQGGQVLQTK-
BYPEGAQNQVLQTK-
BYPEQQNQVLKTK-
BYPEGAQNQVLKTK-
BYPEGAKNQVLQTK
d)
 
Figure 2.37: Revealing of false positives by PepNovo/MS BLAST from the data 
obtained by nanoLC-MS/MS analysis of the GST pull-down experiment. 
(a) MASCOT search performed against the C. elegans database hit the protein Y40D12A.1;  
(b) The same spectrum was interpreted de novo, and candidate sequences were submitted to MS 
BLAST search, which matched tryptic peptide originated from GST construct; (c) Protein 
T05C3.3 was identified by MASCOT search against the C. elegans database. (d) MS BLAST 
search performed upon de novo predicted sequences of the corresponding MS/MS spectrum 
matched keratin as confident hit. Both spectra (a) and (c) were searched against the 
comprehensive database and matched GST and keratin peptides, respectively. 
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It should be noted that it is absolutely impractical to perform database searching 
against a comprehensive database, since it considerably increases analysis time. In 
addition all database searching algorithms rank identified hits according their scores, 
which basically express their abundance. Thus, low abundant proteins from the 
organism of interest might be ranked far below high abundant and totally irrelevant 
background proteins (in the presented case GST construct, keratins, E. coli proteins, 
bovine trypsin), significantly complicating data analysis. 
My next intention, therefore, was to see how successful is database independent 
validation by PepNovo/MS BLAST in revealing false positives compared to the 
database searching in the comprehensive database. Since identification and validation of 
proteins was performed according to the workflow depicted in Figure 2.33 I could 
evaluate this.  
Figure 2.38 presents a distribution of 164 validated borderline hits: 37% of them 
were confirmed by PepNovo/MS BLAST, whereas another 34% were discarded as false 
positives (either by PepNovo/MS BLAST or by MASCOT searches against a 
nonrestricted database), so that the percentage of borderline identifications that still 
remained ambiguous was reduced down to 29%.  
49%
9%
42%
not assigned
29%
Identified by de novo only
rejected
   34 %
confirmed
     37 %
Identified by de novo
and MASCOT
Identified by MASCOT only
 
Figure 2.38: Validation of the borderline hits from the data obtained by nanoLC-
MS/MS analysis of the GST pull-down experiment. 
Confirmed: hits confirmed by PepNovo/MS BLAST method. "Rejected": hits were rejected if 
either MASCOT confidently identified another protein in a full (all species) database 
(designated as "Identified by MASCOT" at the inset), or by PepNovo/MS BLAST probing 
according to the workflow in Figure 2.33 (designated as "Identified by de novo"). "Not 
assigned": borderline hits for which both methods did not produce any conclusive identity 
evidence. 
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Interestingly, among recognized false positives, 49% were identified only by 
PepNovo/MS BLAST, 42% were verifiable by MASCOT searches against a full 
database as well as by PepNovo/MS BLAST, and only 9% were identified by 
MASCOT searches in the full-species database, while PepNovo/MS BLAST failed to 
produce conclusive assignments. Thus, 116 borderline hits (71%) were confirmed or 
rejected, and the total number of ambiguous identifications was considerably reduced 
without any recourse to manual inspection of spectra.  
Taken together, in the performed study nanoLC-MS/MS analysis and database 
searching enabled identification of about 300 proteins, among them 56% were of 
borderline statistical confidence. Supported by database independent PepNovo/MS 
BLAST validation I could considerably reduce number of these ambiguous hits. The 
study confirmed as expected that TPXL-1 and AIR-1 are interaction partners. In further 
experiments Nurhan Özlü showed that the essential function of TPXL-1 is to activate 
and localize Aurora A to the mitotic spindle assembly. This provided mechanistic 
insight into how the converted TPX2 protein family contributes to spindle assembly [4].  
 
2.2.6.2 Determination of RSA-1 associated proteins required for mitotic spindle 
assembly in C. elegans.  
In the course of a genome-wide screening, the uncharacterized gene RSA-1 (for 
regulator of spindle assembly 1) was remarked because its silencing resulted in a 
dramatic spindle assembly defect. Annelore Schlaitz (Prof. Tony Hyman, MPI-CBG, 
Dresden) studied RSA-1 (RNAi) phenotype and found out that is required for two 
separable centrosomal pathways in spindle formation: 1) the promotion of microtubule 
outgrowth from centrosomes in a process downstream of tubulin-mediated nucleation 
and 2) the stability of kinetochore microtubules.   
RSA-1 (C25A1.9) encodes 404 amino-acid protein with sequence similarity to B-
type regulatory subunits of Protein Phosphotase 2A (PP2A), most closely related to B’’ 
subunits of the TON2 subfamily. Interestingly, the Arabidopsis thaliana B’’ PP2A 
subunit TON2 has been implicated in aspects of microtubule cytoskeleton organization 
[306].  
In order to see whether RSA-1 indeed functions as PP2A regulatory subunit and 
to find the interactions partner of RSA-1, co-immunoprecipitations experiments were 
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carried out. First, the anti-RSA-1 antibody was used to immunoprecipitate RSA-1 and 
associated proteins from extracts of C. elegans embryos. NanoLC-MS/MS analysis of 
this IP resulted in a large number of proteins (including high number of borderline hits, 
which have been validated by PepNovo/MS BLAST), among them the core centrosomal 
protein SPD-5 and the uncharacterized protein Y48A6B.11. Interestingly, Y48A6B.11 
had been previously found to interact directly with RSA-1 in a large-scale yeast-two-
hybrid screen [305]. However, no phosphotase subunits were detected in this 
preparation.  
The antibody only binds the extreme C-terminus of RSA-1, which is the region 
with the largest sequence conservation among regulatory B-subunits. One explanation 
for failure to detect PP2A subunits might therefore be that the anti-RSA-1 antibody only 
precipitates the fraction of RSA-1 that is not engaged in a PP2A complex and that the 
epitope recognized by this antibody is not accessible in the heterotrimetric complex.  
Annelore Schlaitz therefore chose a different approach for immunoprecipitating 
the protein, using a worm strain that expressed GFP-tagged RSA-1. Extracts were 
prepared from GFP::RSA-1 worms and subjected to co-immunoprecipitation with anti-
GFP antibodies, followed by nano LC-MS/MS analysis. This IP experiment was 
performed twice, using different controls: in the first experiment, random IgG 
antibodies were incubated with GFP::RSA-1 extract; in the second experiment, the anti-
GFP antibody was incubated with extracts from wild-type worms that did not express 
the transgene. Moreover, salt conditions were modified, as compared to the previous, 
high-background anti-RSA-1 IP, resulting in far fewer co-purifying proteins.  
Although, the second IP experiment was more efficient, several proteins identified 
here were of borderline statistical confidence. Among them was protein SPD-5, which 
was expected to be associated with RSA-1. SPD-5 was hit by a single peptide 
(K)EAENKVEHASSEK upon MASCOT search in a C. elegans database (confidence 
threshold 36) with the ion score of 47 (Figure 2.39a). According to the selection criteria 
described before (chapter 2.2.4) this hit was considered as borderline and subjected to 
further validation. To this end the corresponding MS/MS spectrum was sequenced de 
novo (PepNovo), and predicted sequence candidates were submitted to MS BLAST 
search. MS BLAST could confidently confirm this hit (Figure 2.39b).  
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The results of both IP experiments were combined and only those proteins 
identified in both preparations were considered. Four proteins were found to 
reproducibly and specifically associate with RSA-1. These were the Protein 
Phosphatase 2A catalytic subunit LET-92 and the PP2A structural subunit PAA-1 as 
well as Y48A6B.11 and SPD-5, two proteins that had already been found through 
immunoprecipitations using the antibody against the endogenous protein (Figure 2.40).  
 
de novo sequences
       (PepNovo)
    MS BLAST search  (spd-5) Caenorhabditis elegans
PepNovo score 8.5
a)
Score = 67 (35.8 bits)
Identities = 9/14 (64%), Positives = 10/14 (71%)
Query:    80 BXXXNQVEHASSEK 93
             +   N VEHASSEK
Sbjct:   883 KEAENKVEHASSEK 896
BXXXXNQVEHASSEK-
BXXXXNGAVEHASSEK-
BXXXXGGQVEHASSEK-
BXXXXGGGAVEHASSEK-
NQVEHASSEK-
BXXXNQVEHASSEK-
BXXXNGAVEHASSEK
b)
 
Figure 2.39: PepNovo/MS BLAST validation of the C. elegans protein SPD-5. 
 (a) MASCOT search was performed against the C. elegans database and hit SPD-5. Search 
against a comprehensive database also confirmed this hit. Trypsin was specified as proteolytic 
enzyme in both searches. (b) The spectrum was interpreted de novo, and candidate sequences 
were submitted to MS BLAST search, which confidently confirmed SPD-5.  
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F56A3.4 (SPD-5)
Y48A6B.11 (RSA-2)
C25A1.9 (RSA-1), bait
F48E8.5 (PAA-1)
F38H4.9 (LET-92)
158
116
97
66
56
43
35
RSA-1 IPmarker, kDa control
 
Figure 2.40: Proteins co-immunoprecipitating specifically with RSA-1. 
Coomassie-stained gel represents protein marker (left panel), control (middle panel) and 
proteins, which specifically immunoprecipitate with RSA-1 (right panel).  
Extracts were prepared from GFP::RSA-1 worms and subjected to co-immunoprecipitation with 
anti-GFP antibodies. The control for this experiment was prepared by incubating the anti-GFP 
antibody with extracts from wild-type worms that did not express the transgene. Gel lanes of 
control and immunoprecipitates were cut in 6 equal bands and analyzed by nano LC-MS/MS, 
followed by MASCOT database searching in the C. elegans database.  
 
 
Taken together, supported by comprehensive LC-MS/MS analysis and PepNovo / 
MS BLAST validation we identified proteins associated with the novel protein RSA-1 
(RSA complex). Further experiments allowed Annelore to discover and characterize a 
new regulatory pathway in C. elegans spindle assembly [5]. 
 
2.2.6.3 Validation by PepNovo/MS BLAST: what was achieved? 
          Performed studies demonstrated that combination of de novo sequencing by 
PepNovo and MS BLAST searches efficiently complements the conventional (based on 
database searching) protein identification routine. This method provides an independent 
means of automated validation of hits with borderline statistical confidence and 
substantially helps to reduce the rates of both false-positive and false-negative 
identifications. 
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3 CONCLUSION AND PERSPECTIVES 
Bottom-up proteomics includes four important steps: 1) protein digestion, 2) 
peptide separation, 3) peptide fragmentation, and 4) data analysis.  
Protein digestion is the most important step, in which proteins are cleaved in 
peptides of suitable size for mass spectrometric analysis. To address efficiency and 
completeness of in-gel digestion thermostable trypsin conjugates, obtained by 
modification of conventional bovine trypsin with oligosaccharides, were tested in 
accelerated in-gel digestion of proteins [2]. The modification of trypsin did not 
considerably increased its molecular weight (from ~25 to 33 kDa) but significantly 
improved its thermostability (for selected MAT-BT, RAF-BT, RAFR-BT and STA-BT, 
T50 increased by about 20°C) and suppressed autolysis, without affecting its cleavage 
specifity. MALDI TOF PMF of in-gel digests obtained by trypsin conjugates showed 
less autolytic peaks in the m/z range of 700 – 2700 compared to unmodified BT, 
simplifying protein identification.  
To evaluate catalytic efficiency of trypsin conjugates in accelerated in-gel 
digestion of proteins a comprehensive kinetic study was carried out, where effect of the 
temperature, enzyme concentration and digestion time on the yield of digestion products 
was evaluated. To quantify in-gel digestion yield two different quantification 
approaches were tested and established: stable isotope labeling strategy, which employs 
18O-labeled peptide internal standards and is based on MALDI TOF analysis as well as 
label-free quantification approach, which utilizes mass spectral peak intensities of 
peptide ions from nanoLC-MS/MS data. Both quantification studies provided consistent 
results and demonstrated that the initially set goal to shorten sample preparation time 
and to improve recovery of conventional in-gel digestion is not realizable using 
glycosylated trypsins. Thus, at the best 60 to 70% of conventional digestion yield could 
be reached by in-gel digestion of proteins using trypsin conjugates (MAT-BT, RAF-BT 
and RAFR-BT) at accelerated conditions.  
The obtained results suggested that one of the major factors responsible for the 
reduced in-gel digestion efficiency of the tested trypsin conjugates is their bulky 
structure (caused by the attached sugar chains), which significantly decreases their 
diffusion mobility in polyacrylamide gel matrix.  
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Therefore it seems to be reasonable to test glycosylated trypsins in gel-free 
shotgun proteomics, which relies on direct digestion of proteins in-solution. Current in-
solution digestion of proteins is time-consuming and partially not efficient, especially 
when working with complex protein mixtures or hydrophobic and membrane proteins. 
Several additives such as surfactants, organic solvents, and urea are commonly used to 
denaturate proteins and to improve their solubility. However, such denaturants reduce 
the proteolytic activity of enzymes, setting an upper limit on applicable concentration 
and are often not compatible with mass spectrometry and liquid chromatography, 
requiring sample cleanup prior to LC or LC-MS/MS. The concentration limit of a 
denaturant is often below its desirable amount to fully denature and solubilise proteins 
in complex mixtures. This problem can be addressed by chemically modified trypsin 
conjugates, which have been reported to show noticeable resistance to denaturants such 
as urea, SDS and organic solvents [138, 141]. Therefore as next, the resistance of 
glycosylated trypsins to different denaturants should be tested in in-solution digestion of 
proteins at accelerated temperature, which also promotes denaturing conditions. These 
thermostable and autolysis resistant enzymes might find their use in analysis of complex 
protein mixtures, including hydrophobic proteins such as integral and transmembrane 
proteins, which have been a big challenge in proteomics since high concentrations of 
strong denaturants are required to solubilise them. 
The next important proteomic problem addressed in the presented work concerns 
the reliability of protein identification based on database searching, pointing out 
problem of unrecognized false positives and borderline hits.  
A validation method was developed and established [3], which employs database 
independent interpretation of the acquired tandem mass spectra by de novo sequencing 
software PepNovo combined with mass-spectrometry driven BLAST (MS BLAST) 
sequence similarity searching, which utilizes redundant, degenerate and partially 
accurate peptide sequence candidates and employs an independent scoring scheme to 
evaluate the confidence of database searching hits [220].  
This validation approach was applied in a collaborating project, which aimed to 
prove in vivo interaction between C. elegans proteins TPXL-1 and AIR-1 and determine 
other possible interaction partners of the uncharacterized protein TPXL-1 [4]. NanoLC-
MS/MS analysis of 10 in-gel digests of Coomassie-stained protein bands identified, in 
total, more than 290 proteins of varying abundance, among them 164 hits (56%) were of 
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borderline confidence. Using a combination of MASCOT and PepNovo/MS BLAST 
searches, the assignment of more than 70% of borderline hits could be independently 
confirmed or rejected without manual inspection of raw MS/MS spectra. PepNovo/MS 
BLAST was further applied in another collaborating projects to validate borderline hits 
obtained by identification of proteins associated with the novel C. elegans  protein 
RSA-1 (RSA complex) [5]. 
The presented study demonstrated that a combination of MASCOT software, de 
novo sequencing software PepNovo and MS BLAST, bundled by a simple scripted 
interface, enabled rapid and efficient validation of a large number of borderline hits, 
produced by matching of one or two MS/MS spectra with marginal statistical 
significance. 
However, the method performance was inherently limited by the ability of de 
novo sequencing software to produce meaningful sequence candidates from tandem 
mass spectra with either insufficient fragment representation, or having too complex 
fragment patterns. Thus, it seems promising to employ simultaneously several 
independent peptide fragmentation methods within the same nanoLC-MS/MS 
experiment, which might increase the accuracy of de novo sequencing without 
compromising the analysis throughput and, presumably, sensitivity [180]. 
 
 
 
 
 
 
 
.  
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4 MATERIALS AND METHODS 
4.1 Thermostable trypsin conjugates 
4.1.1 Synthesis and bioanalytical characterization 
Glycosylation of bovine trypsin and bioanalytical characterization of the obtained 
trypsin derivates was performed by Prof. Dr. Marek Šebela from Department of 
Biochemistry, Palacky University (Olomouc, Czech Republic) as described [1]. Trypsin 
glycosylation by disaccharides lactose, maltose and mellibiose was partially based on 
the protocol of Vaňková et al. [307]. Whereas modification of trypsin by trisaccharides 
maltotriose and raffinose, tetrasaccharide stachyose as well as α-/ β-cyclodextrines was 
based on the protocol of Morand and Biellmann [308]. Glycosylation of bovine trypsin 
was achieved by coupling oligosaccharides to its lysine residues. In addition, free 
argenyl residues in raffinose modified trypsin (RAF-BT) were optionally reacted with 
biacetyl [309], yielding an RAFR-BT with modified arginine residues.  
Glycosylated enzymes were purified by ion exchange chromatography and 
dialyzed against 20 mM sodium acetate, pH 4.0 or 0.1% formic acid, concentrated by 
ultrafiltration, lyophilized and stored at –80 °C.  
Trypsin activity was determined using a chromogenic substrate Nα-benzoyl-DL-
arginine-4-nitroanilide (BAPNA) as described [2].  
Thermostability of trypsin and its conjugates was evaluated by monitoring the 
changes in their activity upon incubating enzyme aliquots in 20 mM sodium acetate 
buffer, pH 4.0 at 37 °C, 45°C, 55°C, 65°C and 75°C for 30 min.  
Protein content was determined using a modified Lowry method [310].  
Total carbohydrates were determined by the phenol-sulfuric acid method [311].  
Primary amino groups were estimated by TNBS-reagent (2,4,6-
trinitrobenzenesulfonic acid) [312].  
For all obtained trypsin conjugates pI were determined according to the following 
protocol [313].  
Molecular masses of modified trypsin conjugates were determined by tricine-
SDS-PAGE according to Schägger et al.[314] and by MALDI-TOF MS.  
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4.1.2 Study of in-gel digestion kinetics using 18O labeled peptides  
4.1.2.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) and 
were of analytical grade, unless otherwise noted. Concentrations of stock solutions of 
the standard proteins BSA, Aldolase, Myoglobin, and Cytochrom C as well as of the 
applied enzymes (glycosylated trypsin conjugates, methylated porcine trypsin and 
unmodified bovine trypsin) were determined by amino acid analysis performed in the 
laboratory of Dr. P. Hunziker at the University of Zürich. Isotopically enriched water 
(95% H218O) used for preparation of internal peptide standards was from Sigma-
Aldrich Chemie (Steinheim, Germany). Modified porcine trypsin was purchased from 
Promega (Mannheim, Germany), unmodified bovine trypsin from Roche Diagnostics 
(Basel, Switzerland). Dithiothreitol (DTT) and iodoacetamide (IAA) were obtained 
from Merck (Darmstadt, Germany). 1-Cyano-4-hydroxycinnamic acid (CHCA) was 
from Bruker Daltonik (Bremen, Germany).  
 
4.1.2.2 Concept of the method 
1.    Gel bands containing 5 pmol of standard protein (BSA) were digested under tested 
conditions. Obtained peptides were extracted from the gel matrix and solvent was 
evaporated. For each quantification experiment at least three samples were prepared in 
parallel. 
2.    18O-labeled internal standards were obtained by digestion of the same standard 
protein (BSA) with known amount (0.3 pmol/μL) in a buffer containing H218O (95%), 
rendering tryptic peptides labeled with one or two 18O atoms at their C-termini. Since 
yield of in-solution digestion is close to 100%, the protein concentration is directly 
proportional to the average concentration of individual tryptic peptides in the digest. 
3.    Tryptic peptides from in-gel digests were redissolved in 10 μL of internal standard 
and analyzed by MALDI TOF MS.  
4.    The yield of an individual peptide was calculated from the amount of the internal 
18O-labeled standard and the ratio of the area of the monoisotopic peak of the unlabeled 
peptide and of the sum of deconvoluted areas of monoisotopic peaks of singly and 
doubly 18O-labeled forms of the internal standard. 
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4.1.2.3 Gel electrophoresis  
One-dimensional SDS-polyacrylamide gel electrophoresis was performed as 
described [314] on the Bio-Rad Mini-Protean II system (Bio-Rad, Hercules, USA) using 
10 and 12% polyacrylamide gels. Aliquots (5 pmol) of a standard protein (BSA, 
Aldolase, Myoglobin and Cytochrom C) were loaded onto each lane of the 7 x 10 cm 
minigel. Electrophoresis was conducted at a constant voltage of 150 V. After 
electrophoresis, protein bands were visualized by staining with Coomassie Brilliant 
Blue R-250 (Serva, Heidelberg, Germany). The bands were excised from the gel slab, 
cut into pieces, and put into 0.65-mL PCR microtubes.  
 
4.1.2.4 In-gel digestion  
Conventional digestion protocol (CDP) by unmodified trypsin. The digestion 
was carried out as described [137]. Proteins were in-gel reduced by 10mM dithiothreitol 
and alkylated by 55mM iodoacetamide. Destained, washed, dehydrated gel pieces were 
rehydrated for 60 minutes in ~0.5 μM solution of unmodified bovine trypsin in 25 mM 
ammonium bicarbonate buffer at 4°C and then digested overnight at 37°C. 
Accelerated digestion protocol (ADP) by saccharide modified trypsin 
conjugates. To establish optimal conditions for accelerated in-gel digestion of proteins 
by glycosylated trypsin conjugates, the effect of enzyme concentration, digestion time 
and digestion temperature on the yield of digestion products was evaluated [2]. After 
the reduction/alkylation step dried gel pieces were rehydrated with trypsin conjugates at 
4°C for 60 min; the enzyme concentration ranged from 0.5 to 3 μM in 25 mM 
ammonium bicarbonate. The digestion was performed at 55°C and 65°C for 30, 90 and 
180 min.  
Extraction of peptides. Peptides from the gel pieces were finally extracted with 5 
% formic acid and acetonitrile as described [137] and the extracts were dried down in a 
vacuum centrifuge.  
 
4.1.2.5 18O-labeled internal standards for quantification 
9 μM BSA solution in 25 mM ammonium bicarbonate buffer in H218O (95%) was 
digested overnight at 37°C by unmodified bovine trypsin at an enzyme/substrate ratio 
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1:10 (w/w). The obtained stock solution of 18O-labeled BSA peptides was diluted 30 
times with H218O (95%) to get 0.3 μM internal standard. Tryptic peptides from in-gel 
digests were redissolved in 10 μL of internal standard and analyzed by MALDI TOF. 
 
4.1.2.6 MALDI analysis 
All experiments were performed using MALDI TOF instrument Reflex IV 
(Bruker Daltonik, Bremen, Germany), equipped with Scout 384 ion source. Spectra 
were processed by Xmass 5.1.1 and BioTools 2.1software (Bruker Daltonik). Proteins 
were identified using MASCOT software (version 2.1, Matrix Science, London, UK) 
installed on a local server; database searches were performed against a non-redundant 
protein database MSDB downloaded from the European Bioinformatics Institute (EBI). 
A 1.2 μL aliquot of the sample was withdrawn onto the AnchorChip 600/384 
target. 0.6 μL of the matrix solution (2 mg/ml 1-cyano-4-hydroxycinnamic acid in 2.5 % 
trifluoroacetic/acetonitrile, 1:2 v/v) was spiked directly into the analyte droplet. The 
mixture was allowed to dry down at room temperature, and the target was washed in 5% 
formic acid [292]. Each experiment was repeated 3 to 5 times; at least 3 samples were 
prepared for each experiment. Typically about 300 laser pulses per spectrum were 
accumulated and smoothed by Savitzky-Golay filter. 
 
4.1.2.7 Deconvolution of isotopic clusters of 18O-labeled peptides 
Since the profile of the isotopic cluster contains singly and doubly O18-labeled 
peptides a deconvolution method was applied, which uses the isotopic ratios calculated 
from the peptide composition. The amount of an individual (non-labeled) peptide (n16) 
was calculated according equation 7:  
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where n18 the amount of internal standard; 1A1 is the monoisotopic peak area of 
the unlabeled peptide; *3A1, *2A1 are the peak areas of the first isotopic peaks of 18O 
single labeled and double labeled peptides (spaced from the monoisotopic peak of the 
unlabeled peptide by 2 and 4 Da, respectively). The theoretic isotopic distributions for 
all peptides used in quantification experiments were calculated using PeptideProspector 
4.0.4 (Univ. of California, http://prospector.ucsf.edu), presuming that the differences in 
isotopic distribution ratios for 18O-labeled and unlabeled peptide are negligible.  
Coefficients f3 and f5 are the calculated ratios of the intensity of, respectively, third (+2 
Da) and fifth (+4 Da) isotopic peaks to the intensity of the monoisotopic peak of the 
unlabeled peptide. 
Equation 7 can be simplified to equation 8, when quantification is performed 
using arginine terminated peptides, which incorporate more than 90 % of 18O in double-
labeled form. 
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(Equation 8) 
 
In the performed kinetic study the yield of the following three Arg-containing 
peptides was determined: YLYEIAR, m/z 927.49; LGEYGFQNALIVR, m/z 1479.79; 
and DAFLGSFLYEYSR m/z 1567.74. The yield of digestion was calculated by 
averaging the amount of these peptides measured in at least 3, parallel runs. 
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4.1.3 Study of digestion kinetics using label-free quantification approach  
4.1.3.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) and 
were of analytical grade, unless otherwise noted. Solvents for liquid chromatography 
were of Lichrosolv grade. Formic acid and trifluoroacetic acid (TFA) were purchased 
from Merck (Darmstadt, Germany). Modified porcine trypsin was purchased from 
Promega (Mannheim, Germany), unmodified bovine trypsin from Roche Diagnostics 
(Basel, Switzerland). Dithiothreitol (DTT) and iodoacetamide (IAA) were obtained 
from Merck (Darmstadt, Germany). Concentrations of stock solutions of the applied 
standard proteins (BSA, myosin, b-galactosidase, alcohol dehydrogenase, and 
myoglobin) as well as of the applied enzymes (glycosylated trypsin conjugates, 
methylated porcine trypsin and unmodified bovine trypsin) were determined by amino 
acid analysis performed in the laboratory of Dr. P. Hunziker at the University of 
Zürich. 
 
4.1.3.2 Concept of the method 
1.    Gel bands containing 1 pmol BSA were digested under tested conditions, obtained 
peptides were extracted from the gel matrix and solvent was evaporated (as described in 
chapter 4.1.2). For each quantification experiment 3 samples were prepared in parallel. 
2.    Peptide mixture was redissolved in 10 μl of 0.05% TFA and 2 μl of the solution 
were subjected to nanoLC-MS/MS analysis. Each analysis was repeated three times to 
get better statistic of the measurements. 
3.    Proteolytic peptides were identified by correlating their fragmentation spectra with 
peptide sequences from MASCOT database. 
4.    For peptides subjected to quantification peak intensity areas were calculated by 
generating extracted ion chromatograms from the full scan mass spectra within a narrow 
m/z range, corresponding to different charge states of the peptides. To determine correct 
retention times of the quantified peptides scan numbers of the corresponding MS/MS 
spectra were used. 
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5.    To quantify tryptic peptides produced by in-gel digestion of BSA in the kinetic 
experiments calibrating curves of the corresponding peptides were generated from in-
solution digest of the same protein with known concentration. 7 aliquots of BSA in-
solution digest containing protein amounts from 12 to 740 fmol (obtained in serial 
dilutions) were analyzed by nanoLC-MS/MS. Each analysis was repeated 3 times to 
ensure better statistic of the measurements. Regression lines were generated for each 
peptide subjected to quantification. The yield of digestion was calculated by averaging 
the amounts of the quantified peptides. 
 
4.1.3.3 Redaction, alkylation and digestion of protein stock solutions  
Stock solutions of the used standard proteins were prepared in 25 mM ammonium 
bicarbonate buffer at concentrations ranging from 50 to 200 µM. The obtained stock 
solutions were diluted down to the concentration of 10 µM and submitted to amino acid 
analysis in the laboratory of Dr. P. Hunziker at the University of Zürich, in order to 
determine their accurate protein concentration. Further each protein solution was 
reduced by adding dithiothreitol (DTT) to a final concentration of DTT ~ 1.5 mM and 
incubated for 30 min at 37°C. To alkulate the protein iodoacetamide (IAA) was added 
to the protein solution to a final concentration of ~ 3 mM and the mixture was incubated 
at the room temperature in the dark. The reduced and alkylated proteins were digested 
by addition of trypsin at the ratio of 1:50. The mixture was incubated for ca. 10 hours at 
37°C. Several aliquots containing 10 µL of each digest were withdrawn and put into 
HPLC vials; the solvent was evaporated in a vacuum centrifuge and the peptide mixture 
was stored at -20°C. 
 
4.1.3.4 NanoLC- MS/MS analysis  
Aliquots of sample digests dissolved in 0.05% TFA were injected into a nanoLC-
MS/MS Ultimate system (Dionex, Amsterdam, The Netherlands) interfaced on-line to a 
linear ion trap LTQ (ThermoElectron Corp., San Jose, CA). Peptides were first loaded 
onto a 1 mm × 300 µm i.d. trapping microcolumn packed with C18 PepMAP100 5µm 
particles (Dionex) in 0.05% TFA at the flow rate of 20µL/min. After a 4 min wash, they 
were back-flush-eluted and separated on a 15 cm × 75 µm i.d. nanocolumn packed with 
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C18 PepMAP100 3 µm particles (Dionex) at the flow rate of 200 nL/min using the 
following mobile phase gradient: from 5 to 20% of solvent B in 20 min, 20-50% B in 16 
min, 50-100% B in 5 min, 100% B during 10 min, and back to 5% B in 5 min. Solvent 
A was 95:5 H2O/acetonitrile (v/v) with 0.1% formic acid; solvent B was 20:80 
H2O/acetonitrile (v/v) with 0.1% formic acid. Peptides were eluted into the mass 
spectrometer via a dynamic nanospray probe (Thermo Electron Corp.). A silicatip 
uncoated needle (20 µm i.d., 10 µm tip ID) (New Objective, Woburn, MA) was used 
with a spray voltage of 1.8 kV, and the transfer capillary temperature was set at 200°C. 
Data-dependent acquisition was controlled by Xcalibur 1.4 software (ThermoElectron 
Corp.). The acquisition cycle consisted of a survey scan covering the range of m/z 350-
1500 followed by MS/MS fragmentation of the three most intense precursor ions under 
the relative collision energy of 35%, triggered by a minimum signal threshold of 500 
counts with the isolation width of 4.0 amu. Spectra were acquired under automated gain 
control (AGC) in three microscans for survey spectra and for MS/MS spectra, with 
maximal ion injection time of 100 ms. The m/z of fragmented precursor ions were 
dynamically excluded for a further 60 s, but otherwise no pre-defined exclusion lists 
were applied. Spectra were exported as dta files using BioWorks 3.1 software (Thermo 
Electron Corp.) under the following settings: peptide mass range, 500-3500; minimum 
total ion intensity threshold, 1000; minimum number of fragment ions, 15; precursor 
mass tolerance, 1.4 amu; group scan, 1; minimum group count, 1. 
 
4.1.3.5 MASCOT database searches 
Tandem mass spectra were searched against an MSDB database (updated May 15, 
2005; contains 2 011 425 protein sequence entries) by MASCOT v. 2.1 software 
(Matrix Science, London, UK) installed on a local 2 CPU server. Mass tolerance for 
precursor and fragment ions was 2.0 and 0.5 Da, respectively. Other search parameters 
were: instrument profile, ESI-Trap; fixed modification, carbamidomethyl (cysteine); 
variable modification, oxidation (methionine). 
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4.1.3.6 Peak extraction 
Peptide ion intensities were calculated using extracted ion chromatograms (XICs), 
which were generated from the full scan mass spectra within a narrow m/z range, 
corresponding to different charge states of the analyzed peptide (triple, double, and 
single). Differently charged ions of each analyzed peptide were extracted from the full 
scan mass spectra using a lower limit of m/z = ((peptide monoisotopic mass – 1) + 
charge)/charge and upper limit of m/z = ((peptide monoisotopic mass + 2) + 
charge)/charge. The ion intensity of a peptide was subsequently calculated by summing 
peak areas of its triple, double, and single charged ions. XICs were generated using 
Xcalibur1.4 software (ThermoElectron Corp., San Jose, CA), which offers peak finding, 
peak smoothing, and integration functions. To enable correct peak finding scan numbers 
of the corresponding MS/MS spectra (confidently identified by MASCOT search) were 
used.  
 
4.1.3.7 Quantification of in-gel digestion products  
To quantify tryptic peptides obtained by in-gel digestion of BSA in the performed 
kinetic study calibrating curves of the corresponding peptides from in-solution digest of 
the same standard protein were generated. To this end a 740 μM stock solution of BSA 
was digested as described in chapter 4.1.3.3. 10 µL of this stock solution were 
withdrawn and put into HPLC vial, the solvent was evaporated in the vacuum centrifuge 
and the peptide mixture was redissolved in 100 μl of 0.05% TFA. The obtained solution 
was used to prepare a dilution series including 7 mixtures. 2 μl aliquots of these 
mixtures containing 12, 23, 46, 93, 185, 370, and 740 fmol of BSA were subjected to 
nanoLC-MS/MS analysis. Each measurement was repeated three times to ensure better 
statistic of the acquisition. Subsequently regression lines for each subjected to 
quantification peptide were generated. 
The concentrations of six tryptic peptides, AEFVEVTK (M = 921.48), YLYEIAR 
(M = 926.49), KQTALVELLK (M = 1141.71), LVNELTEFAK (M = 1162.62), 
HLVDEPQNLIK (M = 1304.71), and KVPQVSTPTLVEVSR (M = 1638.93), were 
determined for each kinetic experiment, and the results were averaged.  
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4.2 Validation of protein identifications with borderline statistical 
confidence 
4.2.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) and 
were of analytical grade, unless otherwise noted. Solvents for liquid chromatography 
were of Lichrosolv grade; formic and trifluoroacetic acids were purchased from Merck 
(Darmstadt, Germany). 
 
4.2.2 Protein datasets 
Proteins were isolated from Caenorhabditis elegans worms in two collaboration 
projects with Prof. A. Hyman's laboratory (MPI-CBG, Dresden) and purified by affinity 
chromatography as described [4], [5]. Purified proteins were then separated by one-
dimensional SDS-polyacrylamide gel electrophoresis; protein bands were visualized by 
Coomassie Brilliant Blue R250 staining and excised from the gel matrix. The excised 
bands were in-gel-digested with trypsin[137]. Tryptic peptides, recovered from the gel 
pieces by extraction with 5% formic acid and acetonitrile, were dried in a vacuum 
centrifuge and stored at -20°C until analyzed. 
 
4.2.3 NanoLC-MS/MS analysis 
Nano LC-MS/MS analysis was carried out as previously described in chapter 
4.1.3.4 only with a difference that MS/MS fragmentation was performed on five most 
intense precursor ions and spectra were acquired (under AGC) in one microscan for 
survey spectra and three microscans for MS/MS spectra. 
 
4.2.4 MASCOT database searches  
Tandem mass spectra were searched against an MSDB database (updated May 15, 
2005; contains 2 011 425 protein sequence entries) by MASCOT v. 2.1 software 
(Matrix Science, London, UK) installed on a local 2 CPU server. Mass tolerance for 
precursor and fragment ions was 2.0 and 0.5 Da, respectively. Other search parameter 
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were: instrument profile, ESI-Trap; fixed modification, carbamidomethyl (cysteine); 
variable modification, oxidation (methionine). Where specified, searches were 
performed against a subset of C. elegans proteins that comprised 30 304 protein 
sequence entries. Hits were regarded as confident if more than three peptides were 
matched by MASCOT search with ions scores above the confidence threshold for a 
species-specific database (36 for C. elegans protein database), or at least one score was 
above the threshold for a comprehensive database (53 for MSDB). Hits were regarded 
as borderline if MASCOT matched less than four peptides and the ion score of at least 
one peptide was within the range of ±30% of the threshold score (from 26 to 46 for C. 
elegans).  
 
4.2.5 De Novo peptide sequencing and MS BLAST searches 
Where specified, files in dta format were converted into MASCOT generic format 
(mgf) and sequenced de novo by a modified version of PepNovo software [179] 
installed on a desktop (Pentium IV) PC. A single MS/MS spectrum was typically 
interpreted de novo in less than 0.5 s, and up to seven partially redundant candidate 
sequences were produced. To each interpreted spectrum, PepNovo assigned a quality 
score, which stands for the expected number of confidently determined amino acid 
residues in the most accurate sequence proposal. This score was derived from the sum 
of the probabilities of the individual amino acids being correct, which were computed 
using a logistic regression model [315]. Candidate sequences were then edited 
according to MS BLAST conventions and merged into a single search string in arbitrary 
order [220, 224, 225]. MS BLAST searches were performed against nr database at 
http://genetics.bwh.harvard.edu/msblast/ under the following settings: Scoring Table, 
99; Filter, none; Expect, 1000. Statistical significance of hits was evaluated according to 
MS BLAST scoring scheme [225]. A typical search with a query of seven candidate 
sequences required less than 15 s to complete. 
 
4.2.6 PepNovo/MS BLAST validation performance  
The entire procedure was performed using script written by Henrik Thomas. A 
simulation dataset was built out of 100 high-quality peptide spectra, each represented by 
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a single dta file. Upon MASCOT database search, each spectrum unequivocally hit a 
single peptide sequence of, on average, 12 amino acid residues with the ions scores 
above 70. In each spectrum, peaks with relative intensities below 1% of the base peak 
intensity were declared noise, and their absolute intensity was left unchanged, whereas a 
dedicated script reduced the absolute intensity of other peaks with the step of 1% and, 
hence, produced the series of 100 spectra with the gradually altered signal-to-noise 
ratios. Their dta files were merged into a single mgf file and submitted to MASCOT 
search, and ions scores of spectra matched to the correct database peptide sequence 
were registered. In parallel, the same mgf file was sequenced de novo by the PepNovo 
program in a batch mode, recording up to seven sequence candidates for each 
interpreted spectrum. PepNovo scores of predicted sequences were registered, and 
sequences were merged into query strings and submitted to MS BLAST searches. The 
outcome of MS BLAST searches was sorted into three groups as follows: where MS 
BLAST produced a hit that was also confident according to MS BLAST scoring scheme 
(first group); where the target peptide was listed in the output of the MS BLAST search 
as a borderline or nonconfident hit (second group); or where the target protein was not 
hit by MS BLAST at all (third group). In each series, I aimed to identify (if possible) the 
two spectra with the lowest signal-to-noise ratios that belonged to the first and second 
groups and registered their ions scores (MASCOT), sequence quality scores (PepNovo), 
and MS BLAST scores (solely for the reference). The same simulation routine was 
applied to all 100 high-quality spectra from the initial dataset.  
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